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Abstract
Animal studies suggest that nitric oxide, a free radical derived from L-arginine by the 
action of nitric oxide synthase (NOS), is a fundamental mediator in the initiation of 
labour. The studies reported in this thesis have investigated the involvement of the L- 
arginine-nitiic oxide system in the maintenance of myométrial quiescence and the 
initiation of parturition in human pregnancy. Further, the effects of nitric oxide donors 
on the pregnant human cervix have been determined.
The studies reported in chapter 2, were performed to detenmine whether a decrease in 
NOS enzyme activity and expression aie involved in the final activation of spontaneous 
labour at term. Using immunocytochemistry, each of the three isoforms of NOS was 
localised in myometrium, placenta and fetal membranes collected before and during 
labour at term. NOS enzyme activity in each of these tissues was determined by 
measuring the conversion of radiolabelled L-arginine to L-citrulline. There were no 
differences in either the expression or enzyme activity of NOS within each tissue 
following the onset of labour indicating that a decrease in NOS enzyme activity is not 
involved in the final activation of labour at term in the human.
The enzymes superoxide dismutase (SOD) and xanthine oxidase (XO) are known to 
prolong and attenuate respectively, the biological activity of nitric oxide. Studies, 
presented in chapter 3, were therefore undertaken to determine whether changes in the 
uterine expression of these enzymes are associated with the onset of human parturition.
Both SOD and XO were shown to be widely expressed within the pregnant uterus, 
although there was no difference in their expression in tissues collected before, 
compared with after the onset of labour. These data suggest that SOD and XO may be 
important in maintaining uterine quiescence in pregnancy, but that a change in the I
expression of these enzymes is not involved in the initiation of labour.
In chapter 4, the expression of the constitutive isoforms of NOS, eNOS and bNOS, 
was investigated in the non-pregnant uterus, the preterm pregnant uterus and the teim 
pregnant uterus to determine whether these isoforms ai'e up-regulated in the uterus 
during pregnancy. Using immunocytochemistry and Western blotting, eNOS and 
bNOS protein concentrations were greater in preterm, pregnant myometrium than non­
pregnant myometrium, (p<0.01 and p<0.05, respectively). eNOS, but not bNOS, 
protein concentration was lower (p<0.05), in myométrial samples obtained at term 
compared with those obtained preterm. These data indicate that the constitutive 
isoforms of NOS are upregulated in human pregnancy and may play a role in 
maintenance of myométrial quiescence.
Concurrent histological studies on tissues obtained before and during spontaneous 
labour, reported in chapter 5, revealed that inflammatory cells infiltrate the myometrium 
during labour. Analysis of individual cell types using immunocytochemistiy showed 
significantly more inflammatory cells, predominantly neutrophils and macrophages, in 
labouring myometrium compared to non-labouiing biopsies, (Scheffe's test, p = 
0.0001). The infiltrate was present in both lower and upper uterine segment 
myometrium, with significantly more inflammatory cells present in the lower uterine 
segment myometrium, (Scheffe's test, p < 0.02). These observations indicate that 
inflammatory cell infiltration is part of the physiological mechanisms that occur in the 
myometrium during labour.
The cervical ripening effects of nitric oxide donors, isosorbide mononitrate (IMN, 40 
mg) and glycetyl trinitiate (GTN, 500 |Lig), were determined in a prospective, 
randomised tiial involving women scheduled for surgical teimination of pregnancy in 
the first trimester. During the operative procedure, the cervical resistance was measured 
objectively using a force sensing appaiatus. The data, presented in chapter 6, showed 
that both IMN and GTN significantly reduced the cervical resistance, compared with no 
treatment (p<0.006 and p<0.05, respectively). A further randomised trial involving 66
primigravid women was performed to compare the side effect profile of IMN in 
comparison with the prostaglandin analogue gemeprost. Significantly more women 
remained asymptomatic following IMN (64%) than following gemeprost (14%). 
Pretreatment with gemeprost resulted in abdominal pain in 73% of women and vaginal 
bleeding in 32%, compared with 3% and 0% respectively following IMN. These data, 
reported in chapter 7, suggest that nitiic oxide donors may have advantages over the 
prostaglandins for cervical ripening.
In summary, an up-regulation of NOS expression in myometrium during pregnancy 
suggests an involvement of the L-arginine-nitric oxide system in the maintenance of y
myométrial quiescence. A decrease in this system and in the expression of enzymes 
known to influence the bioavailability of nitric oxide, do not coincide with the onset of
::spontaneous labour at term, suggesting that a withdrawl of nitric oxide is not the final 
activating factor in the initiation of laboui' in women. This work has demonstrated that 
nitric oxide donors produce effective ripening of the human cervix in the first trimester
of human pregnancy with fewer side effects than prostaglandins. Nitric oxide donors 
represent alternative cervical ripening agents, at least in the first trimester of human
-ipregnancy.
4Chapter 1 
Literature Review 
Introduction
Every moment dies a man,
Every moment one is born.
Alfred, Lord Tennyson (1809 - 1892)
The control and timing of delivery is crucial in the survival of any species, and in most, 
the interval between conception and parturition varies little. This is not the case in 
human pregnancy, where delivery can occur many weeks before or after the expected 
date. It is recognised in women that intervention by induction of labour in pregnancies 
prolonged beyond 41 weeks' gestation reduces the likelihood of perinatal mortality 
(Grant, 1994). However, the single biggest cause of perinatal and neonatal death in the 
developed world is preterm delivery. This is defined as delivery before 37 completed 
weeks of gestation (Hall et aL, 1997). The incidence of preterm delivery is between 
5% and 10% of aU births and has remained relatively stable over the last two decades; 
approximately 13 million infants are born preterm worldwide each year (Lumley 1993; 
Villar et at., 1994). Severe neonatal morbidity, especially respiratoiy distress 
syndrome, intraventricular haemorrhage and necrotizing enterocolitis, is more common 
in preterm than in teim infants (Robertson et aL, 1992), as is long-term impairment, 
such as cerebral palsy, broncho-pulmonary dysplasia, visual impairment and healing 
loss (Knoches and Doyle, 1993).
The prevention of preterm labour remains one of the primary goals of obstetric 
reseaich. An understanding of the mechanisms underlying preterm labour in women is 
fundamentally linked to an understanding of the mechanisms of paiturition at term.
Indeed, they share a common terminal pathway of uterine contractility, cervical ripening 
and activation of the membranes. Romero et aL, (1997) propose that the fundamental 
difference between term and preterm labour is that the former results from physiological 
activation of the components of the common terminal pathway, while preterm labour 
results from disease processes activating one or more of the components of this 
pathway. At present, the factors maintaining myométrial quiescence during pregnancy, 
and those which stimulate the onset of uterine contractions and cervical ripening at term 
remain obscure. Until these factors aie elucidated, it seems unlikely that effective 
strategies for the ti'eatment of preterm labour will be found (Goldenberg and Rouse, 
1998).
Part I. 
The Factors Controlling the Onset of Parturition
Parturition is a physiological process - the same in the countess and in the cow 
W.W Chipman (1866 - 1950)
Despite major advances in molecular biology and the science of reproduction, the 
signals controlling the onset of human parturition remain elusive. The search for the 
triggering mechanism initiating human labour, which focused on oxytocin in the eaiiy 
20th century, has since included prostaglandin production, growth factors, cytokines, 
endothelins, gap junction formation and, more recently, placental corticotropin- 
releasing hormone (Kai*alis et aL, 1996) and nitric oxide withdrawal (Izumi et aL,
1993). In non-primate mammals, the end of pregnancy is associated with a fall in 
maternal progesterone concentrations (Csapo, 1977), which together with increasing 
oestradiol concentrations, activates multiple pathways, including stimulation of 
oxytocin release, oxytocin receptors, and prostaglandin synthesis, which contribute to 
the initiation of labour (Casey and MacDonald, 1988; Liggins, 1994).
It would seem reasonable that the conceptus should trigger the onset of labour when 
maturity is adequate for extra-uterine survival, and this is certainly the case in sheep. In 
sheep, fetal cortisol triggers paiturition by increasing the activity of placental enzymes, 
including 17a-hydroxylase and P450 C-17,20 lyase, that enable progesterone 
conversion to oestradiol (Flint et aL, 1975). The resultant increase in the ratio of 
oestradiol to progesterone stimulates myométrial oxytocin receptors, gap junction 
formation, prostaglandin production and maternal pituitary oxytocin release, events 
leading directly to labour and delivery (Schwartz, 1997). These same pathways are 
activated at term in human pregnancy when circulating levels of fetal plasma cortisol are 
also raised. However, the target for cortisol action in the ovine placenta, 17 a-
7hydroxylase, is absent in human placenta, and there is no consistent rise in maternal 
plasma concentrations of oestrogens or any consistent decline in progesterone 
concentrations before the onset of labour in man (Tulchinsky et aL, 1972; Flint 1979). 
Hence, if fetal cortisol is a factor controlling the onset of human paiturition, its mode of 
action must be different from that in sheep.
The onset of human paiturition is associated with an increase in the production of 
prostaglandins within the uterus. Prostaglandins are synthesised from arachidonic acid 
via the enzyme cyclo-oxygenase (COX), of which there are two isoforms. The type-1 
gene (COX-1) encodes a constitutively expressed form of the enzyme, whilst the type-2 
enzyme (COX-2) is inducible. With the onset of labour at term, there is an increase in 
COX-2 expression in the amnion and chorion-decidua (Slater et aL, 1995; Slater et aL, 
1998) and an increase in the production of prostaglandins E2 and F2 a by these tissues 
(Keirse, 1979; Mitchell, 1984; Casey and MacDonald, 1988). Prostaglandin 
production is stimulated by platelet-activating factor and various cytokines, including 
interleukin-1, interleukin-6 and tumour necrosis factor (Challis and Mitchell, 1994). 
Loss of chorionic prostaglandin dehydrogenase activity may be significant in initiating 
labour, particularly in preterm labour (Keirse, 1995), although in vitro studies have not 
found any change in prostaglandin metabolism with labour at term (Brennand et al., 
1998).
The myometrium is stimulated directly by both prostaglandins and oxytocin derived 
from the chorion-decidua (Fuchs et aL, 1984). Other myométrial stimulants, such as 
platelet-activating factor and endothelin, may also be involved in the initiation of 
myométrial contractions (Wolff a/., 1996). Simultaneously, the connective tissue of 
the cervix undergoes complex biochemical changes that lead to softening and 
distensibility. Cervical ripening has been compared to an inflammatory reaction and is 
characterised by an accumulation of leukocytes in the cervical stroma (Junqueira et aL, 
1980; Liggins, 1981; Bokstrom et aL, 1997).
The signal to this chain of events is unknown although the progesterone-withdrawal 
theoiy remains the leading hypothesis. Progesterone inhibits human myométrial 
contractions and decreases gap junction formation (Beck et al, 1978; Ambrus and Rao, 
1994). Labour is an inflammatoiy process (Kelly, 1996) and progesterone is 
recognised to be an anti-inflammatory agent (Sitteri et a l,  1977). Whilst exogenous 
progesterone does not postpone the onset of parturition in humans as it does in sheep, 
antiprogesterones activate many of the pathways involved in the onset of labour and 
induce uterine contractility and ceivical ripening (Lelaidier et a l ,  1994; Chwalisz,
1994). These observations propose a role for progesterone in the maintenance of 
pregnancy and suggest that a decline in progesterone sensitivity, or an uncoupling of 
progesterone action in late pregnancy, without an actual fall in the hormone's 
concentration, could be an important factor in the initiation of human labour. Possible 
uncoupling mechanisms include local metabolism of progesterone, progesterone 
inactivation by a specific binding protein (Westphal et a l ,  1977), by an endogenous 
antiprogesterone (Casey and MacDonald, 1993; Wilson and Parsons, 1996), or by a 
change in the number or affinity of progesterone receptors (Khan-Dawood and 
Dawood, 1984).
A role for corticotropin-releasing hormone (CRH) in the initiation of human labour has 
been proposed. CRH is a peptide hormone which was originally recognised as a 
hypothalamic releasing factor, and is now known to be secreted by placental trophoblast 
into the maternal circulation (Keelan et al., 1997). Maternal plasma CRH levels rise 
exponentially during pregnancy and elevated plasma CRH levels have been associated 
with preterm labour (Kurki et a l,  1991). The bioavailability of chculating CRH is 
known to be influenced by the CRH binding protein (CRH-BP) which binds to the 
hormone in an equimolar ratio and prevents its recognition at the CRH receptor. CRH- 
BP is present in the maternal circulation in concentrations that will block the bioactivity 
of CRH until the final three weeks before the onset of spontaneous labour (McLean et
ga l,  1995). At this time the continuing rise in plasma CRH concentrations is 
accompanied by an abrupt fall in CRH-BP concentrations in the maternal circulation and k.
amniotic fluid (Florio et a l,  1997). CRH receptors are present in the myometrium i
(Hillhouse et a l ,  1993) and fetal membranes (Petraglia et a l,  1990), and CRH 
stimulates the release of prostaglandins from human amnion and decidua in vitro (Jones 5
and Challis, 1989) and has been reported to potentiate the action of oxytocin and 
prostglandin F^a in stimulating myométrial contraction in vitro (Benedetto et a l , 1994) 
and in vivo (McLean et a l ,  1994). CRH is present in the amniotic fluid and fetal 
circulation where it is capable of stimulating the fetal pituitary-adrenal axis to increase 
fetal adrenal glucocorticoid secretion, promoting fetal organ maturation. Further, CRH
.7induces the synthesis of prostaglandins and glucocorticoids, which in turn stimulate 7
7further placental CRH secretion, creating positive feedback loops in the maternal, fetal
. ''•and amniotic compartments, which may drive the onset of labour (Challis and Hooper,
1989). I
Inflammatory mediators are recognised to play a cmcial role in uterine contractility, 
cervical ripening and activation of the fetal membranes, (Kelly 1996). Inflammatory ®
cells are known to infiltrate the cervical stroma, placenta, maternal decidua and the fetal 
membranes during parturition, and may play a role in spontaneous rupture of the 
membranes (Halgunset ef aZ., 1994, Rosenberg et a l,  1996). There are, however, no 
reports of inflammatory cells infiltrating the myometrium during parturition. In Chapter |
5 of this thesis, the results of a study to determine whether inflammatory cells infiltrate 
the uterine myometrium, are reported.
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Part II. 
The Physiology of Uterine Contractility
The uterus is spontaneously active, and using electromyographic measurements, 
contractile activity can be detected in both pregnant and non-pregnant women 
(Morrison, 1996). Two different types of electromyographic activity have been 
described in the uterine myometiium of the pregnant rhesus monkey, referred to as 
contractures and contractions, and are believed to be present in most species 
(Nathanielsz et a l,  1992). Contractures represent low amplitude, long-acting uterine 
activity which commence early in pregnancy; in women these were first observed by 
Braxton Hicks in 1873, and are still known by his name. Contiactions are high 
amplitude and of short duration, and are characterized by nocturnal or labour uterine 
activity (Nathanielsz et a l,  1992). The level of activity in the utems throughout 
pregnancy is regarded as relatively low, compared with that measured both during 
labour and the immediate puerperium, when strong contractions occur to expel the fetus 
and placenta, and then maintain haemostasis.
Organisation of myométrial smooth muscle
The myometiium is composed of interlacing bundles of long, spindle-shaped smooth 
muscle fibres arranged in ill-defined layers. The myométrial smooth muscle cells aie 
surrounded by extracellular material composed of collagen fibres, fibroblasts and bone 
maiTow derived cells (Garfield and Yallampalli, 1994). During pregnancy, the 
myometrium grows diamatically due to hypertrophy and an increase in the number of 
smooth muscle cells by division, (Carsten, 1968). The myométrial cells communicate 
with one another through intercellular channels called gap junctions, which were first 
observed in myométrial cells in rats just prior to and during parturition (Garfield et a l , 
1977) . Gap junctions consist of channels which connect the interiors of two cells.
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The channels are composed of proteins, teimed connexins, which span the plasma 
membranes to form a pore. They provide a low-resistance pathway between individual 
myométrial smooth muscle cells and allow the passage of inorganic ions and small 
molecules (Cole et a l,  1988). The number of gap junctions increases in the 
myometrium at the time of labour in most if not all species. They are under hormonal 
control, with progesterone inhibiting, and oestradiol stimulating their formation. In 
addition prostaglandins regulate gap junction formation and function (Garfield, 1994).
Unlike striated muscle, the actin and myosin filaments of myometrium are not organised 
into fibres and fibrils, but instead occur in random bundles throughout the myocyte 
(Somlyo, 1980; Garfield, 1984). However, like skeletal muscle, myometiial 
contiactions occur from a sliding of actin and myosin filaments, without any change in 
the length of either filament (Huxley, 1971). A rise in intracellular* calcium (Ca^+) 
promotes the binding of calcium to calmodulin. Calcium-calmodulin activates myosin 
light chain kinase (MLCK) which itself phosphoiylates myosin. The phosphorylated 
myosin filaments bind to actin, and contraction occurs with the hydrolysis of ATP.
Electrical activity
The myometiial smooth muscle cells are spontaneously active, such that isolated strips 
of pregnant or non-pregnant uterus will produce regular spontaneous contractions. 
These spontaneous contractions are preceeded by action potentials. Myométrial cells 
have a negative resting membrane potential of approximately -50 mV (Inoue et a l ,
1990). Changes in the myométrial membrane potential occurring from ion flow across 
the membrane, aie fundamental to the control of uterine activity, (Wray, 1993). When 
the magnitude of this potential is reduced beyond a certain threshold, an action potential 
may be stimulated. The basis of this myogenic mechanism is the spontaneous 
depolarisation of pacemaker cells within the myometrium. Unlike cardiac muscle, the
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pacemaker cells in the myometrium are not anatomically fixed or defined and it is 
unclear why some cells or groups of cells should become pacemakers.
Calcium and uterine contractions
An increase in intracellulai* calcium is essential for uterine contiactility. In the resting 
state, intracellular calcium is maintained at a concentration of about lO"'^  M which 
increases to 10"  ^ M during contraction, (Thornton and Gillespie, 1992). The 
extracellulai' calcium concentration is 10 3 M. Intracellular Ca^+ can be increased by 
several mechanisms, and different agents aie thought to operate via different routes. 
Voltage-dependent and receptor-operated calcium channels are two important 
mechanisms (Hurwitz, 1986). When the membrane is depolarised to an appropriate 
level, voltage-dependent calcium channels convert to an activated or open state, thus 
allowing a substantial calcium influx into the cell. Receptor-operated calcium channels 
are opened in response to activating ligands, such as hormones or neuroti'ansmitters, 
which bind to specific receptors associated with the channel. Calcium may be released 
into the cytoplasm from stores within the cell. The sarcoplasmic reticulum represents 
the major intracellulai* store for calcium and in the myometrium it is well developed, 
though less well so than in skeletal and cardiac muscles (Gaifield and Somlyo, 1985; 
Somlyo et al., 1985). Inositol 1,4,5-trisphosphate (Cai'sten and Miller, 1985) or an 
increase in intracellular calcium itself, can stimulate the release of calcium from the 
sarcoplasmic reticulum.
Relaxation occurs with the dephosphorylation of myosin light chains by a phosphatase. 
Further, cell repolarisation results in a lowering of intracellulai’ calcium by extrusion 
across the sarcolemma and uptake into the internal stores, thus activating the calcium- 
calmodulin MLCK complex.
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Control of myométrial function
(i) Neuronal modulation
It has been recognised for more than a century that the uterus receives an extensive 
autonomic innervation (Krantz, 1959), yet the contribution of neuronal modulation of 
uterine activity has been less well characterised than the hormonal factors involved. 
Myométrial smooth muscle cells possess all four main types of adrenergic receptors, 
(oci, Œ2 , Pi and P2 ), (Bottaii et al, 1985). It has been postulated that ai-receptors 
mediate contiaction and p2 -receptors are predominantly responsible for relaxation 
(Bulbring and Tomito, 1987). The a 2 -receptors seem to have no contractile action 
(Hoffman e ta l ,  1981). Both Pi- and p2 -receptors are coupled to adenylate cyclase via 
an intermediate G-protein (Gg). Activation of adenylate cyclase results in an increase in 
cAMP which activates cAMP-dependent kinase. This in turn leads to a reduction in 
phosphorylation of myosin light chains and relaxation. Other mechanisms whereby 
cAMP may result in relaxation include calcium sequestration and efflux of calcium 
through the cell membrane (Diamond, 1990; Thornton and Gillespie, 1992). The a- 
adrenoceptor is coupled to adenylate cyclase by an inhibitory G-protein (Gi). This G{ 
may directly reduce adenylate cyclase activity or may prevent stimulation of the enzyme 
by Gg.
Cholinergic stimulation causes uterine contractions by increasing inositol 1,4,5- 
trisphosphate and hence elevating intracellular calcium, (Marc et a l , 1986). However, 
it is well established that contractions and expulsion of the fetus can proceed in the 
absence of neuronal activity (Reynolds, 1965) suggesting that the role of these nerves 
in the contractile activity of the uterus is of minor importance (Wray, 1993). Other 
neurotransmitters which aie known to be present within the uterus include, vasoactive 
intestinal polypeptide (Aim a/., 1977; Huang e ta l ,  1984), neuropeptide Y (Owman 
et a l,  1986), substance P (Aim et a l ,  1978), calcitonon gene-related peptide (Gibbins
- - —     ■
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et a l,  1985; Samuelson et al,  1985), galanin, and gastrin-releasing peptide (Stjernquist 
e ta l ,  1986).
(ii) Hormonal modulation
Oestrogen and progesterone
Changes in hormonal conditions have profound effects on uterine activity. The steroid 
hormones oestrogen and progesterone have long been known to influence myometiial 
contractility, (Bozler, 1941; Fuchs, 1978). Human pregnancy is characterised by a 
state of markedly increased oestrogen levels, predominantly 17|3-oestradiol and 
oestriol. Although oestrogens are known to stimulate prostaglandin production in the 
decidua, promote the formation of gap junctions and increase the synthesis of oxytocin 
receptors, their role in the initiation of parturition in the human remains uncertain, 
(Batra, 1994).
Progesterone is essential in the maintenance of pregnancy (Csapo, 1956), and has 
ti'aditionally been perceived as having a "relaxing" effect on human myometrium. The 
proposed mechanisms for this have included diminished myométrial cell membrane 
permeability for calcium, increased adenosine monophosphate synthesis and an 
inhibition of decidual prostaglandin formation, (Egaiter and Husslein, 1992). 
Furthermore, treatment with an anti-progesterone such as mifepristone, increases both 
uterine activity and myometiial sensitivity to prostaglandins (Swahn and Bygdeman, 
1988). However, the role of progesterone in the onset of human parturition is 
unknown, since a fall in plasma progesterone is not seen in human pregnancy (Batra, 
1985). In addition, administration of progesterone to strips of isolated human, 
pregnant myometrium in vitro, increases the frequency and strength of contractions, 
and enhances sensitivity to oxytocin (Fu et al, 1993).
(Oishi et a l ,  1991). The importance and role of oxytocin in the initiation of human 
parturition remains conti'oversial (see Zeeman et a l,  1997 for review). There is a 
marked gestational difference in the pharmacological ability of oxytocin to cause uterine 
contractions, oxytocin being most effective in the third trimester. This is due to the 
presence of a higher concentration of oxytocin receptors at this time and is the basis of 
human uterine sensitivity to oxytocin throughout pregnancy (Theobald et a l ,  1969; 
Fuchs et a l,  1984). Fetal oxytocin and local uterine and decidual sources of oxytocin 
can act on the myometrium in an endocrine and paracrine manner to initiate and maintain 
effective uterine contractions (Chard et a l,  1971). Furthermore oxytocin is now 
recognised to be released in discrete pulses of short duration and that pulse frequency 
and duration increase during spontaneous labour in women (Fuchs et a l,  1991).
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O xytocin
Oxytocin is a powerful stimulator of uterine activity and can enhance the force, the 
frequency and the duration of uterine contractions. It is a nine amino acid peptide 
which is synthesised within the supraoptic and pai'aventriculai* nuclei of the 
hypothalamus as a large precursor molecule (Dawood and Khan-Dawood, 1985). This 
molecule is subsequently broken down to the active hormone and its neurophysin 
which aie transported along neurones to the posterior pituitary gland. In 1909, Blair- 
Bell demonstrated the uterotonic action of posterior pituitary extracts at a Caesarean 
section. Since then, the pituitaiy extracts, and later purified oxytocin, have been used 
to arrest postpartum haemoiThage and to induce or augment labour. Whilst oxytocin 
has classically been described as being released from the posterior lobe of the pituitaiy 
gland, it is also expressed in amnion, chorion and decidua (Chibbar et al, 1993).
Oxytocin stimulates uterine contraction by mechanisms involving activation of receptor- 
operated calcium channels and release of calcium from sarcoplasmic reticulum. 
Calcium-independent oxytocin contraction has been described (Matsuo et al, 1989) and
7:'-'
is probably due to a protein phosphorylating either a contractile or cytosolic protein,
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Oxytocin antagonists are currently being investigated as tocolytic agents in the 
management of preterm labour, (Zeeman et al, 1997).
Prostaglandins
The prostaglandins PGE2  and PGp2a increase uterine contractile activity in association 
with an rise in intracellulai* free calcium, which seems to be due primaiily to an influx of 
exti'acellulai* calcium (Morrison and Smith, 1994). In contrast to oxytocin, 
prostaglandins do not increase inositol 1,4,5-trisphosphate production in human 
myometrium or release intracellular calcium stores in cultured myométrial cells 
(Thornton and Gillespie, 1992). There is strong evidence that prostaglandins play a 
central role in the initiation of human parturition, although the evidence for a regulatory 
role of eicosanoids is unavailable (see Schellenberg and Liggins, 1994 for review).
Endothelins
Endothelin (ET), a potent vasoconstrictor, is capable of contracting several non- 
vascular smooth muscles including non-pregnant and pregnant rat myometrium (Calixto 
and Rae, 1991) and human myometrium in vitro (Word et a l ,  1990). The increase in 
smooth muscle force appears to be related to a dose-dependent rise in intracellular free 
calcium due to its release from stores and increased influx, producing increased myosin I
phosphorylation (Word et a l,  1990). ETa endothelin receptors and a smaller 
proportion of ETb endothelin receptors have been identified in human myometrium 
(Bacon et a l ,  1995). Whilst ETa is known to mediate myométrial contractility, ETg 
receptors might be involved in myométrial relaxation (Wolff et al, 1996).
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(ii) Metabolic modulation
A variety of metabolic factors are thought to play a crucial role in the control of 
myometiial contractility. These include myométrial blood flow, uterine phosphorus 
metabolites, hypoxia, pH and stretch, and have been reviewed by Wray (1993) and 
Morrison (1996).
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Part III. 
The Physiology of Cervical Ripening
Thi’oughout normal pregnancy, the cervix must remain closed and non-compliant to 
maintain the conceptus within the uterine cavity. With the onset of cervical ripening, it 
is converted into a compliant and easily dilating structure which allows the uterine 
contractions to effect the transport of the fetus thi'ough the birth canal. Our 
understanding of the physiological mechanisms involved in cervical ripening is far from 
complete. Interest in this process has mainly been concerned with the development of 
phamiacological agents to ripen the cervix in order to facilitate induction of labour. In 
contrast, research on preteim labour and therapeutic strategies aimed at preventing it 
have concentiated on abolishing the associated uterine contractions whilst largely 
ignoring the cervix, (Olah and Gee, 1992). This interest in tocolytic agents has arisen 
since the presence of uterine contractions is the most obvious manifestation of preterm 
labour. Yet it is clear that the process of cervical ripening is likely to begin prior to the 
onset of myométrial activity, as in normal labour at term, or at least concurrently. 
Hence a better understanding of the processes involved in cervical ripening may lead to 
new therapeutic strategies in the prevention of preterm delivery.
Structure of the cervix
The main formed element of the cervical stroma is extracellular connective tissue matrix. 
The extracellular matrix is made up of type I (66%) and type III (33%) collagen, 
(Kleissl et al., 1978) with a small amount of type IV collagen in the basement 
membranes. The fibrils of collagen are bound together into dense bundles which confer 
on the cervix the rigidity which characterises its non-pregnant and early pregnant 
condition. A small amount of elastin is also present within the cervix. While the
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collagen confers rigidity, elastin may be responsible for providing elasticity; this assists 
in closing the cervix after delivery and thereafter returning it to its non-pregnant shape.
The collagen is embedded in a ground substance consisting of large molecular weight 
proteoglycan complexes containing a vaiiety of glycosaminoglycans (GAGs). 
Glycosaminoglycans are long chains of highly negatively charged repeating 
disaccharides containing one hexosamine (glucosamine or galactosamine) and one 
uronic acid (glucuronic or iduronic). There are several different GAGs, such as heparin 
and heparan sulphate and dermatan and chondroitin sulphate. These vary in their 
composition with regard to the exact combination of hexosamine and uronic acid 
residues, and each varies intrinsically with regard to chain length. In ceiwical tissue the 
most abundant GAGs are chondroitin and its epimer, dermatan sulphate, (von Maillot et 
a l,  1979; Uldbjerg et a l,  1983). As well as forming the ground substance of the 
tissue, proteoglycans invest collagen fibrils (Scott and Orford, 1981), with their protein 
cores attaching to the collagen. The relationship between the GAG side chains and the 
collagen fibrils is important in orientating the collagen and conferring on the ceiwix its 
mechanical strength (Lindahl and Hook, 1978). The binding affinity of GAGs to 
collagen increases with increasing chain length and charge density. Hyaluronic acid 
binds least strongly of the GAG molecules and will act to destabilise the collagen 
fibrils. GAGs such as dermatan sulphate, containing iduronic as opposed to glucuronic 
acid, bind strongly and promote tissue stability (Obrink, 1973). Changes in the 
proteoglycans/GAG composition can therefore alter collagen binding and facilitate 
collagen breakdown.
The major cellulai' component of cervical connective tissue is the fibroblast. These cells 
appeal’ to be responsible for the synthesis of both collagen and ground substance. 
Whilst the bulk of the cervix consists of fibrous tissue, there is a vaiying amount of 
smooth muscle - usually about 10%, but it can vary between 2% and 40%. The 
functional role of this smooth muscle is controversial, although it is capable of both
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spontaneous and drug induced contractions (Nixon, 1951, Hillier and Karim, 1970). It 
seems that the connective tissue in the cervix is more important than the muscle 
component. The muscle is unlikely to act as a sphincter mechanism, both on the basis 
of its low concentration and also its spatial arrangement within the cervix. It is 
proposed that it protects important blood vessels during labour and brings about prompt 
closure of the cervix following deliveiy (Calder, 1994).
The cervix during pregnancy
During pregnancy the cervix becomes metabolically more active. In the non-pregnant 
state, the cervix consists of around 80% water (Liggins, 1978) and this increases to 
around 86% in late pregnancy (Uldbjerg et a l,  1983). This water interacts with the 
matrix proteins and facilitates the function of elastin. Since GAGs are hydrophilic, 
these molecules may be important in controlling tissue hydration, with increased 
hydration destabilising the collagen fibrils and promoting ripening. There does not 
seem to be a change in ceiwical water content immediately before or after delivery in 
humans (Leppert, 1992). Whilst messenger RNA for tropoelastin, the precursor for 
elastin, is increased in pregnancy, the cervical elastin content does not appear to change 
throughout gestation (Leppert, 1992). The smooth muscle cells of the ceiwix become 
enlarged and prominent during pregnancy. Smooth muscle enlargement may play a role 
in cervical tissue rearrangement as collagen bundles are aligned in close approximation 
to the smooth muscle bundles.
The collagen content of the cervix, both type I and type III, undergoes marked changes 
in pregnancy. The spaces between the collagen bundles become dilated as early as 8-14 
weeks' gestation. Although there is an increase in the total collagen content of the 
cervix at term, the collagen concentration is reduced by 30-50% compared to the non­
pregnant cervix (Fosang ef a/., 1984; Kokenyesi and Woessner, 1990; Jeffrey, 1991). 
The cervical collagen concentration measured biochemically also decreases (Danforth et
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a l,  1974; Uldbjerg et a l,  1983; Granstrom et a l ,  1989). This arises because other 
components of the cervix, the water and non-collagen proteins are increasing in 
relatively greater amounts. In addition, the collagen fibrils are reduced in size (Danforth 
et a l,  1960). This decline in cervical collagen appears to be even more marked when 
studied histologically using stains specific for polymerised collagen. A much lower 
proportion of the collagen exists as intact fibres in the dilated cervix at term (Obrink, 
1973). Several mechanisms have been proposed to explain these changes in collagen 
composition; essentially, these are increased enzymatic collagen degradation and/or 
alteration in the proteoglycan/GAG composition of the ground substance.
Collagen is amenable to breakdown by the action of lytic enzymes. These include 
collagenases, (MMP-1, MMP-8 and MMP-13) which aie produced by fibroblasts and 
leukocytes, and leukocyte elastase produced by macrophages, neutrophils and 
eosinophils. Collagenase is secreted in a latent form, procollagenase, which is activated 
by cleavage of the proenzyme by plasmin or stromelysin (MMP-3) to the active form. 
The activated collagenase specifically breaks down the triple helix of the collagen fibril 
by hydrolysing peptide bonds (Wooley, 1984; Stricklin and Hibbs, 1988). Radiolabel 
studies suggest that the cells critically involved in collagen degradation during cervical 
dilatation are not the cervical fibroblasts, but rather neutrophils migrating from blood 
vessels. The neutrophils secrete both elastase and collagenase (MMP-8) (Osmers et a l,  
1993). Elastase breaks down collagen by acting on the telopeptide non-helical 
domains. Elastase can degrade not only elastin and collagen, but also proteoglycans, 
and it may act synergistically with collagenase on collagen. As the ceiwical collagen 
content decreases through pregnancy, the leukocyte elastase and collagenase activities 
increase (Uldbjerg et a l,  1983). In addition, the amount of soluble collagen (reflecting 
par tly degraded collagen) in the tissue increases in parallel with the increased enzyme 
activities (Ito et a l ,  1979; Uldbjerg et a l ,  1983). Mature collagen with many cross 
links may be broken down during pregnancy and replaced with new collagen which has 
fewer cross links and is more amenable to rapid breakdown at the time of parturition.
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As the pregnancy advances, collagen is more easily extracted from cemcal tissues, with 
the immature cross links in newly synthesized collagen contributing to this 
phenomenon.
In addition to increased collagen breakdown, there are changes in the ceiwical 
proteoglycan and GAG content as pregnancy advances. The total GAG content of the 
cervix increases substantially by term, indicating active synthesis although the 
concentrations of GAGs may remain relatively constant (Golichowski, 1980). Whilst 
some studies have shown an increase in the hyaluronic acid concentration in pregnancy, 
(von Maillot et a i,  1979; Golichowski, 1980), other studies have found no increase 
(Uldbjerg e ta l ,  1983; Fosang eta l ,  1984; Uldbjerg and Malmstrom, 1991). Although 
this could reflect variation between species, these discrepancies could also be attiibuted 
to variations in the site of the cervical biopsies used in each study (Leppert, 1995). 
Studies employing more recently developed biochemical techniques have demonstrated 
that the concentiation of hyaluronic acid increases almost 12-fold at 2-3 cm dilatation 
(Leppert, 1992). This GAG may help to "loosen" the collagenous network of the 
cervix whilst an increase in the hyaluronic acid available to bind water may be 
associated with an increase in tissue hydration, and tissue deformability. There may be 
a relative decrease in chondroitin and dermatan sulphate, compared to the non-pregnant 
cervix. It has been proposed that tissues become more rigid with increasing chondroitin 
sulphate concentration. Thus, a reduction in the chondroitin sulphate concentration 
might result in increased compliance and is likely to reduce the mechanical strength of 
collagen fibrils, and make them more amenable to breakdown by proteolytic enzymes.
The predominant proteoglycan in the non-pregnant, human cervix is dermatan sulphate 
proteoglycan II (decorin or DSPGII), a small proteoglycan with one dermatan sulphate 
side chain (Uldbjerg etal., 1983). In addition, there are small amounts of two other 
proteoglycans, one with two dermatan sulphate side chains, biglycan (DSPG I) and a 
larger one with chondroitin /dermatan sulphate side chains called PGL (Norman et a l ,
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1991). It is proposed that the amount of decorin increases in the pregnant cervix 
(Leppert, 1995), until late pregnancy when the proteoglycan concentration decreases to 
about 50% of that in the non-pregnant cervix. After the onset of cervical ripening, the 
amount of decorin still dominates in the cervix, but there is an increase in the other 
proteoglycans (Norman et a l ,  1993). Such an alteration in the proteoglycan and 
collagen composition of the ground substance might explain the altered biomechanical 
properties of the cervix (Greer, 1992). In the rat, a strong correlation exists between 
the cervical linear circumference and the decorin:collagen ratio (Kokenyesi and 
Woessner, 1990) supporting this contention.
The increase in total GAGs probably reflects an increased production by fibroblasts 
which become increasingly active as pregnancy advances (Junqueira et a l ,  1980; Parry 
and Ellwood, 1981). Additionally, the increase could reflect breakdown of the 
proteoglycan complexes to provide free hyaluronic acid and proteoglycans. The 
proteases required for this could come from the activated fibroblasts, or the leukocytes 
which infiltrate the cervical connective tissue.
Cervical ripening
The phenomenon of cervical ripening is a prelude to the onset of labour and is most 
obvious during the last five or six weeks of pregnancy although it may have its origins 
even earlier. Clinically, ripening refers to the increased softening, distensibility, 
effacement and early dilatation which can be detected by pelvic examination. These 
changes are the result of profound alterations in the biomechanical properties of cervical 
tissue and include a reduction in collagen concentration, an increase in water content 
and a change in proteoglycan/GAG composition (Calder and Greer, 1992). One 
important change involved in cemcal ripening is a rearrangement and realignment of 
collagen (Leppert, 1995). The cervical connective tissue at term shows widely scattered 
and dissociated fibrils of collagen and a marked increase in the ground substance when
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compared to the non-pregnant or early pregnant cervix. The process of cervical 
ripening has been compared to an inflammatory reaction (Liggins, 1981) and infiltration 
of cemcal tissue with inflammatory cells has been shown in experimental 
circumstances (Junquiera a/., 1980; Rath e ta l ,  1988; Chwalisz, 1988).
The control of cervical ripening
Cervical ripening appears to be an active process in view of the changes which occur 
within the cervical connective tissue and cellular components. Furthermore, animal 
studies have shown that cemcal ripening occurs even when the cervix is physically 
isolated from the uterus (Stys et a l ,  1980; Ledger et a l,  1985). Those factors 
controlling cervical ripening, and which may be implicated in the pathophysiology of 
preterm labour, are incompletely understood.
Prostaglandins
Prostaglandins undoubtedly play a role in the control of cervical ripening in the human. 
The main prostaglandins produced by the cervix are PGE2 , PGI2, and to a lesser extent 
PGp2a and their production increases in association with cervical ripening (Ellwood et 
a l,  1980). Physiologically, PGE2 is probably much more important than PGF2 a, 
while the role of PGI2 in cervical ripening is rather uncertain. Amniotic fluid 
concentrations of PGE2 and PGp2a correlate directly with the cemcal score in women 
at term who are not in labour (Calder, 1980). In addition, receptors for PGE2 and 
PGp2a can be demonstrated in the cervix (Crankshaw et al,  1979). These data suggest 
that prostaglandins have a physiological role in cervical ripening; there is no doubt that 
natural and synthetic prostaglandins are effective pharmacological agents for ripening 
the cervix at any stage in pregnancy (Calder, 1980; Calder and Greer, 1991). 
Prostaglandins might effect cervical ripening by inducing the breakdown of collagen. 
Alternatively, they could modify the binding of collagen and the hydration of tissue by 
altering the GAG/proteoglycan composition. Prostaglandin E2 treatment will reduce
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collagen concentration similar to the changes seen in physiological ripening (Ekman et 
aL, 1986; Uldbjerg et al., 1981), but it is uncertain whether this is the result of 
collagenolysis. While some studies have shown an increase in collagenase activity |
following the administration of PGE2 , (Szalay et al., 1989; Ding et a i,  1990), others
Ihave shown no such change (Ellwood et al., 1981; Uldbjerg et al., 1983; Rath et a l,
■■i1987). While these conflicting results may, to some extent, reflect difficulties in is
iSassessing collagenase activity, Rath et al., (1987) supported their findings by 
demonstrating an absence of collagen breakdown fragments on electrophoresis 
following prostaglandin therapy. In this study significant cervical ripening occurred in 
the treated group.
There is evidence that prostaglandins act by altering the ground substance in cervical 
tissue (Uldbjerg et al., 1981; Uldbjerg et al., 1983). An increase in hydration and 
hyaluronic acid concentration has been demonstrated in animal studies, after PGE2 
administration (Cabrol e ta l ,  1987). Prostaglandin E2 can influence cemcal fibroblast 
production of collagen and GAG. The production of these two substances is inversely 
related such that an increase in GAG production occurs when collagen synthesis is 
reduced (Norstrom, 1984; Norstrom a/., 1985); Johnston e ta l ,  (1993) have shown 
that PGE2 administration in late pregnancy results in an increase in circulating levels of 
chondroitin sulphate, similar’ to those seen in spontaneous labour. Thus, PGE2 
mediated cervical ripening may be explained by alterations in GAG/proteoglycan 
content which will disperse and destabilise the collagen fibrils thereby increasing tissue 
compliance.
O estrogens
Other naturally occurring agents also act to control cervical structural changes. 
Oestrogens, such as oestradiol have been used to bring about cervical ripening in the 
clinical situation (Gordon and Calder, 1977; Allen e ta l ,  1989; Magann et al., 1995).
The mechanism underlying the effects of oestradiol may be due in part to the induction
- 4
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of prostaglandin synthesis within the tissues (Horton and Poyser, 1976). Oestradiol 
might also be responsible for the influx of protease-producing leukocytes which could 
induce ripening (Calder and Greer, 1992).
Progesterone & Antiprogesterones
Progesterone inhibits the effects of collagenase within the uterine coipus (Jeffrey et a l , 
1971), and may have a similar role within the cervix. It has an inhibitory effect on 
cervical ripening and parturition in those animals where a decrease in progesterone at 
term results in ripening and labour. Such a decrease does not occur in the human but 
progesterone is a potent anti-inflammatory agent (Sitteri eta l,  1977), and could still be 
an important physiological inhibitor of the ripening process in vivo by inhibiting 
neutrophil influx and activation (Jeffrey and Koob, 1980). This is supported by the 
observation of the cervical softening effect of the antiprogesterones prior to termination 
of pregnancy (Gupta and Johnson, 1990; Radestad et a l,  1990), and which is 
associated with a neutrophil influx in animal models (Chwalisz, 1988). In addition, 
antiprogesterones might exert their effects through prostaglandins as they appear to 
stimulate prostaglandin synthesis and reduce catabolism in vitro (Kelly et a l,  1986; 
Kelly and Bukman, 1990). Morphological and biochemical studies in humans and 
animals, have shown evidence of collagenolysis in the cervix after treatment with 
antiprogesterones (Hegele-Hartung e ta l ,  1989; Radestad et al,  1993). Other workers, 
however, have failed to show any change in cervical collagen content (Norman, 1992; 
Bokstrom and Norstrom, 1995).
Relaxin
There is good theoretical evidence that relaxin, a 6-kD dimeric peptide hormone, plays a 
role in the process of cervical ripening in the human. Relaxin increases collagenase 
activity (von Maillot et a l ,  1977) perhaps via a mitogenic effect on fibroblasts which 
aie known to exhibit relaxin receptors (McMurty et a l,  1980). Phaimacologically, 
porcine relaxin has been shown to cause cervical ripening in women (MacLennan et a l ,
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1980; Evans et a l,  1983). More recently, the efficacy of recombinant human relaxin, 
administered vaginally, has been investigated; while no adverse effects could be 
attributed to the preparation, recombinant human relaxin had no appreciable effects on 
cervical ripening (Bell et a l,  1993; Brennand et a l,  1997). While the specific role of 
relaxin during human pregnancy is unknown, increased relaxin concentrations in the 
maternal circulation aie associated with preterm labour, perhaps by altering cervical 
connective tissue (Petersen e ta l ,  1992; Weiss et al, 1993).
Inflammatory Mediators
Cervical ripening is considered to be a physiological inflammatoiy process, 
characterised by an accumulation of neutrophils and macrophages in the cervical stroma 
(Junquiera et a l ,  1980; Liggins, 1981; Bokstrom et al., 1997). Interleukin-8 is an 
inflammatory cytokine which is capable of producing a selective neutrophil chemotaxis 
and activation (Baggiolini et a l,  1989). This cytokine can be produced by fibroblasts 
in the human cervix (Barclay et a l,  1993), and can induce cervical ripening in 
nonpregnant and pregnant rabbits (El Maradny et a l ,  1994). Interleukin-8 may have a 
synergistic interaction with prostaglandin E2 in promoting cervical ripening (Colditz,
1990). Other cytokines, including interleukin-IB (El Maradny et al,  1995) and tumour 
necrosis factor a  (Chwalisz et a l,  1994a) have been shown to produce cervical 
ripening in animal studies. Recent work has indicated that the inflammatory mediator 
nitric oxide plays a crucial role in cervical ripening in animals (Buhimschi et a l ,  1996; 
Chwalisz e ta l ,  1997). The role of nitric oxide in ceiwical ripening in women will be 
discussed later in this chapter, and also in chapters 6 and 7 of this thesis.
A p o p to s is
Cervical ripening occurs spontaneously in a timely, species specific manner suggesting 
that apoptosis, or programmed cell death, may be involved (Leppert, 1995). Apoptosis 
is a phenomenon characterised by the shrinkage of cells, compaction of chromatin into 
uniformly dense bundles and clear halo nuclei. One study in pregnant rats showed that.
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as gestation advanced, the numbers of dying smooth muscle cells in the cervix 
increased along with DNA degradation fragments and cemcal softening, (Leppert and 
Yu, 1994).
As the processes involved in cervical ripening at term become clearer, then therapeutic 
strategies aimed at preventing this process occurring prematurely will become available. 
While the list of potential mediators of cervical ripening continues to grow, there are 
few reports of inhibitory substances for cemcal maturation in vivo. Studies have 
shown that fetal urine and amniotic fluid contain large amounts of a substance called 
urinary trypsin inhibitor (UTI), (El Maradny et a l,  1994). UTI, which has been 
localised in myométrial and cemcal cells during pregnancy (Kanayama, 1994) has an 
inhibitory effect on several enzymes including elastase, hyaluronidase and plasmin 
(Kosuzume et al, 1983). It also inhibits many of the cytokines including interleukin-1 
and interleukin-8, and one study in rabbits has shown that UTI suppresses premature 
cervical ripening (Kanayama et al,  1995). Moreover, UTI has been reported to inhibit 
uterine contractions in patients in preterm labour (Kanayama et a l ,  1992). Similarly, 
interleukin-10 or cytokine synthesis inhibitory factor is a potent natural attenuator of 
inflammatoiy cytokine reactions. These substances may have a therapeutic role in 
suppressing premature cemcal ripening when an inflammatory aetiology is implicated 
(Keirse, 1995).
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Part IV. 
Nitric oxide
Nitric oxide has only recently been identified as a crucial biological mediator, involved 
in such diverse activities as smooth muscle relaxation, neurotransmission and host 
defence (Nathan, 1992). In 1987, Moncada and his colleagues showed that nitric oxide 
accounted for the biological activity of endothelium-derived relaxing factor and that L- 
arginine was its precursor (Palmer et al., 1987, 1988). Only then did it become 
apparent that the therapeutic effects of glyceryl trinitrate, which has been employed in 
the management of angina pectoris for over one hundred years, are derived by the 
liberation of nitric oxide in the vascular endothelium (Feelisch, 1991).
Nitric oxide is a reactive gas with a very short physiological half life. It is synthesised 
from L-arginine by the enzyme nitric oxide synthase, of which three isoforms have 
been identified at present. These enzymes have common features with cytochrome 
P450 reductase and contain oxidative and reductive domains. The three isoforms of 
nitric oxide synthase (NOS) are known as endothelial NOS, (eNOS), neuronal or brain 
NOS, (bNOS) and macrophage or inducible NOS, (iNOS), and the genes for each of 
these enzymes has been localised to chromosome 7, 12 and 17 respectively. There is 
significant homology between the amino acid sequences of NOS from different species 
and between each of the different isoforms. Whilst the isoforms of NOS are named 
after the cell type in which they were first identified, it is now recognised that the three 
isoforms are widely distributed in a vaiiety of tissues. bNOS was originally purified 
and cloned from neuronal tissues but is now known to have an important level of 
expression in skeletal muscle. iNOS was originally purified and cloned from an 
immunoactivated macrophage cell line, and has since been identified in neutrophils, 
mast cells, endothelial cells, vascular smooth muscle, cardiac muscle and hepatocytes. 
eNOS, the last of the thiee mammalian NOS isoforms to be isolated, was originally
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purified and cloned from vascular endothelium, but has since been identified in caidiac 
myocytes, blood platelets, brain and elsewhere (Michel and Feron, 1997).
For all three NOS isoforms, nitric oxide synthesis depends upon the enzyme's binding 
of the calcium regulatory protein, calmodulin. For eNOS and bNOS, increases in 
inti'acellulai* calcium concentrations are required for their binding calmodulin, and 
consequently for their becoming fully activated. By contrast, iNOS appears able to 
bind calmodulin with extremely high affinity, even at the low intracellulai" 
concentrations characteristic of resting cells. Thus, in contrast to iNOS, the activity of 
eNOS and bNOS may be closely regulated by changes in intracellular calcium. eNOS 
and bNOS are constitutively expressed by cells although their expression can be 
induced or up-regulated. When cells containing constitutive NOS, that is eNOS and 
bNOS, (cNOS) ai'e stimulated by for example, acetylcholine, bradykinin, glutamate, 
thrombin, ADP, physical pressure and shear stress, activation leads to an increase in 
cytosolic calcium, which activates the cNOS to produce nitric oxide. In general, 
expression of iNOS occurs after activation of cells with stimuli, including bacterial 
endotoxin or exotoxin, and inflammatory mediators, including the cytokines tumour 
necrosis factor and interleukin-1. However, iNOS may also function as a "constitutive" 
enzyme under physiological conditions in some cells (Guo et al., 1995). iNOS 
produces larger amounts of nitric oxide than the other NOS isoforms (Anggard 1994).
The initial step in nitric oxide biosynthesis is hydroxylation of the nitrogen in the 
guanidino group of L-arginine (figure 1.1). This step incorporates molecular oxygen 
into nitric oxide and citmlline and requires cofactors including reduced pyridine 
nucleotides, reduced biopteridines and calmodulin. Whilst levels of L-arginine are 
normally sufficient for continuous secretory nitric oxide biosynthesis, under certain 
conditions the local cellular L-arginine levels may be insufficient (Drexler et al., 1991). 
Furthermore, the limited availability of cofactors in vivo can attenuate the production of 
nitric oxide (Werner-Felmayer etal., 1993; Sladek and Roberts, 1996).
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NHz+ COO NHa COO"
NH2 ^ /  NH2 0  ^ ^  NHz
L-Arginine L-Citrul!ine
Figure 1.1 The generation of nitric oxide. Nitric oxide is derived from L-arginine by the 
action of nitric oxide synthase (NOS).
Nitric oxide is a free radical having an unpaired electron, and has a very short 
physiological half life of a few seconds since it readily combines with other free 
radicals (Beckman and Crow, 1993). Nitric oxide is rapidly converted in biological 
systems to nitrate and nitrite, a reaction that is catalysed by transition metals including 
iron. Haemoglobin inactivates nitric oxide by binding it to form nitrosohaemoglobin 
and by catalysing the degradation of nitric oxide to nitrate and nitrite, resulting in the 
formation of methaemoglobin. The very short half life of nitric oxide and its reactivity 
mean that it is most likely to act as a local messenger transferring messages within and 
between individual cells.
Other biological mediators can interact with nitric oxide to alter its effects. The 
biological actions of nitric oxide are abrogated via direct reaction with superoxide 
anion (McCall et ai, 1989; Huie and Padmaja, 1993). In the presence of superoxide 
anions, nitric oxide reacts to form peroxy ni trite which in turn is oxidised to nitrate. 
Superoxide dismutase, which converts superoxide to hydrogen peroxide and oxygen 
(Klug-Roth et ai, 1973) prolongs the biological half-life of nitric oxide by removing 
superoxide. In contrast, xanthine and xanthine oxidase synthesise superoxide anion 
thereby attenuating the activity of nitric oxide (Miyamoyo et al,  1996).
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Nitrovasodilators, such as glyceryl trinitrate and sodium nitroprasside (SNP) are now 
known to produce their clinical effects by releasing nitric oxide. These drugs, known 
as nitric oxide donors, release nitiic oxide either spontaneously, (eg SNP) or after 
metabolic conversion, (eg glyceryl trinitrate). Endogenous nitric oxide levels can be 
raised by administration of the nitric oxide substrate L-arginine. Analogues of L- 
arginine, such as N^-nitro-L-ar’ginine methyl ester (L-NAME) and N^-monomethyl-L- 
arginine (L-NMMA), attenuate the effects of NOS by competing with L-arginine for the 
active site of the NOS (Furchgott et a l,  1990). In experimental systems, nitric oxide 
may be inhibited by the addition of oxyhaemoglobin, or the effects of nitric oxide on the 
second messenger system, guanylate cyclase, may be blocked by methylene-blue.
Nitric oxide synthesised by constitutive isoforms of NOS, (eNOS and bNOS) exerts its 
effects through the stimulation of soluble guanylate cyclase and subsequent formation 
of cyclic GMP (Ignarro, 1992). Cyclic GMP activates protein kinases and leads in turn 
to the dephosphorylation of myosin light chains and muscle relaxation. Alternative 
mechanisms by which nitric oxide could cause smooth muscle relaxation, independent 
of guanylate cyclase, include activation of calcium-dependent potassium channels 
(Bolotina et al, 1994) and ADP ribosylation (Brune and Lapetina, 1990). Nitric oxide 
produced in larger quantities by the activation of iNOS also activates guanylate cyclase, 
but has additional toxic effects. These toxic effects are mediated via the release of free 
copper and iron ions within the victim cell, and the generation of O2  and highly toxic
hydroxyl radicals. These effects, in turn, result in massive oxidative injury.
Since the short half-life of nitric oxide makes direct measurement difficult in 
experimental situations, techniques have been developed to measure nitric oxide activity 
indirectly. These include the Greiss reaction which measures nitrite, the oxidation 
product of nitric oxide (Green et a l,  1982). The protein and mRNA for each of the 
tliree isoforms of NOS can be localised by immunocytochemistry and in situ 
hybridisation, respectively. Quantification of tissue NOS mRNA and protein can be
.
33
achieved by Northern and Western blots respectively. The total activity of NOS in a 
tissue can be quantified by measuring the conversion of radio-labelled L-arginine to L- 
citrulline, in the presence of added co-factors. Identification of NADPH diaphorase 
activity in vitro has been used to identify NOS activity within a tissue since, certainly in 
neuronal tissue, NADPH diaphorase activity co-localises with NOS (Hope et a l ,
1991). However, it is now recognised that not all NADPH diaphorase activity is NOS, 
casting doubt on the validity of this technique (Tracey et al,  1993).
Nitric oxide in Human Parturition
Nitric oxide was first identified in the human reproductive system by Ignano et a l ,  
(1990), who demonstrated that nitric oxide was generated in response to non- 
adrenergic/non-cholinergic neurotransmission-mediated penile erection. Since then, the 
L-arginine-nitric oxide system and each of the three isoforms of NOS, have been 
identified in the female reproductive system, suggesting that locally synthesised nitiic 
oxide is directly involved in the physiology of reproduction.
Identification of the nitric oxide system in the uterus 
Nitric oxide production in the uterus
Human and animal studies suggest that nitric oxide is generated within uterine tissues. 
The abihty of the rat and rabbit utenis to produce large quantities of nitric oxide has 
been demonstrated using the Greiss reaction, (YallampaUi et a l ,  1993; Sladek et a l ,  
1993; YaUampalli et a l ,  1994a; Dong and YallampaUi 1996). Pregnant and non­
pregnant human myometrium can also generate nitrate/nitrite in culture (Buhimschi et al. 
1995b). NOS activity in the rat and rabbit uterus has been detected using the 
radiolabelled arginine to citrulline conversion assay, (Natuzzi et al, 1993; Sladek et a l ,  
1993; YallampaUi et a l ,  1994a). This technique has also provided evidence of NOS 
activity within the pregnant guinea-pig uterus (Weiner et a l ,  1994a) as well as in
34
pregnant human myometrium (Ramsay et a l,  1996). In these studies, both calcium- 
insensitive (iNOS) and calcium-sensitive (eNOS and/or bNOS) activity were identified. 
Rabbit (Sladek et a l,  1993) and human (Sladek et a l,  1994) decidua contained only 
calcium-insensitive NOS activity, which in the rabbit was 6-fold greater than in the 
myometrium.
In human pregnancy NOS activity was identified in myometrium (Buhimschi et a l ,  
1995b; Ramsay e ta l ,  1996), placental villous trophoblast (Gude e ta l ,  1994; Morris et 
a l ,  1995; Ramsay et a l ,  1996; Di lulio et a l,  1996), and amnion (Di lulio et a l ,  
1996). In contrast to Sladek et a l ,  (1994), Di lulio et a l,  (1996) detected no NOS 
activity within the choriodecidua in tissue collected before and during labour.
Localisation o f  uterine NOS
NADPH diaphorase staining has been used to localise NOS within the pregnant and 
non-pregnant uterus of various species and essentially identical patterns of staining have 
been found, (myométrial and vascular smooth muscle nerve bundles, vascular 
endothelium, endometrial epithelium and leukocytes). The density of nerve fibres was 
greater in the cervix than in the myometrium of the body of the uterus. This technique 
has been used in rats (Schmidt et al, 1992; Shew et al, 1993; YallampaUi et al,  1994a; 
Suburo e ta l ,  1995; Papkaeffl/., 1995; Papka et a l,  1996), mice (Grozdanovic et a l ,  
1994; Huang e ta l ,  1995), cows and pigs (Majewski e ta l ,  1995), and humans (Telfer 
et al, 1995; Yoshida et al, 1995; Ekerhovd et al, 1998).
Since NADPH diaphorase activity may not be specific for NOS, other techniques 
including immunocytochemistiy and in situ hybridization have been employed to 
localise each of the three isoforms of NOS in uterine tissues. Using 
immunocytochemsitry, bNOS was localised to the endometrial epithelium (Schmidt et 
a l,  1992), perivascular neurones (Grozdanovic et a l,  1994; Majewski et a l ,  1995), 
and myometiial neurones (Grozdanovic et a l,  1994; Majewski et a l,  1995; Papka et
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al., 1995). eNOS protein has been immunolocalised to vascular endothelium, 
endometrial glandular epithelium and endometrial stromal cells but was not consistently 
detected in myométrial smooth muscle cells (Telfer et al., 1995; Telfer et a l,  1997). 
eNOS mRNA was detected in endometrial glandular epithelium, stroma, myometrium 
and myométrial blood vessels by in situ hybridization (Telfer et a l,  1995). In mouse 
utems, iNOS was identified using immunocytochemistry, in stromal macrophages and 
myométrial mast cells (Huang et a l ,  1995) and in the human non-pregnant uterus, 44:
iNOS was immunolocalised to glandular epithehal cells, and, in some specimens, the 4
vascular smooth muscle of the myometrium and endometrium (Telfer et a l ,  1991). 
Tschugguel et al, (1998) found that expression of iNOS in the glandular epithelial cells 
was strong in secretory phase endometrium but weak or absent in proliferative 
endometrium. They suggest that the increased production of nitric oxide may be 
relevant to the process of menstruation. ï
Using Western blotting, Gangula et al, (1997) demonstrated that rat myométrial cells in 
culture express eNOS constitutively and can be stimulated by cytokines to express 
iNOS. However, it is unclear whether human myométrial smooth muscle cells contain 
NOS (Sladek et a l,  1997). Other human muscles, including cardiac myocytes (Brady 
et a l ,  1992) and vascular- smooth muscle (Nunokawa et a l,  1993) can be stimulated 
with endotoxin and/or cytokines to express iNOS, and human skeletal muscle contains 
bNOS (Nakane et a l ,  1993; Kobzik et a l,  1994). Bansal et a l ,  (1997) have 
demonstrated, using immunocytochemistry and Western blotting, that human myocytes 
express iNOS protein and Myatt et a l,  (1998) observed eNOS immunostaining in 
myocytes in human placental bed biopsies.
The expression of each of the three isoforms of NOS has been described in human 
placenta. eNOS localised to the endothelium of the resistance vasculature and the 
syncytiotrophoblast of term placentae and the endothelium of the umbilical artery and 
vein (Myatt et a l ,  1993a; Buttery et a l,  1994). This distribution was also seen for
_      ___
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mRNA encoding eNOS using in situ hybridization (Conrad et a l ,  1993). Similarly, in 
tissue collected in the first trimester of pregnancy, after spontaneous miscarriage, NOS 
was identified in syncytiotrophoblast, but not cytotrophoblast, using NADPH 
diaphorase activity and immunocytochemistry with an antibody raised against eNOS 
(Eis e ta l ,  1995). In placentae from pregnancies complicated by pre-eclampsia, eNOS 
immunostaining was also identified in small terminal villous vessels (Ghabour et al., 
1995; Myatt e ta l ,  1997a). Using immunocytochemistry, bNOS has been localised to 
the extravascular contractile system cells, the media and endothelium of villous vessels 
and the syncytiotrophoblast (Graf et al, 1994).
Approximately 5-6 per cent of the NOS activity within the placenta is independent of 
calcium/calmodulin stimulation, and therefore characteristic of iNOS (Myatt et a l,  
1993b; Conrad et a l,  1993). Immunolocalisation studies have shown that iNOS is 
present within cells in the villous stroma which have been identified as placental 
macrophages or Hofbauer cells (Myatt et a l,  1997b). In some, but not all placental 
tissue, iNOS staining was also identified in syncytiotrophoblast and vasculai' 
endothelium (Myatt et a l ,  1997b). Schonfelder et a l,  (1996), using reverse- 
transcriptase-polymerase chain reaction. Western blotting and immunocytochemistiy, 
detected no iNOS mRNA and protein in normal term placentae but identified iNOS in 
endothelial cells and syncytiotrophoblast in placentae from pregnancies complicated by 
gestational diabetes.
Within fetal membranes collected from uncomplicated pregnancies at term, Dennes et 
al, (1997) have identified eNOS and iNOS mRNA in amnion and chorio-decidua. The 
expression of bNOS mRNA was not determined. Using immunocytochemistry, Eis et 
a l,  (1997) have localised iNOS within fibroblasts of the amniotic and chorionic 
mesenchyme, and in decidual macrophages.
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Relaxation of myometrium by nitric oxide 
In vitro studies
Whilst the smooth muscle relaxant effects of nitric oxide were described originally in 
blood vessels (Palmer et a l,  1987), numerous studies over the last few years have 
demonstrated that nitric oxide is also a powerful myométrial relaxant, Nitiic oxide gas 
produced complete inhibition of spontaneous contractions of rat myometrium removed 
late in gestation prior to the onset of labour (YallampaUi e ta l,  1993). There aie no data 
showing an effect of nitric oxide gas on the contractions of myometrium obtained either 
from pregnant or non-pregnant women.
More commonly nitric oxide donors have been used to investigate the effects of nitric 
oxide on myométrial smooth muscle. With few exceptions in animal studies, when 
nitric oxide donors have been applied to myometrium in vitro, reductions in contraction 
amplitude and/or frequency have been observed (for reviews, see Norman 1996 and 
Sladek et a l ,  1997). Similaiiy in human studies, nitric oxide donors produced 
inhibition of spontaneous and oxytocin-induced activity when amplitude or force of 
contractions was measured (Buhimschi et a l ,  1995; Lee and Chang, 1995; Norman et 
al,  1997). The effects of nitric oxide releasing agents on the frequency of myométrial 
contractions seem more complex (for review, see Norman, 1996).
Like agents which act by liberating nitric oxide, the precursor of nitric oxide, L-arginine 
inhibited spontaneous and c aibachol-induced, but not KCl-induced, myométrial 
contractions (Izumi e ta l ,  1993; YallampaUi e ta l,  1993, 1994a). This inhibitory effect 
of L-arginine on spontaneous and induced uterine contractility was itself abolished by 
the L-arginine analogue, L-NAME and by inhibitors of guanylate cyclase, including 
methylene blue (YaUampalli et a l,  1993, 1994a). L-NAME had a small stimulatory 
effect on rat myométrial contractility when administered alone in vitro (YallampaUi et
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a l,  1993a,b). In studies of pregnant and non-pregnant, human myometrium, L- 
ai'ginine inhibited spontaneous and oxytocin-induced myometiial contractility (Izumi et 
al, 1993; Lee and Chang, 1995) with a greater effect on frequency than amplitude. In 
both these studies, the inhibitory effect of L-arginine was reversed by the L-arginine 
analogues, L-NAME and N-nitro-L-arginine. Furthermore, when administered alone, 
the analogues L-NAME and L-NMMA have been reported to stimulate contractile 
activity suggesting that in human as in animal myometrium, endogenous nitric oxide 
production may maintain some inhibition of contractile activity in vivo (Buhimschi et 
al,  1995b; Lee and Chang, 1995). However, in contrast to these findings, Jones and 
Poston, (1997) found that neither L-arginine nor L-NAME led to any change in 
spontaneous activity in myometiial strips obtained from women at term or preterm.
Myométrial relaxation in response to cGMP has been tested by using the cell-permeable 
nonhydrolyzable cGMP analogue, 8-bromo-cGMP. 8-bromo-cGMP in vitro produced 
relaxation in nonpregnant rat myometrium (Diamond, 1983; Osa et a l,  1994), and 
human myometrium, though not when the latter was precontracted with endothelin 
(Word e ta l ,  1991).
Growing evidence suggests that the effect of nitric oxide on myométrial contractions is 
dependent on whether the tissue is collected before or after the onset of labour. The 
same dose of L-aiginine was found to completely inhibit spontaneous contractions of 
rat myometrium for longer when the tissue was obtained before the onset of labour, 
compared with tissue collected during labour (Yallampalh et a l ,  1993). Furthermore, 
L-arginine (3mM) completely inhibited caibachol-induced contractions when 
myometrium was collected at mid-gestation, but had no effect when myometrium was 
removed during delivery (Izumi et al, 1993). Similarly, one concentration of 8-bromo- 
cGMP had a profound inhibitory effect on contractions of rat myometrium removed at 
mid-gestation, but concentrations of 1000 times higher were required to produce a 
similar inhibitory effect when myometrium was removed from labouring animals (Izumi
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e ta l ,  1993). Buhimschi e ta l ,  (1995b) have demonstrated a reduction in sensitivity to 
the tocolytic effect of nitric oxide in human myometrium collected following the onset 
of labour.
The presence of placental tissue may be necessary for nitiic oxide donors to achieve 
their maximum effects on the myometrium. Buhimschi et a l,  (1997) have shown that 
the spontaneously releasing nitiic oxide donor, diethylenetriamine-nitric oxide has 
contrasting effects in vivo and in vitro. In vitro studies of rat myométrial contractility 
showed decreased inhibitoiy responses to diethylenetiiamine-nitric oxide in tissues 
collected during spontaneous labour compared with tissues collected before the onset of 
labour. In contrast, studies in vivo showed that the nitiic oxide donor can decrease 
uterine contractility even more effectively during delivery, suggesting that the feto­
placental unit increases the availability of nitric oxide in vivo. Segal et a l ,  (1998) have 
recently demonstrated that the addition of placental tissue to the organ bath markedly 
increases the sensitivity of rat myometrium to the relaxant effects of glyceryl trinitrate.
In vivo studies
It has long been recognised that in the clinical arena, nitric oxide donors relax the 
human uterus. As early as 1882, Barnes reported the use of amyl nitrite to facilitate 
manual removal of a retained placenta. More recently, intravenous glyceryl trinitrate 
(GTN) has been reported in uncontrolled case reports to allow correction of uterine 
inversion (Altabef et a l ,  1992; Bay hi et a l,  1992; Dayan and Schwalbe, 1996), to 
facilitate intrapartum external cephalic version (Belfort, 1993), and to allow internal 
podalic version of a second twin (Wessen et al, 1995). In a prospective observational 
study, intravenous GTN produced relief of intrapartum fetal distress related to uterine 
hyperactivity (Mercier et a l ,  1997). This agent has also been used to facihtate fetal 
delivery during Caesarean section (Mayer and Weeks, 1992), although a recent
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randomised trial found that administration of GTN leads to no clinically relevant effect 
on fetal extraction (David et al, 1998).
i'Two uncontrolled, observational studies have investigated the effects of GTN patches 
in women with a diagnosis of preterm labour (Lees et a l ,  1994; Rowlands et a l,
1996). Although these studies concluded that GTN can arrest preterm labour, further 
controlled trials and side effect data are required before these agents are widely adopted 
as tocolytic agents, (Norman, 1996; Sladek et a l,  1997). Uterine activity can only be 
quantified accurately with the use of an intrauterine pressure transducer and this 
technique has only rarely been employed in clinical studies. Inhaled amyl nitrite 
suppressed oxytocin-induced contractions during human labour at term, but not 
spontaneous contractions (Kumar et a l,  1965). Administration of the nitric oxide f
donor S-nitroso-N-acetylpenicillamine (SNAP), suppressed preterm hysterotomy-
induced contractions in rhesus monkeys (Jennings et a l,  1993), and intravenous GTN 
suppressed spontaneous term labour in sheep (Heymann et a l,  1993). In contrast,
Norman et a l,  (1995) found that intravenous GTN had no effect on intrauterine 
pressure or uterine contractions in women undergoing second trimester therapeutic 
termination of pregnancy, in whom uterine activity had been induced using ^
mifepristone. :
The role of nitric oxide in parturition
Animal studies suggest that a nitric oxide 'withdrawal' may be involved in the timing of 
the onset of parturition. Several studies have demonstrated an up-regulation of uterine 
nitric oxide production during pregnancy, and down-regulation during term and preteim 
labour (Natuzzi et al, 1993; Sladek et al, 1993; YaUampalli et a l,  1993; YallampaUi et 
a l,  1994a). Hence, there is a consensus on a decrease in uterine NOS activity at the 
end of pregnancy, although the precise timing of the decrease has not been completely 
elucidated. NOS activity is high during rabbit pregnancy and progressively decreases.
XL:'/
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(by 80%), in decidua during the last 4 days of gestation (Sladek et a l ,  1993). Other 
studies, comparing 16 (Natuzzi e ta l ,  1993) and 18 days' gestation (YallampaUi et a l,
1993) with labouring rats (22 days), have reported that NOS activity decreases with 
advancing gestation in whole rat uterus, decidua and myometrium. However, these 
studies leave a 4- to 6-day window in which the rat uterine NOS activity decrease takes 
place. Examining this window, Sladek and Roberts, (1996) found that NOS activity 
decreased between days 15 and 21 of gestation and did not decrease further at term (day 
22). These workers propose that the decrease in pregnant rat uterine NOS activity 
coincides with the preparation of the uterus for parturition rather than the final activation 
of labour. Although uterine NOS activity is increased during rat pregnancy, the 
isoforms responsible are not known (YallampaUi et a l,  1998). Data from gene 
knockout animals suggests that an absence of any single isoform of NOS has no effect .1on the normal gestational period (Huang et a l,  1993; Huang et a l,  1995; Wei et al,
1995). I
Changes in NOS activity appeal' to be less important during pregnancy in the guinea-pig 
{Weimr et a l ,  1994a). In this species, there was no significant difference in NOS |
activity, measured by the arginine to citrulline conversion assay, between pregnant and 
non-pregnant animals. Despite this, there was a 200-fold increase in cGMP content 
from mid- to late-pregnancy, suggesting that factors other than nitric oxide are I
responsible for the changes in cGMP.
In human pregnancy, the L-arginine-nitric oxide system has been identified within 
myometrium (Buhimschi et al, 1995), placenta (Myatt et al, 1993a), and fetal 
membranes (Di lulio et al, 1996). It may be possible for nitric oxide derived from each 
of these tissues to regulate myométrial contractions. However, because of its short half 
life of a few seconds and its reactivity, it seems likely that nitiic oxide produced within 
the myometrium itself, or tissues in close apposition to the myometrium, will influence 
myométrial contractility. Several studies have attempted to determine whether a change
..,4
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in NOS activity occurs at the onset of human parturition (Gude et al., 1994; Di lulio et 
a l,  1996; Ramsay et a l ,  1996). Examining tissues collected at Caesarean section,
('before' labour and 'during' labour), and assessing NOS activity using the arginine to 
citrulline conversion assay, these studies concluded that there was no significant fall in 
NOS activity during human parturition. Indeed, Ramsay et a l ,  (1996) found a slight
j::.increase in NOS activity in myometrium collected during labour compared with that 
collected before labour. One possible explanation for this apparent increase in NOS 
activity is given in chapter 5 of this thesis, in which data are presented showing that 
inflammatory cells, which are a rich source of NOS (Riesco et a l ,  1993; Kolb et a l ,
1994), infiltrate the myometrium during labour.
Chapter 2 of this thesis, describes a study to determine the activity and expression of 
each of the 3 isoforms of NOS in uterine tissue collected from women before and
#during spontaneous labour at term. Since other biological mediators, including 
superoxide dismutase and xanthine oxidase, can interact with nitric oxide to alter its 
effects, changes in the expression of these molecules might be involved in the onset of 
parturition. In chapter 3, the results of a study to investigate the expression of 
superoxide dismutase and xanthine oxidase during normal pregnancy and parturition are 
reported.
Bansal et a l ,  (1997) recently reported that myométrial iNOS expression, assessed by 
immunohistochemistry and Western blotting, was greater in the early third trimester 
(26-34 weeks gestation) than either the late third trimester (37-41 weeks gestation) or in î?
the non-pregnant state. These data suggest that an increase in myométrial INOS
V
expression might contribute to the maintenance of uterine quiescence during pregnancy.
In chapter 4, the results of a study to investigate the uterine expression of each of the 
constitutive isoforms of NOS (eNOS and bNOS) in non-pregnant women and pregnant 
women delivered preterm and term, are reported.
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Factors controlling the up-regulation in uterine NOS expression during pregnancy 
remain uncertain. In animals both oestrogen and progesterone have been proposed as 
regulators of NOS in vivo. Oestrogen upregulates guinea pig constitutive NOS 
expression (Weiner et al., 1994b). In sheep uterine artery, oestrogen enhanced 
endothelial NOS activity, and in rat hypothalmus, oestrogen increased bNOS 
expression (Veille etal., 1996; Cecatelli etal., 1996). In studies of women treated with 
a GnRH analogue together with either oestrogen replacement or placebo, fasting plasma 
nitrate concentrations were higher in the estrogen treatment group, suggesting that 
oestrogen stimulated nitric oxide production (Ramsay et al., 1995). In contrast, 
YallampaUi et al., (1994b) have demonstrated that treatment with either oestradiol alone 
or oestradiol and progesterone, resulted in lower nitrite/cGMP content in rat uterus, 
compared with animals treated with vehicle alone.
Nitric oxide and cervical ripening
The results of recent animal studies on nitric oxide production and NOS expression in 
the cervix indicate that nitric oxide may play a role in cemcal ripening. The nitric oxide 
generating system is present in the rat cervix and in contrast to the body of the uterus, it 
is down-regulated during pregnancy, but up-regulated during term and preterm labour 
(Buhimschi et al,  1996). Treatment of pregnant guinea-pigs with the NOS inhibitor L- 
NAME induced preterm labour but delayed physiological cemcal ripening resulting in 
prolonged deliveries (Chwalisz et a l,  1994b). Furthermore, L-NAME treatment of 
pregnant rats significantly prolonged the duration of labour, suggestive of cervical 
dystocia, whilst a decrease in cervical extensibilty was observed after in vitro incubation 
with L-NAME (Buhimschi e ta l,  1996). Chwalisz et a l ,  (1997) demonstrated that the 
local application of the nitric oxide donor sodium nitroprasside, produced effective 
ripening of the guinea-pig cervix, assessed by both force resistance measurements and 
morphological evaluation. It seems that, at least in animal pregnancy, nitric oxide 
represents a final metabolic pathway of cervical ripening. Acting in concert with
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prostaglandins, particularly PGE2 , nitric oxide might induce local vasodilatation and 
increase vascular permeability and leukocyte infiltration, and perhaps also activate 
matrix metalloproteinases and other mechanisms responsible for the extracellular matiix 
remodelling (Chwalisz et al,  1997).
There aie no studies investigating the L-aiginine nitric oxide system in the pregnant, 
human cervix. The effects of the nitric oxide donor GTN, administered sublingually, 
on the non-pregnant cervix have been subjectively assessed. Shaker et a l ,  (1993) 
found that GTN had no significant effects on the ease of embryo transfer after in-vitro 
fertilization. Yadava, (1990) reported that GTN facilitated the transcervical introduction 
of intia-uterine contraceptive devices. Chapter 6, describes the results of a study to 
determine the effects of the nitric oxide donors glyceryl tiinitrate and isosorbide 
mononitrate on the first trimester human cervix. In chapter 7, the results of a 
randomised controlled trial to determine the side effect profile of isosorbide mononitrate 
in comparison with the prostaglandin analogue geraeprost, when used to ripen the first 
trimester human cervix, is reported and the clinical effectiveness of the nitric oxide 
donor for this indication, investigated.
In summaiy, the work in this thesis aims to determine whether changes in the activity 
and expression of the L-arginine nitric oxide system within the uterus, are involved in 
the maintainence of human pregnancy and the onset of parturition.
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Chapter 2 
Nitric oxide synthase activity and localisation do not change 
in uterus and placenta during human parturition 
Introduction
Animal studies have suggested a role for nitiic oxide in the onset of parturition. NOS 
activity is up-regulated during pregnancy and inhibits uterine contractility until term. At 
the onset of paiturition, NOS activity decreases, thus freeing the myometrium from the 
relaxant effect of nitric oxide and stimulating uterine contractions (Yallampalli et al, 
1993a; Natuzzi et al, 1993; Sladek et al, 1993; Yallampalli et al, 1994). In human 
pregnancy, the L-arginine-nitric oxide system is present within myometrium 
(Buhimschi et al, 1995), placenta (Myatt et al, 1993), and fetal membranes (Di lulio et 
al, 1996). It may be possible that nitric oxide derived from each of tliese tissues 
regulates myométrial contractions. However, its short half life of a few seconds, and 
its reactivity mean that nitric oxide is most likely to act as a local messenger molecule 
transferring messages within and between individual cells (Vallance and Collier, 1994). 
It seems likely therefore that only the myometrium itself, or tissues in close apposition 
to the myometrium will influence myométrial contractility. Several studies have 
attempted to determine whether a change in NOS activity occurs at the onset of 
parturition (Gude et al, 1994; Ramsay et al, 1996; Di lulio et al, 1996). These 
studies have failed to assess all of the cell types within the pregnant uterus and have 
relied solely upon in vitro analysis of NOS activity.
Since nitric oxide is produced within the pregnant human uterus, we hypothesise that in 
humans, as in animals, NOS activity is high during pregnancy and decreases at the 
onset of parturition. Such a mechanism would contribute to the control of the onset of 
labour. The aim of this study was to determine whether the expression of NOS
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isoforms is altered in myometrium, placenta, decidua and fetal membranes in women 
before and after the onset of labour at term, and to localise, using 
immunocytochemistry, each of the three NOS isoenzyme proteins. Furthermore, we 
assessed whether a reduction in NOS enzyme activity occurs in these tissues following 
the onset of spontaneous labour.
Materials & methods
Subjects and collection of tissue
Twenty-two women, undergoing Caesaiean section at term, (>37 weeks' gestation), 
were recruited to the study. Eleven of these women had an elective Caesarean section 
performed prior to the onset of labour. A further 11 were delivered by emergency 
Caesarean section during active labour, (cervical dilatation greater than 4 cm and less 
than 9 cm). Women were excluded from the study if they had a multiple pregnancy, or 
evidence of active infection, or following induction of labour. At operation, a 
myométrial strip was obtained from the upper margin of the lower uterine segment 
incision. In addition full-thickness biopsies of placenta and fetal membranes with 
attached decidua capsulaiis were obtained within 10 minutes of delivery. The biopsies 
were divided; one half was fixed in 10% neutral buffered formalin (BDH, UK) and 
embedded in paraffin, and the other half was snap frozen in liquid nitrogen and 
subsequently stored at -70°C. Infonned consent was obtained from each woman prior 
to recruitment and the study was approved by the Local Research Ethics Committee.
Immunocytochemistry for eNOS
Eight micrometer thick sections were cut from the paraffin embedded tissues and 
mounted on silane-coated slides, heated to 60°C for 35 min, depai’affinized in xylene 
and rehydrated in a graded alcohol series. The sections then underwent enzymatic
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digestion in a 0.01% (w/v) solution of calcium chloride containing 0.01% (w/v) 
protease type XXIV (Sigma, Poole, UK), for 10 min at 37°C. The sections were pre- 
incubated with 3% (w/v) immunoglobulin-free bovine serum albumin (BSA, Sigma) in 
PBS (10 mM sodium phosphate, pH 7.5, 120 mM sodium chloride) for 20 min at room 
temperature. They were then incubated for one hour at room temperature with a 
monoclonal antibody raised against a 20.4 kDa protein fragment corresponding to 
amino acids 1030-1209 of human eNOS (Affiniti, Nottingham, UK) diluted 1/100 in 
3% BSA. Next, sections were washed in 0.1% Triton-X 100, followed by two washes 
in PBS before incubation with biotinylated anti-mouse immunoglobulin. This 
antibody, from a Vectastain Elite ABC kit (Vector, Peterborough, UK) was first diluted 
in 3% BSA and 1.5% normal human serum. After washing as before, sections were 
placed in 3% hydrogen peroxide in methanol for 10 min at room temperature. The 
sections were thoroughly washed again, then incubated for 30 min with avidin DH / 
biotinylated horseradish peroxidase H reagent (Vectastain Elite ABC kit) in PBS before 
final washing, hnmunoreactive eNOS was localised using 1 mg/ml diaminobenzidine 
tetrahydrochloride (DAB), 0.02% H2 O2  in 50mM Tris.Cl, pH7.6, and appeared as a
brown end-product.
Negative controls included sections incubated without the primary antibody and 
sections incubated with a mouse monoclonal antibody against IgGl Aspergillus niger 
glucose oxidase (Dako Ltd., High Wycombe, UK), an enzyme which is not expressed 
in mammalian cell systems. A section of human umbilical cord was used as a positive 
control. Immunostaining for eNOS was confined to the endothelium.
Immunocytochemistry for bNOS
Immunocytochemistry was performed on eight micrometer paraffin-embedded sections 
using a polyclonal antibody raised against amino acids 724-739 of rat brain NOS 
(Serotec, Oxford, UK). This antibody recognises human bNOS, (100% sequence
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homology) with no reported cross-reactivity with iNOS or eNOS. It was used on 
membranes, decidua and placenta in a working dilution of 1/1750 and 1/2000 on 
myometrium, with a rabbit IgG Vectastain ABC kit (Vector) according to the 
manufacturer’s instructions. The sections were pretreated by microwaving at full 
power for 4 X 5 min in citrate buffer (lOmM, pH 6.0).
Negative controls included slides incubated without the primary antibody and slides 
incubated with non-immune rabbit serum (SAPU, Carluke, UK), in place of the 
primary antibody. In addition, liquid-phase absorption controls were performed by 
incubating the primary antibody with increasing concentrations of the bNOS 
immunogen (0.01-100 nmol/ml), (Serotec, Oxford, UK) for 60 min at 37°C prior to 
incubation with the sections. A section of rat brain was used as a positive control.
Immunocytochemistry for iNOS
Immunocytochemistiy was performed using 3 different rabbit polyclonal iNOS 
antibodies (table 2.1).
Tahle 2.1 iNOS primaiy antibodies used for immunocytochemistry
Antibody Immunogen Dilution Presentation Source
PA3-030 a.a. 1131-1144 of 
murine iNOS
1/800-1000 affinity purified Cambridge Bioscience
SC-649 a.a. 1135-1153 of 
human iNOS
1/100-600 affinity purified Santa Cruz
N053 C- terminal heptamer 
of human iNOS
1/20 000 neat antisemm Merck Research*
* Donated by Dr R. A. Mumford, Merck Research Laboratories, USA
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Sections of each tissue were stained as follows:
(i) the polyclonal antibody PA3-030 (Cambridge Biosciences, Cambridge, UK) was 
used on untreated paraffin sections at a dilution of 1/800 to 1/1000, and a rabbit IgG 
Vectastain ABC kit (Vector, UK).
(ii) the polyclonal iNOS antibody, sc-649, (Santa Cruz, Heidelberg, Germany) was 
employed on serial sections of each tissue. With this antibody, the sections required 
antigen retrieval by microwaving at full power for 4 x 5 min in one litre of citrate buffer 
(lOmM, pH 6.0). The antibody was used in a dilution of 1/100 to 1/600, and 
immunocytochemistry was carried out using a rabbit IgG Vectastain ABC kit (Vector, 
UK) according to the manufacturer's instructions.
(iii) an iNOS antibody (N053) raised against a synthetic peptide containing the extreme 
carboxy-terminal heptamer of human iNOS, was kindly gifted to us by Dr R. A. 
Mumford, (Merck Research Laboratories, Rahway, USA). Since this antibody has 
been validated on cryosections, five micrometer thick sections were cut from the frozen 
tissue and mounted on silane coated slides. The sections were fixed in acetone for 10 
mins., and then pre-incubated with 25% (w/v) normal goat semm/pooled human semm 
(SAPU, Caiiuke, Scotland) for one hour at room temperature. The antibody was then 
applied at a dilution of 1/20,000 and incubated for 16 hours at 4° C. Thereafter, the 
procedure was carried out as previously described using a rabbit IgG Vectastain ABC 
kit (Vector, UK).
For each of these antibodies, control slides were incubated without the primaiy 
antibody and liquid-phase absorption controls were performed using the appropriate 
immunogen peptides (Cambridge Biosciences, Cambridge, UK, Thistle Peptide, 
Glasgow, UK, and Merck Research Laboratories, Rahway, USA, respectively). 
Furtheimore, antibody PA3-030 was used to immunolocalise iNOS protein on sections
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of endometrium and myometiium from a wild type mouse and an iNOS knock-out 
mouse (gifted by Professor E.Y. Liew). This test could not be applied to antibodies sc- 
649 and N053 which do not recognise murine iNOS. A section of diseased human 
lung tissue was used as a positive control, (Nicholson et al 1996).
Vimentin and Cytokeratin Immunocytochemistry
In order to identify decidua and trophoblast respectively, immunocytochemistry was 
undertaken on serial paraffin sections using antibodies directed against vimentin and 
cytokeratins, thereby facilitating the localization of the NOS staining. A polyclonal 
antibody directed against vimentin, isolated from calf lens (Euro-path, Cornwall, UK) 
was used in a dilution of 1/150 with a rabbit IgG Vectastain ABC kit (Vector, UK). 
Control slides were incubated without the primary antibody. In addition, 
immunocytochemistiy was performed using a monoclonal antibody directed against 
human cytokeratins (numbers 5, 6, 8, 17 and 19), (Dako, High Wycombe, UK). The 
sections required enzymatic digestion with a 0.1% (w/v) trypsin (Sigma, UK) solution 
in Tris buffer (pH 7.6) containing 0.1% (w/v) calcium chloride, for 10 min at room 
temperature, and the procedure was performed using a mouse IgG Vectastain ABC kit 
(Vector, UK).
Nitric oxide synthase enzyme activity
Nitric oxide synthase enzyme activity was determined by conversion of [^^C] L- 
ai'ginine to [ '^^ C] L-citmlline using a commercial kit, (NOS detect assay, Alexis 
Corporation, Nottingham). Frozen tissue was homogenised in five volumes of cold 
250mM Tris-HCl (pH 7.4), lOmM EDTA and lOmM EGTA. Homogenised tissue was 
centrifuged at llOOOg for 5 min at 4°C, thereafter supernatants were collected and kept 
on ice for no longer than 15 min before assay. The supernatant was incubated for either 
60 min (placenta) or 90 min (myometrium and membranes) at 37‘’C with buffer
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containing co-factors required for NOS enzyme activity, (ImM NADPH, 0.05ji.Ci 
[14c] L-Arginine, 0.6jlM tetrahydobiopterin, 0.2|aM flavin adenine dinucleotide, 
0.2|iM flavin adenine mononucleotide and 0.6mM Ca CI2 ). After incubation, 0.4ml of 
50mM HEPES buffer (pH 5.5), 5mM EDTA was added to each tube. This mixture was 
added to lOOpl of resin and transferred to a spin cup. This allows elution of the 
negatively charged L-citmlline but retains the positively charged L-ai ginine. The eluate 
was collected after spinning for 30 seconds in a microcentrifuge at full speed and 
counted in a liquid scintillation counter. Samples were incubated both in the absence 
and presence of ImM nitro-L-arginine methyl ester (L-NAME), a competitive inhibitor 
of NOS. NOS activity was determined from the difference between [^^C] citrulline 
produced from control samples and samples containing ImM L-NAME.
Protein content was determined in homogenate supernatants using the Lowry reaction 
(Lowry et al, 1951), and NOS activity was expressed as fmol of product formed per 
min per mg protein. The lower limit of detection of the assay is 0.5 fmol/min/mg 
protein.
Analysis of results
The localisation of each of the 3 isoforms of NOS and intensity of staining were 
recorded by two investigators independently, who were blind to the timing of biopsy in 
relation to labour. Intensity and consistency of staining was scored on a scale of 0 to 6, 
(0 = staining absent, 1 = weak, variable staining, 2 = weak, consistent staining, 3 = 
moderate, variable staining, 4 = moderate, consistent staining, 5 = strong, variable 
staining and 6 = strong, consistent staining). To determine whether there was a 
difference in the intensity of staining between those tissues obtained before and during 
labour, contingency table analysis of the scores was performed, and a chi-square p 
value of <0.05 was taken as significant.
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NOS enzyme activity (fmol/min/mg protein) in those tissues obtained before and after 
labour, was analysed using a Mann-Whitney U test. A value of p<0.05 was taken as 
significant.
Results
(i) Patient characteristics
The mean age (SD), of the 11 women delivered prior to the onset of labour was 30 (6), 
years and their mean (SD), gestation at delivery was 38.2 (0.6), weeks. The mean age 
(SD), of the women in spontaneous labour at term was 30 (5), years and their mean 
(SD), gestation at delivery was 40.1 (0.9), weeks. One of the non-labourers and 3 of 
the labouring women were smokers.
(ii) Immunocytochemistry
Serial sections of placenta and fetal membranes were incubated with antibodies directed 
against vimentin and cytokeratins. These antibodies localised decidua and trophoblast 
respectively and these sections were used to identify the sites of staining produced by 
each of the NOS antibodies.
eNOS
eNOS protein was detected in all of the tissues before and after labour. There was no 
significant difference in staining intensity and localisation for eNOS, between individual 
cell types before and during labour. There was however, a considerable variability in 
the intensity of staining between samples which was not related to whether the sample 
was obtained in or outwith labour. Within myométrial sections, the protein was 
localised to the myométrial smooth muscle cells (myocytes) and the endothelium of
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blood vessels, (figure 2.1 a). Within the placenta, the eNOS staining was of greatest 
intensity in the syncytiotrophoblast, of moderate intensity in the endothelium of blood 
vessels and was weakly present in villous stroma, (figure 2.1 b). In the fetal 
membranes, staining was strongest in the amniotic epithelium, moderately intense in the 
trophoblast (the remains of the cytotrophoblastic cells of the trophoblastic shell), and 
absent in the chorionic connective tissue. eNOS protein was also localised within the 
stromal cells of the decidua, (figure 2.1 c). There was no staining in the negative 
control slides.
bNOS
There was no significant difference in staining intensity and localisation for bNOS, 
between individual cell types before and during labour. In myométrial sections, bNOS 
protein was localised within the myocytes and in the smooth muscle and endothelium of 
blood vessels, (figure 2.2 a). The protein was detected in the placenta, within the 
syncytiotrophoblast, the villous sti’oma and endothelial cells, (figure 2.2 b). The 
amnion, chorion and trophoblast of the fetal membranes were positive, and the protein 
was also localised within the maternal stromal cells of the decidua capsularis, (figure
2.2 c). Staining was absent when the primary antibody was omitted. In liquid phase 
absorption controls, the staining disappeared when 10 nmol/ml of the bNOS 
immunogen was added to the primaiy antibody prior to incubation with the sections.
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Figure 2.1 Localisation of endothelial NOS (eNOS) in (a) myometrium, (b) placenta and (c) 
fetal membranes with attached decidua. There was no significant difference in staining 
intensity and localisation for eNOS, between individual cell types before and during labour, 
(a) eNOS localised to the myométrial smooth muscle cells and the endothelium of blood 
vessels (arrows), (b) Within the placenta, the eNOS staining was of greatest intensity in the 
syncytiotrophoblast, of moderate intensity in the endothelium of blood vessels and was weakly 
present in villous stroma, (c) In the fetal membranes, staining was strongest in the amniotic 
epithelium, moderately intense in the trophoblast and absent in the chorionic connective tissue. 
eNOS protein was also localised within the stromal cells of the decidua. Nuclei were 
visualised with haematoxylin. M = myocytes, E = endothelium, ST = syncytiotrophoblast, 
A = amnion, C = chorion, T = extra-villous trophoblast and D = decidua. Bar = 50 pm.
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Figure 2.2 Expression of brain NOS (bNOS) in (a) myometrium, (b) placenta and (c) fetal 
membranes with attached decidua. There was no significant difference in staining intensity 
and localisation for bNOS, between individual cell types before and during labour, (a) bNOS 
localised to the myométrial smooth muscle cells and the endothelium of blood vessels 
(arrows), (b) Within the placenta, bNOS staining was expressed in the syncytiotrophoblast, 
the endothelium of blood vessels and the villous stroma, (c) In the fetal membranes. bNOS 
was expressed in the cells of the amniotic epithelium, the trophoblast and the fibroblasts of the 
chorion. bNOS protein was also localised within the stromal cells of the decidua. Nuclei were 
visualised with haematoxylin. The negative controls, (see Materials and methods) exhibited 
no reactivity. M = myocytes, E = endothelium, ST = syncytiotrophoblast. VS = villous stromal 
cells, A = amnion, C = chorion, T = extra-villous trophoblast and D = decidua. Bar = 50 pm.
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iNOS
iNOS protein was localised in all the tissues sampled, and localisation was similar with 
the anti-murine iNOS, PA3-030 (Cambridge Bioscience), and anti-human iNOS, sc- 
649 (Santa Cruz) antibodies. However, there were some differences between the 
pattern of staining obtained with these antibodies and that obtained with antibody N053 
(Merck Research Laboratories).
(i). Cambridge Bioscience (PA3-030) and Santa Cruz (sc-649) antibodies.
There was no significant difference in staining intensity and localisation for iNOS, 
between individual cell types before and during labour. In myométrial sections, iNOS 
protein was localised with weak staining to the myocytes and vascular smooth muscle 
(figure 2.3 a). Within the placental sections, there was weak, variable staining for the 
protein in the syncitioti'ophoblast, and more consistent staining within the vascular 
smooth muscle and stromal cells (figure 2.3 b). In the fetal membranes, staining for the 
iNOS protein was weak in the amniotic epithelial cells, and of moderate intensity in the 
chorionic connective tissue, the cells of the extravillous trophoblast and the stromal cells 
of the decidua (figure 2.3 c). Staining was absent when the primary antibody was 
omitted and, in liquid phase absorption controls, the staining disappeai'ed when the 
primary antibody was incubated with the immunogen, prior to incubation with the 
sections. iNOS was localised to endometrial glandular epithelium and myométrial 
smooth muscle cells of the wild type mouse. There was no staining in the tissue 
sections from the iNOS knock-out mouse.
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Figure 2.3 Localisation of inducible NOS (iNOS) in (a) myometrium, (b) placenta and (c) 
fetal membranes with attached decidua, using antibodies PA3-030 (Cambridge Bioscience) 
and sc-649 (Santa Cruz). There was no significant difference in staining intensity and 
localisation for iNOS, between individual cell types before and during labour, (a) iNOS 
localised to the myométrial smooth muscle cells and the smooth muscle of blood vessels 
(arrow) with weak intensity, (b) Within the placenta, iNOS staining was expressed in the 
syncytiotrophoblast, the endothelium of blood vessels and the villous stroma, (c) In the fetal 
membranes, iNOS was weakly expressed in the cells of the amniotic epithelium, and localised 
with moderate intensity in the trophoblast, the fibroblasts of the chorion and the stromal cells 
of the decidua. Nuclei were visualised with haematoxylin. The negative controls, (see 
Materials and methods) exhibited no reactivity. M = myocytes, E = endothelium, 
ST = syncytiotrophoblast, VS = villous stromal cells, A = amnion, C = chorion, T = extra­
villous trophoblast and D = decidua. Bar = 50 pm.
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(ii). Merck Research Laboratories, (antibody N053).
Using antibody N053, iNOS protein was localised in myométrial sections with weak 
staining in the myocytes and vascular smooth muscle (figure 2.4 a), a similar pattern to 
that obtained with PA3-030 and sc-649. Within the placenta, iNOS was localised in
occasional and isolated cells within the villous stroma and in extravillous trophoblast. 
The villous trophoblast and endothelial cells were negative (figure 2.4 b). In the fetal 
membranes, staining was present in the amniotic epithelium and the extra-villous 
trophoblast, but in contrast to the results obtained with PA3-030 and sc-649, staining 
was absent in the cells of the chorion and decidua (figure 2.4 c). Control slides, 
including preabsorption with the immunogen peptide, showed no staining.
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Figure 2.4 Expression of inducible NOS (iNOS) in (a) myometrium, (b) placenta and (c) fetal 
membranes with attached decidua, using antibody N053 (Merck Research Laboratories). 
There was no significant difference in staining intensity and localisation for iNOS, between 
individual cell types before and during labour, (a) iNOS localised with weak intensity to the 
myométrial smooth muscle cells, (b) Within the placenta, iNOS was localised in occasional 
and isolated cells within the villous stroma (arrow). The villous trophoblast and endothelial 
cells were negative, (c) In the fetal membranes, iNOS was present in the amniotic epithelium 
and the extra-villous trophoblast, but in contrast to the results obtained with PA3-030 and 
sc-649, staining was absent in the cells of the chorion and decidua. Nuclei were visualised 
with haematoxylin. The negative controls, (see Materials and methods) exhibited no 
reactivity, M = myocytes, ST = syncytiotrophoblast, A = amnion, C = chorion, 
T = extra-villous trophoblast and D = decidua. Bar = 50 pm.
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(ii) NOS enzyme activity
There was no significant difference in NOS enzyme activity in myometrium, placenta or 
fetal membranes, with attached decidua, before compared with during labour at term, 
(p>0.05), (figure 2.5). NOS enzyme activity was much greater in placenta than in the 
other tissues sampled. The median value of NOS enzyme activity in each tissue was: 
myometrium before labour = <1, myometrium during labour = <1, fetal membranes 
before labour = 5, fetal membranes during labour = 9, placenta before labour = 520, 
placenta during labour = 420 fmol/min/mg protein.
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Figure 2.5 NOS enzyme activity (fmol/min/mg protein) in each of the tissues before, (no 
lab) and after, (lab) the onset of labour. Activity is plotted on a log 10 scale and n = 9 in 
each group. There is no significant difference (p>0.05, Mann Whitney U tests) in NOS 
enzyme activity in any of the tissues following the onset of labour, (myo = myometrium, 
memb = fetal membranes with attached decidua, and plac = placenta).
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Discussion
We have localised each of the three isoforms of NOS in human myometrium, placenta, 
fetal membranes and decidua before and after the onset of par turition at term. Using a 
quaUtative method to assess the intensity of staining, and a quantitative measure of 
enzyme activity, we have found no difference in either staining intensity and 
distribution, or enzyme activity of NOS in myometrium, placenta or membranes before 
and during labour at term. These results suggest that, in contrast to animal studies, a 
decrease in NOS enzyme activity may not be involved in the onset of parturition at term 
in the human.
Animal studies in the rat and rabbit have provided convincing evidence that nitiic oxide 
has a physiological role in the maintenance of pregnancy and that a reduction in NOS 
enzyme activity is involved in the onset of parturition, (Yallampalli et al,  1993a; 
Natuzzi etal ,  1993; Sladek etal,  1993). Studies of human parturition have found no 
decrease in NOS enzyme activity, assessed as the conversion of L-arginine to L- 
citmlline, after the onset of spontaneous labour in myometrium (Ramsay et al,  1996), 
placenta (Gude et al,  1994; Di lulio et al,  1996) or fetal membranes (Di lulio et al,  
1996). Indeed, Ramsay et al, (1996) found an increase in calcium-independent NOS 
activity (iNOS activity) in myométrial samples obtained during labour compared with 
those obtained before the onset of labour.
We have failed to find a decrease in NOS activity following the onset of human 
parturition. In contrast to the rat, changes in nitric oxide appeal' to be less important 
during guinea-pig parturition (Weiner et al, 1994). In this animal model, although a 
decrease in cyclic guanosine 3',5’-monophosphate levels, (cGMP, the second 
messenger system through which nitric oxide exerts its effects) can be demonstrated 
following the onset of labour, factors other than changes in NOS activity are
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responsible. In human myometrium, a sirailai' fall in cGMP has been demonstrated 
following the onset of labour (Buhimschi et al,  1995), and again our data and others 
suggests that agents other than nitric oxide are involved. Whilst a decrease in NOS 
activity may be involved in the initiation of parturition in some animal species, nitric 
oxide may be less important in others, and caution should be exercised in extrapolating 
from one species to another.
One caveat to this conclusion relates to the method of measurement of NOS activity. 
All of the studies investigating NOS activity in human parturition, including our study, 
have assessed enzyme activity by measuring the conversion of radio-labelled L-arginine 
to L-citmlline. However, in vitro NOS enzyme activity may not reflect in vivo uterine 
NOS activity (Sladek and Roberts, 1996), where the limited availability of cofactors can 
attenuate the production of nitric oxide. Furthermore, availability of such co-factors 
may be regulated by cytokines in vivo (Werner-Felmayer et al, 1993).
Whilst our results indicate that there is no reduction in either NOS activity or expression 
during human parturition, nitric oxide might still play a role in the onset of human 
labour. Lee and Chang, (1995) have demonstrated an increased sensitivity of human 
myometrium to the tocolytic effect of nitric oxide during pregnancy compared to non­
pregnant myometrium, whilst Buhimschi et al,  (1995) have demonstrated a decreased 
sensitivity to the tocolytic effect of nitric oxide following the onset of labour. This 
change in sensitivity will cause an increase in myometiial contractions following the 
onset of parturition even in the presence of constant levels of nitric oxide. It is unclear 
at present whether this change in sensitivity is specific to nitric oxide or also includes 
other myométrial relaxants (Norman, 1996). Other biological mediators can interact 
with nitiic oxide to alter its effects, for example the enzyme superoxide dismutase 
(SOD) prolongs the biological half-life of nitric oxide (Huie and Padmaja, 1993). SOD 
is known to be present within the endometrium of the non-pregnant utems (Sugino et 
al, 1996), and a reduction in SOD enzyme activity within uterine tissues at the onset of
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labour would, in turn reduce the biological activity of nitric oxide, and stimulate uterine |
contractions. Such a hypothesis is addressed in chapter 3 of this thesis.
Immunocytochemical studies investigating the expression of NOS isoenzymes, and in Î;
particular iNOS, in human cells have aroused concern regarding the specificity of the
gantibodies employed (Nicholson et al,  1996). Amin et al, (1995), reported that a 
commercially available monoclonal antibody reactive with murine macrophage iNOS 
(Transduction Laboratories, Lexington, USA), binds to both human and rat bNOS.
In this study we observed differences in the localisation of iNOS protein when different 
antibodies were employed, suggesting either that these antibodies recognise different 
proteins or that there is non-specific binding. Although one of these antibodies, PA3- 
030, (Cambridge Biosciences), has recently been reported to bind specifically to mouse 
macrophage and human hepatocyte iNOS (Amin et al, 1995), the specificity of 
antibody N053 has been more rigorously characterised and validated (Nicholson et al,
1996). Furthermore, the results obtained with antibody N053, (Merck Reseaieh 
Laboratories) demonstrating an absence of iNOS staining in placental villous 
trophoblast, aie in keeping with published data. No evidence of iNOS protein or gene 
expression can be demonstrated by in situ hybridisation, immunocytochemistry, (using 
both an IgG2a-monoclonal antibody and a polyclonal antibody), or polymerase chain 
reaction in human placentae under physiological conditions, (Conrad et al,  1993;
Garvey et al,  1994; Schonfelder et al,  1996). In contrast, we observed variable 
staining for the iNOS protein in the syncitiotrophoblast, and more consistent staining 
within the vascular smooth muscle and stromal cells with PA3-030 and sc-649.
The localisation of eNOS and bNOS enzymes within the placenta is consistent with 
previous morphological and immunocytochemical investigations, (Myatt et al,  1993;
Myatt etal,  1997; Graf et al, 1994). There have been no published data regarding the 
localisation of any of the NOS enzymes in fetal membranes, decidua or pregnant human
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myometrium. However, our results reported here showing iNOS staining in pregnant 
human myometrium is in keeping with our previous results showing iNOS 
immunoreactivity in the myométrial smooth muscle cells of the non-pregnant uterus 
( ïqXîqx et al, 1997).
We and others (Ramsay et al, 1996; Di lulio et al, 1996), have demonstrated that NOS 
enzyme activity is much greater in placenta than in the other tissues sampled. This 
finding is consistent with large amounts of constitutive NOS (bNOS and eNOS) within 
the trophoblast and endothelial cells of this tissue (Di lulio et al, 1996).
The study was designed to investigate NOS enzyme activity in human tissues obtained 
before and after the onset of labour at term and, extiapolating from animal studies, 
assumed that nitric oxide, a smooth muscle relaxant, maintains uterine quiescence until 
the onset of labour. Sladek and Roberts, (1996) recently found that spontaneous labour 
did not begin until more than 24 hours after the final decrease in uterine NOS activity in 
the gravid rat uterus at term. They concluded that the decrease coincides with the 
preparation of the uterus for parturition rather than the final activation of labour. 
Perhaps we have failed to demonstrate a decrease in NOS activity in the human utems at 
term since the decrease occurs before 37 weeks' gestation, and this may be one of the 
factors governing the transition from Braxton Hicks contractions to the myométrial 
contractions of labour. This hypothesis is examined in chapter 4.
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Chapter 3
The expression of superoxide dismutase and xanthine oxidase 
in myometrium, fetal membranes and placenta during normal 
pregnancy and parturition. 
Introduction
A role for nitric oxide in the control of rat and rabbit parturition is supported by a 
vai'iety of studies. Nitric oxide production within the uterus is high during animal 
pregnancy, but decreases at term thus initiating uterine activity at the onset of parturition 
(Sladek eta l ,  1993; Natuzzi etal ,  1993; Yallampalli etal ,  1993). In contrast, we and 
others, have found no evidence that NOS activity is decreased following the onset of 
labour in human parturition either in the myometrium itself or in placenta or fetal 
membranes (Ramsay etal ,  1996; Di lulio et a l ,  1996; Thomson et a l ,  1997 - chapter 
2). However, a change in nitric oxide activity may control parturition by mechanisms 
other than nitric oxide production. The biological actions of nitric oxide are abrogated 
via direct reaction with superoxide anion (McCall et al ,  1989; Huie and Padmaja, 
1993). Moreover superoxide dismutase (SOD), which converts superoxide to 
hydrogen peroxide and oxygen (Klug-Roth et al ,  1973) prolongs the biological half- 
life of nitric oxide by removing superoxide. SOD exists as three isoenzymes, which are 
widely distributed. An intracellulai* copper/zinc containing enzyme is found 
predominantly in the cytoplasm and nucleus (Crapo et a l ,  1992), a manganese 
containing SOD (Mn SOD) is found predominantly in mitochondria (Weisiger and 
Fridovich, 1973) and a third isoenzyme, extracellular SOD, is found in the extracellular 
matrix (Marklund, 1984). The importance of SOD in the augmentation of nitric oxide 
activity is illustrated by experiments showing that diethyldithiocarhamate (DETCA), an 
inhibitor of Cu/Zn SOD, diminishes nitric oxide-mediated relaxation of vascular smooth 
muscle (Rubanyi, 1988; Mugge eta l ,  1991; Omai' etal,  1991).
■I:
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Whilst SOD breaks down superoxide anion, xanthine oxidase synthesises superoxide. 
Xanthine oxidase appears to be one of the major superoxide producing enzymes in 
vessel walls (Jarasch et al., 1986). Nitric oxide-induced relaxation can be potentiated in 
blood vessels by xanthine oxidase inhibitors (Miyamoyo et al,  1996), suggesting that 
xanthine oxidase is an important regulator of nitric oxide activity.
We hypothesised that expression and activity of SOD and xanthine oxidase might 
change with the onset of labour in such a way that the biological activity of nitric oxide 
would be attenuated. The purpose of this study was to test this hypothesis by 
determining the activity and localisation of Cu/Zn, Mn SOD and xanthine oxidase in 
human myometrium, placenta and fetal membranes before and after the onset of labour.
Materials and methods
Tissue collection
Twenty-two women undergoing Caesarean section at term (>37 weeks' gestation) were 
recruited to the study. Eleven had an elective Caesarean section prior to the onset of 
labour. The other eleven were delivered by emergency Caesarean section during active 
labour, (cervical dilatation greater than 4 cm). Exclusion criteria and collection of 
tissue, (myometrium, placenta and fetal membranes with attached decidua) was as 
described in chapter 2. Each of the biopsies was divided; half was fixed in 10% neutral 
buffered formalin (BDH, UK) and embedded in paraffin. The other half was snap 
frozen in liquid nitrogen and stored at -70°C. Informed consent was obtained from each 
woman and the study was approved by the Local Research Ethics Committee.
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Immunocytochemistry
Five micrometer sections of paraffin embedded tissues were cut and mounted on silane- 
coated slides, heated to 60°C for 30 min, deparaffinized in xylene and rehydrated in a 
graded alcohol series. Negative control slides were incubated without primary 
antibody. Two independent observers scored the intensity of staining in five different 
microscope fields. Intensity and consistency of staining was scored on a scale of 0 to 
6, as described in chapter 2. Data were analysed using contingency tables and Chi 
squared p values were obtained.
Immunocytochemistry for Cu/Zn SOD
Immunocytochemistry was carried out using a monoclonal antibody against human Cu- 
Zn SOD (Sigma, Poole, UK) diluted 1/200, and an anti-mouse IgG peroxidase kit 
(Vectastain Elite ABC kit. Vector, Peterborough) as the detection system. 
Immunoreactive Cu-Zn SOD was localised using Img/ml diaminobenzidine 
tetrahydrochloride (DAB, Sigma) and 0.02% H2 O2  in 50mM Tris HCl, pH 7.6. 
Following immunocytochemistiy sections were washed in distilled water, conterstained 
with Harris hematoxylin and mounted in DPX (BDH, UK).
Immunocytochemistry for Mn SOD
Immunocytochemistry was performed using a polyclonal antibody raised against human 
Mn SOD (The Binding Site, Birmingham, UK) diluted 1/250. Sections were pre- 
treated with a 0.01% (w/v) solution of protease type XXIV (Sigma, Poole, UK) in 
0.01% (w/v) calcium chloride for 10 min at 37°C then washed in water and phosphate- 
buffered saline (PBS), pH 7.5. Antibody binding was detected using an anti-sheep 
IgG peroxidase kit (Vectastain Elite ABC kit, Vector) and D/kB as substrate.
Immunocytochemistry for xanthine oxidase
Immunocytocheinistry was carried out on paraffin-embedded sections using a 
polyclonal antibody raised against purified xanthine oxidase from bovine buttermilk 
(Lome Laboratories, Reading, UK). This antibody has been shown to cross-react with 
human xanthine oxidase. The antibody was diluted 1/1000 and antibody binding was 
detected on protease-treated sections using an anti-rabbit IgG peroxidase kit (Vectastain 
Elite ABC kit, Vector).
Isolation of mitochondria for SOD assay
Frozen tissue was homogenised in homogenisation medium (HM) containing 0.3M 
sucrose, 5mM [morpholinojpropanesulfonic acid (MOPS) and ImM EDTA and the 
resultant homogenate spun at 2500 g for 5min. An aliquot of the supernatant was 
collected for assay of total SOD activity and the remainder was spun at 10000 g for 10 
min to separate mitochondrial and cytoplasmic cell fractions. The supernatant was 
collected (cytoplasmic fraction) for SOD assay and the pellet was resuspended in HM 
medium. Homogenization and low and high speed centrifugation was repeated and the 
pellet obtained was again resuspended in HM (mitochondrial fraction). The purity of 
this mitochondrial fraction was determined using transmission electron microscopy.
Determination of SOD activity
Frozen tissue was homogenised in HM and spun at 2500 g for 5 minutes to remove cell 
debris. SOD activity was determined using an assay kit from Calbiochem (Nottingham, 
UK). This kit makes use of a proprietary reagent that undergoes alkaline auto-oxidation 
which is accelerated by SOD (Nebot et a l, 1993). Interference from haemoglobin was 
eliminated by precipitation prior to assay using ice-cold ethanol/chloroform 62.5/37.5 
(v/v) followed by centrifugation at 3000 g for 5 min at 4°C. SOD activity was
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determined from the Vs/Ve ratio of the auto-oxidation rates measured in the presence 
(Vs) and absence (Vc) of homogenised tissue. The data obtained was expressed as SOD 
activity units (U-525) per mg protein. One SOD activity unit is the activity that doubles 
the auto-oxidation background (Vs/Vc=2). Protein concentration was measured by the 
method of Lowry (Lowry, 1951). The detection limit of the SOD assay is 0.2U/ml. 
The intra-assay coefficient of variation was determined by calculating Vs/VC on 12 
replicate samples of homogenate of placental tissue. The mean of the obtained data was 
1.69, the SD was 0,09 and the CV was 5.2%. The inter-assay mean was 1.74, the SD 
was 0.09 and CV was 5.2%.
Results
Immunocytochemistry for Cu/Zn SOD in myometrium, placenta and fetal 
membranes
Cu/Zn SOD was identified in each of the tissues examined (figure 3.1 a-c). There was 
no difference in localisation or intensity of staining of Cu/Zn SOD in myometrium, 
placenta or membranes obtained from women delivered before or after the onset of 
labour. In the myometrium Cu/Zn SOD was localised to myocytes and endothelial cells 
of myométrial blood vessels (figure 3.1 a). In the placenta intense immunostaining was 
observed in the syncytiotrophoblast whilst endothelial cells of villous vessels and 
villous stromal cells exhibited moderate staining (figure 3.1 b). In the fetal membranes 
there was either a lack of staining or only veiy weak staining in the amnion, moderate 
staining in the chorion and extra-villous trophoblast and intense staining in decidua 
(figure 3.1 c). Specificity of antibody binding was confirmed by the presence of 
immunostaining for Cu/Zn SOD in epithelial cells in human endometrium, hepatocytes 
in human liver and epithelial cells in human kidney.
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Figure 3.1 Localisation of Cu/Zn superoxide dismutase (Cu/Zn SOD) protein in 
myometrium, placenta and fetal membranes with attached decidua, (a) Cu/Zn SOD localised 
to myocytes and endothelium of blood vessels in myometrium (arrows), (b) in the placenta 
intense Cu/Zn SOD immunoreactivity was observed in the syncytiotrophoblast whilst 
endothelial cells of blood vessels and villous stromal cells exhibited moderate staining, (c) 
Faint staining for Cu/Zn SOD staining in amniotic epithelium and moderate staining in 
chorion and extravillous trophoblast was observed in fetal membranes. Attached decidua 
showed intense Cu/Zn SOD staining. M = myocytes, E = endothelium, VS = villous stromal 
cells, ST = syncytiotrophoblast. A = amnion, C = chorion, T = extra-villous trophoblast, 
D = decidua. Bar = 50 pm.
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Immunocytochemistry for Mn SOD in myometrium, placenta and fetal 
membranes
The cellular distribution of Mn SOD cells in myometrium and placenta was similai' to 
that of Cu/Zn SOD although the intensity of staining varied (figure 3.2 a-c). Mn SOD 
staining was localised to myocytes and endothelial cells in the myometrium (figure 3.2 
a), although the staining was less intense than that observed with the Cu/Zn SOD 
antibody. In the placenta, intense staining of the synctiotrohoblast and moderate 
staining of villous vessel endothelial cells and villous stromal cells was observed (figure
3.2 b). In the fetal membranes, in contast to results with Cu/Zn SOD, intense staining 
of amnion and decidua, moderate staining of extravillous trophoblast and faint staining 
of chorion was observed (figure 3.2 c). There was no difference in the localisation of 
staining or in the intensity of staining between tissue obtained before or after the onset 
of labour. Specificity of antibody binding was confirmed by the presence of
fimmunostaining for Mn SOD in epithelial cells in human endometrium, hepatocytes in |
human liver and epihtelial cells in human kidney and epithelial cells in human lung.
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Figure 3.2 Localisation of Mn superoxide dismutase (Mn SOD) protein in myometrium, 
placenta and fetal membranes with attached decidua, (a) Faint Mn SOD staining was 
observed in myocytes and endothelium of blood vessels in myometrium, (b) Mn SOD was 
localised to syncytiotrophoblast, endothelium and stromal cells of placental villi, (c) 
Localisation of Mn SOD to amniotic epithelium, extravillous trophoblast and decidua. 
M = myocytes, E = endothelium, VS = villous stromal cell, ST = syncytiotrophoblast, 
A = amnion, T = extra-villous trophoblast, D = decidual cells. Bar = 50 pm.
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SOD activity in myometrium, placenta and fetal membranes obtained 
prior to or during term labour
SOD activity in each of the tissues studied is shown in table 3.1. There was no 
significant difference in total or mitochondrial SOD activity between tissue obtained 
before and after labour. Electron microscopy confirmed that the isolation procedure for 
mitochondria resulted in a cell fraction consisting mainly of mitochondria.
Table 3.1 Total and mitochondrial SOD activity (mean ± SD, units/mg protein).
Tissue Total SOD activity (n = 9) Mitochondrial SOD activity (n = 8)
Not in labour In labour Not in labour In labour
myometrium 7.7 ±4.1 11.8 ±7 .0 ND ND
placenta 30.6 ± 7.2 28.6 ± 14.5 ND ND
membranes 10.1 ± 8.9 5.0 ± 3.0 5.7 ±5.8 3.7 ± 4.4
Not significant comparing tissues before and after labour using a Mann Whitney U test. 
ND = not determined.
Immunocytochemistry for xanthine oxidase in myometrim, placenta and 
fetal membranes
Xanthine oxidase immunoreactivity was identified in each of the tissues examined. 
There was no difference in localisation or intensity of xanthine oxidase immunostaining 
in myometrium, placenta or membranes obtained from women delivered before or after 
the onset of labour (figure 3.3 a-c). In the myometrium, myocytes showed a variation 
of staining intensity for xanthine oxidase ranging from absent to moderate (figure 3.3
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a). In myométrial vessel endothelial cells there was either a lack of staining or very 
weak staining. In the placenta weak to moderate immunostaining was observed in the 
syncytiotrophoblast and villous stromal cells whilst endothelial cells of villous vessels 
exhibited only weak staining (figure 3.3 b). In the fetal membranes there was a 
variation in staining intensity ranging from weak to strong in amnion, moderate to 
strong staining in the chorion and extra-villous trophoblast and intense staining in 
decidua (figure 3.3 c).
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Figure 3.3 Immunostaining of myometrium, placenta and fetal membranes with attached 
decidua using a xanthine oxidase antibody, (a) Faint xanthine oxidase staining in myocytes in 
myometrium, (b) Moderate staining in syncytiotrophoblast and villous stromal cells of the 
placenta, (c) Xanthine oxidase staining was observed in amnion, chorion, extravillous 
trophoblast and decidua. M = myocytes, VS = villous stromal cell, ST = syncytiotrophoblast, 
A = amnion, C = chorion, T = extra-villous trophoblast. D = decidual cells. Bar = 50 pm.
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Discussion
The results detailed in this study show that Cu/Zn, Mn SOD and xanthine oxidase are 
present in human myometrium, placenta and fetal membranes and decidua but that there 
is no difference in expression of these proteins as determined by immunocytochemistry 
between tissue obtained before or after labour. In addition we have shown that these 
tissues possess superoxide dismutase activity and that there is no difference in total 
SOD activity between tissue obtained before or after the onset of labour.
The enzyme superoxide dismutase is now implicated in an increasing number of clinical 
disorders. Mutations in the Cu/Zn SOD gene ai'e responsible for familial amyotrophic 
lateral sclerosis, an autosomal dominant degenerative disorder affecting motor neurons 
in the cortex, brain stem and spinal cord (Rosen et a l,  1993). Affected individuals 
have a reduction of Cu/Zn SOD in their erythrocytes which may lead to oxyradical cell 
injury. In Down's syndrome, levels of Cu/Zn SOD are elevated by up to 50% (Garber 
et ah, 1979), probably due to the presence of the extra copy of chromosome 21, on 
which the Cu/Zn gene is located (Tan et a l,  1973). Evidence that CuZn SOD may be 
involved in the pathophysiology of Down's syndrome is suggested by experiments 
showing that overexpression of the CuZn SOD gene may impair neurotransmitter 
transport and alter neuromuscular junctions (Elroy-Stein et a l,  1988, Avraham et a i ,  
1991).
We hypothesised that the interaction between SOD and nitric oxide might be important 
in the regulation of the onset of human parturtion. Superoxide, which is a product of 
both oxidative metabolism and the inflammatoiy process, interferes with the biological 
activity of nitric oxide by convening it to peroxynitrite (Beckman and Croe, 1993). In 
contrast, superoxide dismutase converts superoxide to hydrogen peroxide and oxygen, 
and by removing superoxide anion prolongs the biological half life of nitric oxide. The 
precise mechanism by which the myometrium remains quiescent during pregnancy, and
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is then converted to an actively contiacting organ at the onset of parturition is unknown. 
Animal studies, and the work described in this thesis (chapter 4), have suggested a role 
for the smooth muscle relaxant nitric oxide. Uterine production of nitric oxide is high 
during rat and rabbit pregnancy, and declines at the onset of parturtion, initiating 
myométrial contiactility (Sladek et a l ,  1993; Natuzzi et a l,  1993; Yallampalli et a l,  
1993). Although in human pregnancy nitric oxide is produced within the uterus, a 
decline in nitric oxide production at the onset of parturtion has not been demonstrated 
(Thomson et al, 1997 - chapter 2). Both Cu/Zn SOD and Mn SOD may be important 
in promoting myométrial relaxation. It is believed that nitric oxide produced within the 
placenta, decidua, fetal membranes or myometrium may induce guanylate cyclase 
activity and thereby maintain myométrial quiescence during pregnancy. The biological 
activity of placental, decidual or myometiial nitric oxide will be potentiated by 
cytoplasmic Cu/Zn SOD in these tissues. In mitochondria, nitric oxide inhibits 
oxidative phosphorylation by binding to cytochrome oxidase and inhibiting electron 
transport (Bates et al, 1995). This will in turn decrease ATP production, attenuating a 
large range of cellular* processes including muscle contaction (Brown, 1992). If the 
biological activity of mitochondrial nitric oxide is increased, for example by Mn SOD, 
the effect of nitric oxide on inhibition of smooth muscle contraction should be 
enhanced. Changes in myométrial Mn SOD may therefore have profound effects on 
myométrial contractility.
Previous studies have also reported SOD and xanthine oxidase within the human 
reproductive tract. Cu/Zn SOD has been identified within the endometrium, and 
increases immediately prior to implantation (Narimoto et a l,  1991; Sugino et a l,  
1996). Furthermore, decidual cells of early pregnancy show strong immunostaining 
for Cu/Zn and Mn SOD (Sugino et a l,  1996). These results agree with our own data 
showing intense immunostaining for Cu/ZnSOD and Mn SOD in decidual cells at term, 
and suggest that these enzymes may be expressed in the decidua throughout gestation. 
In vitro in the placenta, Mn SOD but not Cu/Zn SOD is induced in cultured human
I ' i
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trophoblast during differentiation (Church et al 1992). These results appear to be at 
variance with our own showing both Cu/Zn and Mn SOD expression in the placenta, 
but these differences may be explained by the fact that they were obtained in vitro. 
Xanthine oxidase activity and mRNA have previously been detected in placenta (Many 
etal., 1996). Immunostaining for xanthine oxidase has previously been detected in 
villous trophoblast and non-villous trophoblast of the fetal membranes, but in contrast 
to our data was not identified within the villous stroma (Many et al, 1996).
If SOD does not play a role in the initiation of paiturition what is its function in the 
reproductive tissues within which it has been identified? After fertilization, embryonic 
and endometrial expression of both Cu/ZnSOD and Mn SOD has been observed 
(Harvey et al,  1995; Sugino et a l,  1996). It has been suggested that such expression 
is important for successful implantation, by protecting the blastocyst from damage by 
superoxide radicals. The function of decidual SOD expression is not known, but 
expression of Mn SOD may protect the decidua from TNF-mediated cell damage. 
Deqidual cells and predecidual cells produce tumour necrosis factor (TNF) (Tabibzadeh, 
1991) and TNF production increases during labour (Opsjon et a l,  1993). TNF may 
damage cells via superoxide anion production (Zimmerman et a l ,  1989), but TNF- 
resistant cells produce Mn SOD which protects them from the cytotoxicity of TNF 
(Wong and Goedell, 1988). Mn SOD is itself induced by TNF (Wong and Goeddel, 
1988), and it may be that in decidua Mn SOD is expressed in order to protect decidual 
cells from high local concentrations of TNF.
In the placenta, SOD may be important in preventing lipid peroxidation. Lipid 
peroxidation involves oxidative or enzymatic conversion of unsaturated fatty acids to 
primary products known as lipid hydroperoxides and a variety of secondary metabolites 
(Carpenter, 1981; Taylor and Morris, 1983). Peroxidation of membrane-associated 
fatty acids and cholesterol alters membrane fluidity and may eventually induce 
widespread membrane damage (Kagan, 1988). Pre-eclampsia is associated with
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elevated levels of lipid peroxidation products and it has been suggested that lipid 
peroxidation may play a role in aetiology of the disease (Hubei et al, 1989). If lipid 
peroxidation is not prevented during pregnancy, diseases such as pre-eclampsia may 
ensue. Moreover, placental and systemic SOD activity and mRNA is lower in pre­
eclampsia compared with normal pregnancy (Wang and Walsh, 1996; Poranen et al.„
1996), suggesting that SOD plays a role in the prevention of pre-eclampsia.
We have failed to show a decline in SOD activity following the onset of labour. 
Notwithstanding, the SOD present within the uterus may play a role in maintaining 
myométrial quiescence prior to the onset of paiturtion. There is some evidence that the 
uterus is more sensitive to the tocolytic effects of nitric oxide in vivo during pregnancy 
compared with isolated myométrial strips in vitro (Lees et a l ,  1994; Rowlands et a l,  
1996; Norman et a l,  1997). In vitro studies have shown that the inhibitory effect of 
nitric oxide donors on myometiial contractility can be potentiated by the inclusion of 
placental tissue within the organ bath (Segal et al, 1997). Taken together, these results 
suggest that the placenta contains an agent which enhances the effect of nitric oxide 
during pregnancy. This agent could be SOD.
In conclusion we have detected systems for synthesis and destruction of superoxide in 
the myometrium and the surrounding placenta, fetal membranes and decidua and have 
discussed ways in which alterations in the balance between nitric oxide and superoxide 
production and destruction may affect myométrial contractility. We have failed to 
demonstrate a change in superoxide production or destmction following the onset of 
labour and it seems unlikely that these processes are implicated in the initiation of 
labour. The widespread distribution of Cu/Zn and Mn SOD in reproductive tissues 
suggests that these enzymes may be important in other reproductive processes such as 
implantation, the prevention of pre-eclampsia and the maintenance of myometiial 
quiescence during pregnancy.
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Chapter 4
The expression of constitutive nitric oxide synthase in the 
non-pregnant, preterm and term uterus: myométrial nitric 
oxide synthase expression is increased during pregnancy. 
Introduction
We and others have demonsti'ated no change in nitric oxide synthesis in myometrium, 
placenta, fetal membranes or decidua, in tissues obtained immediately before and after 
the onset of labour at term (Gude et al., 1994; Ramsay et al., 1996; Di Iulio et al, 
1996; Thomson et al, 1997a - chapter 2). Whilst nitric oxide withdrawl may not be the 
final "trigger" in the initiation of human labour, nitric oxide may still be responsible for 
the maintenance of uterine quiescence during pregnancy. Two strands of evidence 
support this hypothesis. Firstly, nitric oxide relaxes human myometrium both in vitro 
(Buhimschi et al, 1995; Lee and Chang, 1995; Norman et al, 1997) and in vivo ( Lees 
et al,  1994; Rowlands e ta l ,  1996), and secondly, products of the NO-cGMP pathway 
are present within both the non pregnant (Yallampalli et a l,  1994; Buhimschi et a l ,  
1995; Telfer et al,  1997) and pregnant human myometrium (Buhimschi et a l,  1995; 
Thomson et a l,  1997a). Taken together, these data suggest that nitric oxide is 
produced in the myometrium during pregnancy, and could maintain uterine quiescence 
via a relaxant effect on the myometrium.
In support of a role for nitric oxide in the maintenance of pregnancy, Bansal et a l  
(1997) have reported that myométrial INOS expression, assessed by 
immunohistochemistry and Western blotting, was greater in the eaiiy third trimester 
(26-34 weeks gestation) than either the late third trimester (37-41 weeks gestation) or in 
the non pregnant state. These data suggest that an increase in myometiial iNOS 
expression might contribute to the maintenance of uterine quiescence during pregnancy.
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The role of the constitutive isoforms of NOS (eNOS and bNOS) has not been 
determined. We hypothesise that the constitutive isoforms of NOS might also be 
involved in the regulation of uterine activity during pregnancy. The aim of the studies 
described here was to test this hypothesis, by localising and quantifying eNOS and 
bNOS isoforms in non-pregnant, preterm pregnant and term pregnant myometrium. 
We also assessed NOS expression in other tissues within the pregnant uterus (decidua, 
placenta and membranes).
Materials and methods 
Tissue collection
Three groups of women were recruited to the study;
(i) Thirteen non-pregnant, premenopausal women with regular menstrual cycles 
undergoing hysterectomy for benign disease.
(ii) Eleven pregnant women who were delivered preterm (25-34 weeks gestation) 
prior to the onset of labour.
(iii) Eleven pregnant women who were delivered at term (>37 weeks gestation) prior 
to the onset of labour.
Informed consent was obtained from each woman prior to recruitment and the study 
was approved by the local research ethics committee. Women were excluded from the 
study if they had a multiple pregnancy or evidence of active infection. The indications 
for delivery in the pregnant women delivered preterm were; pre-eclampsia (n=4), 
intrauterine growth restriction (n=2), HELLP syndrome (n=2), placenta praevia (n=2) 
and fetal distress of unknown aetiology (n=l).
In the non-pregnant uteri, myométrial biopsies were taken from the anterior wall of the 
lower uterine body immediately after hysterectomy. In the pregnant women myométrial 
biopsies were taken from the upper margin of the lower uterine segment incision during
82
Caesearean section. In all groups, myometrium was separated from surrounding 
structures by shaip dissection. Biopsies of placenta and fetal membranes with attached 
decidua capsulaiis were also obtained from pregnant women at the time of Caesarean 
section.
Once the biopsies were obtained they were divided in two; one half was snap frozen in 
liquid nitrogen and stored at -70“C for Western analysis. The other half was fixed in 
10% neutral buffered formalin (BDH, UK) and embedded in paraffin for 
immunohistochemistry.
Western blotting
Western blotting was performed on randomly selected biopsies, six from non-pregnant 
women, five from preterm pregnant women and six from pregnant women at term. The 
indications for delivery in the preterm group were placenta praevia (n=2), pre-eclampsia 
(n=l), HELLP syndrome (n=l) and intrauterine growth restriction (n=l). Myométrial 
extracts were prepared by homogenising frozen tissue in lOmM Tris HCl (pH 7.4), 1% 
SDS containing protease inhibitors (BDH, UK). Cell debris was removed by 
centrifuging at 12 000 x g for 5 min. Protein content of the samples was determined by 
using the BCA protein reagent (Pierce, Chester, UK) and bovine serum albumin 
reference standards. Electrophoresis was performed using 75 jig aliquots of protein 
extract in 1 x loading buffer (Bio-Rad, Hemel Hempstead, UK) in 7.5% SDS- 
polyacrylamide gel. Resolved proteins were transferred onto Hybond-ECL membrane 
using electrophoresis (Amersham, Little Chalfont, UK). The membranes were allowed 
to air dry and then placed in blocking buffer (10% non-fat milk, 10 mM Tris, lOOmM 
NaCl, 0.1% Tween-20, pH 7.5) for 1 h at room temperature.
The following primary antibodies were used: eNOS - monoclonal antibody raised 
against a 20.4 kDa protein fragment corresponding to amino acids 1030-1209 of human 
eNOS (Affiniti, Nottingham, UK) at a dilution of 1/1500; bNOS - a polyclonal
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antibody raised against amino acids 724-739 of rat brain NOS (Serotec, Oxford, UK) at 
a dilution of 1/7500. Each primary antibody was diluted in lOmM Tris, lOOmM NaCl,
0.1% Tween-20, pH7.5 (TBS-T). The blots were washed for 2 x 2 min, 1 x 15 min 
and 2 x 5  min in TBS-T then incubated with horseradish peroxidase-conjugated anti­
mouse IgG (1/10 000) for eNOS, or anti-rabbit IgG (1/30 000) for bNOS in TBS-T for 
Ih. The membranes were washed as before then incubated with Amersham ECU 
detection reagent for 1 min. Thereafter, the membranes were exposed to 
autoradiographic film (Hyperfilm ECU, Amersham) and the intensity of specific 
immunoreactive bands was quantified using densitometric scanning. In each blot, one 
lane was loaded with protein from a positive control (human endothelial cells for eNOS 
and lysates of rat brain for bNOS). Density of immunostaining was corrected for 
transfer differences by comparison with intensity of positive control bands. Data were 
analysed statistically using a Mann Whitney U test. P < 0.05 was assumed to indicate 
statistical significance.
Immunocytochemistry
Immunohistochemistry for eNOS and bNOS was performed on each of the biopsies as 
previously described in chapter 2. Paraffin embedded sections of 8 jxm diameter were 
pretreated with protease digestion (0.01% [w/v]) protease type XXIV in a 0.01% (w/v) 
solution of calcium chloride (Sigma, Poole, UK) for 10 min at 37“C prior to staining 
for eNOS or microwaving (4x5  min at full power in citrate buffer) prior to staining for 
bNOS. Antibodies were used as for Western blotting, at the following dilutions: eNOS 
1/100 and bNOS 1/1750 for placenta and fetal membranes and 1/2000 for myometrium.
Negative controls for eNOS included sections incubated without the primaiy antibody 
and sections incubated with a mouse monoclonal antibody against IgGl Aspergillus 
niger glucose oxidase (Dako Ltd., High Wycombe, UK), an enzyme which is not 
expressed in mammalian cell systems. A section of human umbilical cord was used as 
a positive control. Immunostaining for eNOS was confined to the umbilical cord
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endothelium. Negative controls for bNOS included slides incubated without the 
primary antibody and slides incubated with non-immune rabbit serum (S APU, Carluke, 
UK), in place of the primary antibody. In addition, liquid-phase absorption controls 
with the immunogen peptide were performed as described in chapter 2. A section of rat 
brain was used as a positive control.
The localisation of each of the two isoforms of NOS and intensity of staining were 
recorded by two investigators independently, who were blind to the source of the 
biopsy. Intensity and consistency of staining was scored on a scale of 0-6 as described 
in chapter 2. Contingency table analysis was performed to determine whether there was 
a difference in the intensity of staining between the three groups. A chi squared p value 
of <0.05 was assumed to indicate statistical sigificance.
Results
Western blotting
1. eNOS
The antibody against eNOS reacted with a band at 135kDa in the lysate of human aortic 
endothelial cells. Similar bands were detected in samples of human myometrium 
(figure 4.1). Densitometric analysis of bands indicated that eNOS protein levels were 
significantly higher in preterm myométrial biopsies compared with either term (p <
0.05) or non-pregnant myométrial biopsies (p < 0.01) (figure 4.2).
2. bNOS
The bNOS antibody reacted with a 160 kDa protein in the rat brain lysate corresponding 
to bNOS. Similar bands were detected in samples of human myometrium (figure 4.3). 
Densitometric analysis of bands indicated that bNOS protein levels were significantly 
higher preterm (p < 0.05) compared with non-pregnant, but that there were no 
significant differences in levels in term and preteim myometrium (figure 4.4).
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Figure 4.1 Western blots of non pregnant (A) (n-6), preterm (B) (n=5) and term (C) (n=6) 
myometrium using an antibody directed against eNOS. The putative eNOS band is seen at 
135k Da.
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Figure 4.2 Graph showing mean (SE) relative optical density of bands of eNOS protein in 
non pregnant (n=6), preterm pregnant (n=5) and term pregnant (n=6) myometrium after 
Western blotting. Optical density was greater in the pretenn pregnant than the non pregnant 
group (* p < 0.01); and in the preterm pregnant compared with the term pregnant group (** 
p < 0.05).
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Figure 4.3 Western blots of non pregnant (A) (n=6), preterm (B) (n=5) and term (C) (n=6) 
myometrium using an antibody directed against bNOS. The putative bNOS band is identified 
at 160 kDa.
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Figure 4.4 Graph showing mean (SE) relative optical density of bands of bNOS protein in 
non pregnant (n=6), preterm pregnant (n=5) and term pregnant (n=6) myometrium after 
Western blotting. Optical density was greater in the preterm pregnant than the non pregnant 
group (* p < 0.05).
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Immunocytochemistry
eNOS
Within sections of myometrium, the eNOS protein was localised to myometiial smooth 
muscle cells (myocytes) and endothelial cells lining blood vessels. Intensity of staining 
within myocytes was greater in preterm myometrium compared to both non-pregnant (p 
< 0.001) and term myometrium (p < 0.005) (figure 4.5). Similar differences were seen 
in endothelial cells within the myometrium (p < 0.05 and p < 0,01 respectively). 
Myocytes in sections obtained at term had a significantly greater staining intensity to 
those in non pregnant samples (p < 0.05). No such differences were observed in 
endothelial cells.
Within the placenta, eNOS staining was of greatest intensity in the syncytiotrophoblast, 
of moderate intensity in endothelial cells and was weakly present in villous stromal 
cells. eNOS immunostaining was significantly more intense within syncytiotrophoblast 
and endothelial cells in preterm sections than those at term (p < 0.02) (figure 4.6). 
There was no difference in the staining intensity within stromal cells in the two groups. 
In fetal membranes, eNOS immunoreactivity was localised to amniotic epithelial cells, 
extravillous trophoblast (the remains of the cytotrophoblastic cells of the trophoblastic 
shell) and decidual stromal cells. Staining was absent from chorionic connective tissue. 
There was no difference in the intensity of staining in any of the above cell types when 
comparing preterm to term sections. There was no staining in the negative control 
slides.
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Figure 4.5 Immunohistochemical localisation of endothelial NOS (eNOS) in (a) non- 
pregnant. (b) preterm pregnant and (c) term pregnant myometrium. eNOS localised to the 
myométrial smooth muscle cells and the endothelium of blood vessels (arrow). Expression of 
eNOS was greater in preterm myometrium compared to both non-pregnant and term pregnant 
myometrium. The negative controls (see Methods) exhibited no reactivity. M = myocytes, 
E = endothelium. Bar = 50pm.
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Figure 4.6 Expression of endothelial NOS (eNOS) in (a) preterm and (b) term placenta. 
Immunostaining for eNOS was more intense in syncytiotrophoblast and endothelial cells in 
preterm sections than those at term. The negative controls (see Methods) exhibited no 
reactivity. E = endothelium, ST = syncytiotrophoblast. Bar = 50pm.
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bNOS
In myometrium, bNOS protein was detected within myocytes and endothelial cells 
(figure 4.7). The intensity of staining within myocytes was gieater in preterm sections 
than either that of non-pregnant (p < 0.001) or term (p < 0.05) sections. In addition, 
bNOS staining in myocytes in sections obtained at term had a significantly greater 
staining intensity to those in non-pregnant samples (p < 0.05). Immunostaining 
intensity in myométrial vessel endothelial cells was greater in the preterm pregnant 
compaied with the non pregnant group ( p < 0.05). There were no other differences in 
the groups in endothelial cell staining.
bNOS protein was detected in syncytiotrophoblast cells, villous stromal cells and 
endothelial cells in placenta and within amniotic epithelial cells, chorion, trophoblast 
and decidual cells of the fetal membranes. There was no significant difference in the 
intensity of staining within any of these cell types when comparing the two groups of 
pregnant women. Staining was absent when the primary antibody was omitted. In 
liquid phase absorption controls, the staining disappeaied when 10 nmol/ml of the 
bNOS immunogen was added to the primary antibody prior to incubation with the 
sections, indicating specificity of the primary antibody for bNOS.
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Figure 4.7 Immunohistochemical localisation of brain NOS (bNOS) in (a) non-pregnant. (b) |
preterm pregnant and (c) term pregnant myometrium. bNOS localised to the myometiial j
smooth muscle cells and the endothelium of blood vessels. Expression of bNOS was greater |
in preterm myometrium compared to both non-pregnant and term pregnant myometrium. The i
negative controls (see Methods) exhibited no reactivity. M = myocytes. Bar = 50pm. j
I
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Discussion
These studies demonstrate that the myométrial expression of constitutive NOS, (eNOS 
and bNOS), determined using Western blotting and immunohistochemistry, has been 
up-regulated by the early third trimester of pregnancy compaied to the non-pregnant 
state. Furthermore, there is a decline in myométrial eNOS (assessed by 
immunohistochemistry and Western blotting), and in myométrial bNOS (assessed by 
immunohistochemistry) from the early third trimester to term. Taken together with the 
results of Bansal et al., (1997) these data indicate that the myometiial expression of 
each of the three isoforms of NOS is increased during human pregnancy and declines 
during the third trimester. Since NO is a myometiial relaxant, we propose that such an 
increase in NOS will contribute to the quiescence of the myometrium during pregnancy.
The timing of parturition is a crucial event in the survival of any species, and it seems 
unlikely therefore to be contiolled by a single biochemical pathway. In human 
pregnancy, numerous factors, including prostaglandin production, cytokines, gap- 
junction formation, corticotrophin releasing factor, G protein and thiol protein 
disulphide isomerase appear to play a role in the regulation of uterine contractility 
throughout gestation and at the onset of labour (Europe Finner et al., 1994; McLean et 
al., 1995; Hirst et al., 1995; Morrison et al., 1996; Schwartz, 1997). It seems cleai' 
that nitric oxide withdrawal does not play a part in the acute stimulus to labour at temi 
since NOS expression decreases prior to the onset of labour. Furthermore there is no 
change in NOS activity or expression comparing uterine tissues taken immediately 
before and after the onset of labour (Thomson et al,  1997a - chapter 2). However, it is 
recognised that myometrium from women in late gestation or in active labour, is less 
sensitive to tocolytic agents, and more sensitive to agents which stimulate uterine 
contractions than myometrium from women in mid-pregnancy (Soloff et al., 1979; 
Yallampalli and Garfield, 1994; ICim et al, 1995). A decline in myométrial NOS
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activity prior to the end of the third trimester might be one of the mechanisms by which 
the utems is sensitised to contractile agents, and thus prepared for the onset of labour.
We have shown that each of the isoforms of constitutive NOS is upregulated in the 
myometrium during pregnancy. Although NOS is increased during rat pregnancy, the 
isoforms responsible are not known. Data from gene knockout animals suggests that 
an absence of any single isoform of NOS has no effect on the normal gestational period 
(Huang e ta l ,  1993; Huang et al, 1995; Wei et al, 1995). Taken together, these data 
imply that each of the isoforms of NOS contributes to the maintanance of uterine 
quiescence during pregnancy, but that no single isoform is by itself crucial
Factors controlling the observed up-regulation in myometiial constitutive NOS 
expression during parturition remain obscure. In animals both estrogen and 
progesterone have been proposed as regulators of NOS in vivo. Estrogen upregulates 
guinea pig constitutive NOS expression (Weiner et al., 1994). In sheep uterine artery, 
estrogen enhanced endothelial NOS activity, and in rat hypothalmus, estrogen increased 
bNOS expression (VeiUe et ah, 1996; Cecatelh et a l,  1996). In studies of women 
treated with a GnRH analogue together with either estrogen replacement or placebo, 
fasting plasma nitrate concentrations were higher in the estrogen treatment group. This 
suggests that estrogen increased "total body" nitric oxide synthesis (Ramsay et a l ,  
1995). Since human pregnancy is associated with an increase in circulating estradiol 
concentration (Turnbull et a l ,  1974), it is tempting to speculate that estrogen is 
responsible for the observed increase in myométrial constitutive NOS expression. 
Further studies are required to determine whether this hypothesis is correct.
A potential concern with our study is that the "preterm" group were made up of women 
with abnormal pregnancies. The majority of biopsies from women in the preterm 
Caesaiean section group were collected from patients delivered either because of pre­
eclampsia or intrauterine growth restriction. It is possible that the observed differences
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between the groups reflect the indications for delivery rather than the differences in 
gestation. However, there is no evidence that eNOS expression in myocytes is altered 
by pre-eclampsia or intrauterine growth retardation. Indeed, in our study, when 
histological slides of preterm myometrium obtained from women with pre-eclampsia or 
intrauterine growth retardation were compared with preterm myometrium obtained from 
women delivered for other reasons, no differences were observed in eNOS or bNOS 
staining in myoctes. A fonnal statistical analysis was not performed because of the 
small size of the group. We believe therefore that the myométrial changes in eNOS and 
bNOS are dependent upon the stage of gestation rather than the indications for 
Caesarean section.
It is more likely that the observed differences in placental eNOS are due to the 
indications for delivery. We assessed the expression of eNOS and bNOS in placenta 
and fetal membranes, collected from women at term and preterm. Whilst the sites of 
localisation of cNOS were similar at each gestation, we found that the intensity of 
staining for eNOS (but not bNOS) was greater in preteim placental syncytiotrophoblast 
and preteim placental endothelium than in tissues obtained at term. We did not attempt 
to perform Western blotting on placenta to confirm this finding because of the multiple 
cell types present therein, each of which has variable expression of NOS (Thomson et 
al., 1997a - chapter 2). Again, the majority of histochemically examined biopsies from 
women in the preterm Caesarean section group were collected from patients delivered 
either because of pre-eclampsia or intrauterine growth restriction. Each of these 
conditions is associated with an increase in placental eNOS expression (Myatt et al.,
1997). It has been postulated that the greater intensity of eNOS staining in the placenta 
in the preterm group is a compensatory mechanism attempting to increase feto-placental 
blood flow in this condition. We propose that differences we observed placental eNOS 
expression when term and preterm tissues were compaied may reflect the indications 
for preterm Caesarean section in these patients, rather than a tme gestational effect.
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Endothelial NOS (but not bNOS) expression was also greater in myométrial vessels 
from preterm compared with term women. Previous studies have shown that the 
myométrial vessels in women with pre-eclampsia aie different from those in normal 
pregnant women (Brocklesby et al, 1998). The difference in eNOS expression 
between term and preterm myométrial vessels may be due to the high proportion of 
women with pre-eclampsia or intrauterine growth restriction in the preterm group. 
Further work is required to confirm this hypothesis.
We have demonstrated that the myométrial expression of each of the constitutive 
isoforms of NOS is increased during pregnancy, but declines during the third trimester. 
Bansal et a l,  (1997) showed that preterm labour was associated with lower 
concentrations of myométrial iNOS. These data suggest that the timing of parturiton 
might be manipulated by the use of agents which will increase or decrease myométrial 
NOS expression. We suggest that the use of therapeutic agents which either liberate 
nitric oxide or alter myométrial NOS activity, should be taigeted specifically to the 
myometrium. Later in this thesis (chapter 6), it is shown that nitric oxide donors induce 
ceiwical ripening in the first trimester of human pregnancy (Thomson et aL, 1997b). If 
such a mechanism also operates in late pregnancy, then the systemic administration of 
nitric oxide donors, whilst inducing myométrial relaxation, would stimulate cervical 
ripening and therefore potentially promote preterm delivery. If however, agents could 
be devised which would stimulate myométrial NOS expression specifically, these 
agents may be useful in the treatment of preterm labour, and reduce the substantial 
morbidity and mortality associated with this condition.
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Chapter 5 
Leukocytes infiltrate the myometrium during human 
parturition: further evidence that labour is an inflammatory 
process 
Introduction
The studies reported in chapters 2 and 4 of this thesis focused on the smooth muscle 
relaxant effects of nitric oxide and investigated their involvement in the maintenance of 
myométrial quiescence and in the initiation of parturition in human pregnancy. 
However, nitric oxide is also a potent inflammatory mediator and leukocytes are 
recognised to be a rich source of nitric oxide (Michel and Feron, 1997). iNOS was 
originally purified and cloned from a macrophage cell line and has since been identified 
in neutrophils and mast cells (McCall et al., 1989; Kolb et al., 1994; Huang et al., 
1995). Similarly, the constitutive isoforms of NOS (eNOS and bNOS) have been 
identified within leukocytes (Riesco et al, 1993).
Inflammatory cells play a crucial role in human parturition (Kelly, 1996). Cervical 
ripening, an early event in normal labour, has been compared to an inflammatory 
reaction and is characterised by an accumulation of leukocytes in the cervical stroma 
(Junqueira et al, 1980; Liggins, 1981). The inflammatory infiltrate within the ripened 
cervix consists predominantly of neutrophils and macrophages and accumulates in the 
stroma before the onset of labour at term (Bokstrom et al, 1997). These leukocytes 
contribute to cervical remodelling by releasing proteolytic enzymes such as collagenase 
and elastase (Rajabi et a l,  1988; Osmers et a l,  1992). Elsewhere in the pregnant 
uterus, inflammatory cells are known to infiltrate the placenta, maternal decidua and the 
fetal membranes during parturition, and may play a role in spontaneous rupture of the 
membranes (Halgunset et al,  1994; Rosenberg et al, 1996).
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There are no data on whether inflammatory cells infiltrate myometrium during labour. 
However, indirect evidence suggests that inflammatory cells may infiltrate the 
myometrium at the time of parturition. Rechberger and Woessner, (1993) demonstrated 
that collagenase activity is increased in lower segment myometrium during labour and 
proposed that neutrophils may be responsible for much of the increase. Furthermore, 
Osmers et al, (1995) demonstrated a significant increase in interleukin-8 concentration 
in lower segment myometrium during labour, and proposed that this increase could 
result in an influx of neutrophils. The presence of these leukocytes in myometrium has 
been examined prior to the onset of labour only. Butterworth et a l,  (1991) found no 
neutrophils in the myometrium of both normal and pre-eclamptic women before the 
onset of labour.
The attachment and extravasation of circulating leukocytes is controlled by expression 
of cell surface adhesion molecules on both the circulating cells and the vascular 
endothelium (Akyama et a l,  1989; Bevilacqua, 1993). An increased expression of 
adhesion molecules on the endothelium occurs in inflammatory conditions and supports 
the recruitment and aggregation of leukocytes (Bevilacqua, 1993) The major 
endothelial adhesion molecules involved in leukocyte attachment and transendothelial 
migration include B-selectin, intercellular adhesion molecule-1 and 2 (ICAM-1 and 2), 
platelet endothelial cell adhesion molecule (PECAM) and vascular cell adhesion 
molecule-1 (VCAM-1). The purpose of the present study was to investigate 
inflammatory cell subpopulations in human myometrium during pregnancy and labour. 
Specifically, we aimed to determine whether myometrium in each of the lower and 
upper uterine segments, like cervical stroma, maternal decidua and the fetal membranes, 
is infiltrated by leukocytes during parturition. Furthermore, the expression and 
distribution of the cell adhesion molecules, E-selectin, ICAM-1 and 2, PECAM and 
VCAM-1, were assessed in myometrium during labour to investigate possible 
mechanisms of leukocyte accumulation.
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Materials and Methods 
Subjects and collection of tissue
Pregnant women delivered by lower uterine segment Caesarean section and non­
pregnant women undergoing hysterectomy were recruited to the study. Informed 
consent was obtained from each woman prior to recruitment and the study was 
approved by the Local Research Ethics Committee.
Myométrial biopsies were collected from three groups of women:
( i ). 18 pregnant women who were delivered before the onset of labour at term, (>37
weeks gestation).
( ii) .  18 pregnant women who were delivered during active labour at term, (cervical 
dilatation greater than 4 cm and less than 9 cm). Women were excluded from 
the study if they had a multiple pregnancy, evidence of active infection, or 
following induction of labour.
( iii) .  13 non-pregnant, pre-menopausal women with regular menstrual cycles 
undergoing hysterectomy for benign disease.
In groups (i) and (ii), a myométrial biopsy was obtained from the upper margin of the 
lower uterine segment incision during the Caesarean section. Additionally, in 7 of the 
women in group (i), and 5 of the women in group (ii), a myométrial biopsy was 
obtained from the upper uterine segment by dissecting a strip of myometrium from the 
inner aspect of the posterior uterine wall and inserting a haemostatic suture when 
required. In group (iii), myométrial biopsies were taken from the anterior wall of the 
lower uterine body, immediately following hysterectomy. Each of the 12 upper 
segment and the 13 non-pregnant myométrial biopsies was fixed in 10% neutral 
buffered formalin (BDH, UK) and embedded in paraffin. The 36 lower segment
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myométrial biopsies were divided; one half was fixed in formalin and embedded in 
paraffin, and the other half was snap frozen in liquid nitrogen and stored at -70°C.
Identification of inflammatory cells
Inflammatory cells were detected using immunocytochemistry, with a panel of 
antibodies as shown in table 5.1. Serial sections were stained for naphthol AS-D 
chloroacetate esterase activity, an enzyme considered specific for cells of granulocytic 
lineage, (neutrophils, eosinophils and basophils).
Table 5.1 Primary antibodies used for leukocyte immunocytochemistry
Antigen Cell Type Clone Pretreatment Dilution Supplier
CD 15 neutrophils 2.35.14 microwave 1/60 SAPU, UK
neutrophil neutrophils NP 57 nil 1/150 Dako Ltd, UK
elastase
CD 68 macrophages PG-Ml trypsin 1/300 Dako Ltd, UK
mast cell mast cells AAl trypsin 1/300 Dako Ltd, UK
tryptase
CD 3 T lymphocytes polyclonal microwave 1/50 Dako Ltd, UK
CD 20 B lymphocytes L26 microwave 1/50 Dako Ltd, UK
Immunocytochemistry
1. Neutrophils, macrophages, T-lymphocytes and B-lymphocytes
Inflammatory cells were identified in each of the biopsies obtained before and after the
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onset of labour at term. Eight micrometer thick sections were cut from the paraffin 
embedded tissues and mounted on silane-coated slides, heated to 60°C for 35 mins, 
deparaffinised in xylene and rehydrated in a graded alcohol series. If required (table 
5.1), the sections were then pretreated to retrieve the antigen by microwaving at full 
power for 4 x 5  mins in citrate buffer (lOmM, pH 6.0), or by enzymatic digestion with 
a 0.1% (w/v) trypsin (Sigma, UK) solution in Tris buffer (pH 7.6) containing 0.1% 
(w/v) calcium chloride, for 10 mins at room temperature.
The sections were pre-incubated with 1.5% (w/v) horse serum in PBS (10 mM sodium 
phosphate, pH 7.5, 120 mM sodium chloride) for 30 mins at room temperature. They 
were then incubated for one hour with the primary antibody diluted in 1.5% horse 
serum. Next, sections were washed in PBS before incubation with biotinylated anti­
mouse immunoglobulin. This antibody, from a Vectastain Elite ABC kit (Vector, 
Peterborough, UK) was first diluted in 1.5% horse serum and 1.5% normal human 
serum. After washing as before, sections were placed in 3% hydrogen peroxide in 
methanol for 10 mins at room temperature. The sections were thoroughly washed 
again, then incubated for 30 mins with avidin DH / biotinylated horseradish peroxidase 
H reagent (Vectastain Elite ABC kit) in PBS before final washing. The antigen was 
localised using 1 mg/ml diaminobenzidine tetrahydrochloride (DAB), 0.02% Hp02 in 
50mM Tris.Cl, pH7.6, and appeared as a brown end-product.
Negative controls included sections incubated without the primary antibody and 
sections incubated with a mouse monoclonal antibody against IgGl AspergiUits nlger 
glucose oxidase (Dako Ltd., High Wycombe, UK), an enzyme which is not expressed 
in mammalian cell systems. Tonsillar tissue was used as positive controls for CD 3, 
CD 20 and CD 68.
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2. Mast cells
Mast cells were localised in non-pregnant and pregnant myométrial biopsies. The 
paraffin embedded sections were prepared as before and digested in a trypsin solution 
to reti'ieve the antigen (table 5.1). The sections were then pre-incubated with 20% 
normal goat serum (SAPU, Carluke, UK) in PBS (10 mM sodium phosphate, pH 7.5, :!
120 mM sodium chloride) for 30 mins at room temperature. They were then incubated 
for 90 mins with a monoclonal antibody raised against mast cell tryptase (Dako Ltd.,
High Wycombe, UK) diluted 1/300 in 2% normal goat serum. The primary antibody
■iwas omitted from the negative control slides. Next, sections were washed in PBS ;
before incubation with goat anti-mouse IgG alkaline phosphatase (Sigma, UK) diluted |
1/200 in 2% normal goat serum and 5% normal human serum. The sections were |
thoroughly washed again and immunoreactive tryptase was localised using Fast Red 
Substrate (Sigma, UK). Finally, the sections were counter-stained with Harris 
haematoxylin.
. :?
3, Cell adhesion molecules
Five micrometer thick sections were cut from the frozen tissue and mounted on silane 
coated slides. The sections were fixed in acetone for 10 mins, washed in TBS, and 
placed in 0.5% hydrogen peroxide in methanol for 30 mins at room temperature. The 
sections were then washed as before and pre-incubated with 20% (w/v) normal goat 
serum (SAPU, Carluke, UK) in TBS for 30 mins at room temperature. The sections 
were then incubated for 16 hours at 4“C with the primary antibody diluted in 1.5% 
horse serum. Table 5.2 shows the characteristics of the primary antibodies. The 
primary antibody was omitted from the negative control slides. Next, sections were 
washed in TBS before incubation for one hour with biotinylated goat anti-mouse 
immunoglobulin (Dako Ltd., UK), diluted in 2% normal goat semm and 1.5% normal J
human serum. The sections were thoroughly washed again, then incubated for 30 mins 
with streptavidin horseradish peroxidase (Dako Ltd., UK) in TBS before final |
washing. The antigen was localised as previously described using DAB. '
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Table 5.2 Primary antibodies used for cell adhesion molecule immunocytochemistry
Antigen Clone Dilution Supplier
ICAM-1 BBIG-Il 1/500 R&D Systems, Abingdon, UK
ICAM-2 CBR-IC2/2 1/200 Chemicon, Harrow, UK
PECAM 9G11 1/500 R&D Systems, Abingdon, UK
VCAM BBIG-Vl 1/500 R&D Systems, Abingdon, UK
E-selectin BBIG-E4 1/250 R&D Systems, Abingdon, UK
Identification of granulocytes
Granulocytic cells were identified by staining for naphthol AS-D chloroacetate esterase 
activity. This activity was determined using a commercial kit (Sigma Diagnostics, 
UK). Briefly, 1ml of sodium nitrite solution (0.1 mol/L) was added to 1ml of Fast Red 
Violet LB Base Solution (15 mg/ml fast red violet LB base in 0.4 mol/L hydrochloric 
acid with stabiliser) and allowed to stand for 2 mins. This solution was then added to 
40 ml prewaimed (37°C) deionised water, 5 ml of Trizmal 6.3 Buffer Concentrate 
(TRJZMA maleate, 1 mol/L with surfactant, pH 6.3) and 1 ml of Naphthol AS-D 
Chloroacetate Solution (naphthol AS-D chloroacetate 8 mg/ml and stabiliser). The 
slides were incubated in this solution for 15 mins at 37°C and then rinsed thoroughly in 
deionised water. Sites of activity showed violet granulation.
Quantification of inflammatory cells and statistical analysis
The inflammatory infiltrate was quantified (i) to determine whether infiammatoiy cells 
infiltrate the myometrium during labour at term, (ii) to compare the density of the
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infiammatoiy cell infiltrate in upper and lower uterine segment myometiium and (iii) to 
compai'e mast cell density in non-pregnant and pregnant myometrium. Inflammatory 
cells were identified by either brown staining, (neutrophils, macrophages, T cells and B 
cells) or red staining, (mast cells). In each section of myometrium, the number of 
positive cells was counted in a high powered field, (x400 magnification within parts of 
a lined grid covering an area of 0.02 mm^). Six different fields were counted by two 
observers who were blinded to the specimen details. Areas containing blood vessels 
were avoided so that leukocytes within vessels were not included. The average number 
(arithmetic mean) of positive cells recorded per field by each observer was calculated, 
and then a mean of these two values obtained. Statistical comparisons of the means 
were performed using 3 factor ANOVA with Scheffe's S as a post hoc test. Significant
expression of each of the cell adhesion molecules were recorded by the observers who 
were blinded to the specimen details. Differences in the expression of these molecules 
before and after labour were analysed using the chi-squared test.
Results
Staining for naphthol AS-D chloroacetate esterase activity, which identifies 
inflammatory cells of granulocytic lineage, revealed that myométrial biopsies removed 
from labouring women (group ii) showed a marked inflammatory infiltrate in the 
muscle connective tissue in 17 of the 18 specimens (figure 5.1). In contrast, the 
myometrium in the non-labouring women (group i, n=18) did not exhibit an 
inflammatory infiltrate. The infiltrate was most dense at both the luminal (decidual) 
edge of the myometrium and also in and around blood vessels. Further, the infiltrate 
was most striking in the myometrium obtained from the lower uterine segment, but was 
also present in the myométrial biopsies obtained from the uterine fundus during labour.
àdifferences between groups were explored using Mann Whitney U tests. The sites of |
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Figure 5.1 Identification of granulocytes in myometrium. The granulocytes are localised by 
staining for naphthol AS-D chloroacetate esterase activity and appear as violet granulation, (a) 
Granulocytes are sparse in myometrium collected from non-labouring women (arrow) and (b) 
are abundant in myometrium obtained during labour. Bar = 50 pm.
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Analysis of individual cell types using immunocytochemistry showed significantly 
more inflammatory cells in labouring myometrium compared to non-labouring biopsies, 
(Scheffe's test, p = 0.0001), and significantly more infiammatoiy cells were present in 
the lower uterine segment compaied to the upper uterine segment myometrium, 
(Scheffe's test, p < 0.02).
The leukocyte subpopulations were characterised as follows:
Neutrophils
Neutrophils were sparse in myometrium obtained before the onset of labour and 
abundant in biopsies obtained duiing labour, (figure 5.2). A significant increase in 
myométrial neutrophil density occurred following the onset of labour in both the lower, 
(table 5.3), and the upper uterine segments, (table 5.4). During labour, the neutrophil 
density was significantly greater in the lower than in the upper uterine segment, 
(p<0.02). Within the labouring biopsies, the elastase antigen was localised both within 
the neuti'ophil cytoplasm and extracellulaiiy in the vicinity of the leukocytes, suggesting 
that a proportion of these cells had degranulated.
Table 5.3 Number of infiammatoiy cells in lower segment myometrium before and 
during labour at tenu, median (interquartile range) per high powered field.
Cell type Before labour (n=18) During labour (n=18) Significance
Neutrophils 0.2 (0 - 0.3) 39.2 (17.7 - 92.3) p<0.0005
Macrophages 3.8 (2 - 5.5) 27.5 (11.8 - 34.5) p<0.0005
T-lymphocytes 0.7 (0.2 - 3.2) 10.6(1.8-24.3) p<0.005
B-lymphocytes 0 (0 - 0.3) 0.3 (0 - 0.7) ns
Mast cells 0.2 (0 - 0.7) 0 (0 - 0.2) ns
ns = not significant
106
a;
*> V 1
b .  
%
.  .  ■ ' 4 .
• * *• 4 / V  '  V *' 4? '  .
r  • ,
« * # •
# » « >
Figure 5.2 Identification of neutrophils in lower segment myometrium obtained (a) before 
and (b) during labour. The neutrophils are immunolocalised using an antibody directed 
against the enzyme human neutrophil elastase. Neutrophils are abundant in myometrium 
obtained during labour and sparse in myometrium obtained before the onset of labour (arrow). 
The negative controls, (see Materials and methods) exhibited no reactivity. Bar = 50 pm.
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Table 5.4 Number of inflammatory cells in upper segment myometrium before and 
during labour at term, median (interquartile range) per high powered field.
Cell type Before labour (n=7) During labour (n=5) Significance
Neutrophils 0.2 (0.2 - 0.3) 11.0 (2-22.5) p<0.008
Macrophages 3.8 (2.3 - 6.2) 18.5 (17.5 - 20.0) p<0.01
T-lymphocytes 3.3 (1.8 -4.8) 4.0 (1.2 - 4.5) ns
B-lymphocytes 0 (0 -0 .1 ) 0 (0 - 0.2) ns
Mast cells 0 (0 - 0.5) 0.2 (0 - 0.5) ns
ns = not significant
Macrophages
A population of immunoreactive macrophages was identified in myometiium before the 
onset of labour. The number of macrophages was significantly increased in both lower 
and upper uterine segment myometrium following the onset of labour, (figure 5.3, table 
5.3 and table 5.4). Following the onset of labour, there was no significant difference in 
macrophage density between the upper and lower uterine segments.
Lymphocytes
There was a significant increase in the density of T-lymphocytes in lower segment 
myometrium following the onset of labour, (table 5.3). B-lymphocytes were sparse in 
lower segment myometrium and no significant change in their density occuiTed with the 
onset of labour. There was no significant change in either T or B-lymphocyte density 
following the onset of labour in upper segment myométrial biopsies, (table 5.4).
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Figure 5.3 Identification of macrophages in lower segment myometrium obtained (a) before 
and (b) during labour. The macrophages are immunolocalised using an antibody directed 
against the antigen CD 68. Whilst a population of immunoreactive macrophages is identified 
before the onset of labour (arrows), significantly more macrophages are localised in 
myometrium following the onset of labour. The negative controls, (see Materials and 
methods) exhibited no reactivity. Bar = 50 pm.
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Mast cells
There was no significant difference in mast cell density in myometiium before and after 
the onset of labour at teim (table 5.3). Furthermore, mast cells were sparse in both 
upper and lower uterine myométrial biopsies (table 5.4), with no significant differences 
in mast cell density between the biopsy sites. We assessed mast cell density in non­
pregnant myometrium (group iii), and found that this was significantly greater than in 
biopsies obtained from each of the pregnant groups, term not in labour (group i), and 
term in labour (group ii), (figure 5.4). These results are summarised in table 5.5.
Table 5.5 Presence of mast cells in human myometrium. Values are shown as 
median (interquartile range).
Number of mast cells per high powered field.
Non-pregnant (n=13) 10.4 (6.3 - 14.8)*
Term, not in labour (n=17) 0.2 (0 - 0.7)
Term in labour (n=18) 0 (0 - 0.2)
labour).
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Figure 5.4 Identification of mast cells in (a) non-pregnant myometrium and (b) term, 
pregnant myometrium. The mast cells are immunolocalised (arrows) using an antibody 
directed against the enzyme, mast cell tryptase. There are significantly more mast cells in non­
pregnant myometrium than in pregnant myometrium. The negative controls, (see Materials 
and methods) exhibited no reactivity. Bar = 50 pm.
I l l
Cell adhesion molecules
The cell adhesion molecules were localised as brown staining in serial cryosections of 
lower segment myometrium before, (n = 6) and after (n = 6) the onset of labour (figure 
5.5). There were no changes in the immunolocalisation of ICAM-1, ICAM-2, PECAM 
or VCAM following the onset of labour. ICAM-1 immnostaining was of weak 
intensity and ICAM-2 staining was of moderate intensity in the myometiial vascular 
endothelium although not aU vessels expressed these molecules. PECAM expression 
was strong and consistent in all of the vascular endothelium. In contrast VCAM 
expression was weak and absent in some vessels. E-selectin was not expressed in any 
of the tissues obtained before the onset of labour. However, 3 of the 6 biopsies 
obtained during labour showed immunostaining for E-selectin on the vascular 
endothelium (chi-square p < 0.05).
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Figure 5.5 Localisation of cell adhesion molecules to the vascular endothelium in serial 
cryosections of myometrium. There are no changes in the expression of (a) lCAM-1, (b) 
lCAM-2, (c) PECAM or (d) VCAM in the vascular endothelium following the onset of labour. 
E-selectin is not expressed in any of the biopsies obtained before the onset of labour but is 
identified in 3 of the 6 biopsies obtained during labour, (e) Localisation of E-selectin in the 
capillary vascular endothelium in myometrium obtained during labour. The negative controls, 
(see Materials and methods) exhibited no reactivity. Bar = 50 pm.
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Discussion
We have demonstrated that inflammatory cells, predominantly neutrophils and 
macrophages, infiltrate human myometrium during spontaneous labour at term. The 
inflammatory infiltrate is predominant in the lower uterine segment, but is also present 
in the myometrium of the uterine body. We also observed a significant increase in T- 
lymphocyte density in lower segment myometrium following the onset of labour. 
There was no change in B-lymphocyte and mast cell densities in myometrium during 
parturition.
In this study, we have examined both lower and upper uterine segment myometrium for 
the presence of infiammatoiy cells. Whether lower segment tissue reflects the state of 
the cervix or that of the uterine fundus, has aroused considerable interest over the last 
half century, (Calder, 1994). Some workers contest that lower uterine segment 
biopsies provide an alternative source of . tissue that closely resembles cervix (Rajabi et 
al ,  1988). Because of the difficulties in obtaining cervical tissue for study, lower 
segment biopsies have been used in place of cervical tissue to investigate collagenase 
activity during cervical dilatation (Rechberger et al,  1993). Our results indicate that 
lower uterine segment myometrium behaves quite differently from reported behaviour 
in cervix, and has similarities to upper segment myometrium. Bokstrom et al., (1997), 
demonstrated an abundance of neutrophils and macrophages in cervical biopsies in late 
pregnancy before the onset of labour with no significant increase in their densities 
during labour. In contrast, we have shown that neutrophils and macrophages are 
sparse in lower and upper segment myometrium before, and abundant during labour. 
Although the upper and lower uterine segments behave in a similar manner, they are not 
identical. Duiing labour, the infiammatoiy infiltrate is more dense in lower segment 
myometrium than in upper segment myometrium. Consistent with this histological 
finding, functional studies have demonstrated that in normal labour the upper uterine
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segment contiacts more strongly than the lower, a situation which is reversed in 
abnormal labour, (Caldeyro-Barcia and Poseiro, 1960; Margono et al,  1993).
Activated neutrophils and macrophages are a rich source of inflammatory mediators. 
These include plasminogen activators, eicosanoids, collagenase and elastase, and 
proinflammatoiy cytokines, including interleukin-1 and tumour necrosis factor-a, 
(Nathan, 1987; Osmers et a l ,  1992; Casatella, 1995). Since these mediators have 
many diverse functions, the inflammatory infiltrate could have different roles in 
different regions of the uterus. Within the lower segment it could be involved in tissue 
remodelling and thereby facilitate ceivical dilatation and passage of the fetus. In the 
upper segment, leukocyte products, including eicosanoids, interleukins and tumour 
necrosis factor-a, may stimulate uterine contractions directly, or indirectly by 
facilitating the production of uterotonic prostaglandins, (Casey et al ,  1990). 
Furthermore, inflammatory mediators may also initiate tissue remodelling in the uterine 
body. Granstrom et a l ,  (1989) demonstrated that the connective tissue of the uterine 
isthmus, (lower segment) and the uterine body undergo a biochemical ripening process 
similar to that found in the cervix with an increase in collagenolytic activity following 
the onset of labour. A breakdown of the connective tissue within the myometrium may 
facilitate the co-ordination of uterine contractions by allowing the formation of gap 
junctions, (Garfield and Hayashi, 1981).
Studies investigating the role of nitric oxide in the initiation of parturition have 
measured NOS enzyme activity using the arginine to citmlline conversion assay, in 
tissues collected before and during labour (Gude et al,  1994; Di lulio et a l ,  1996; 
Ramsay et al,  1996). These studies have concluded that there is no significant fall in 
NOS activity during human parturition at term. Conversely, Ramsay et al ,  (1996), 
examining myometrium collected from the lower uterine segment during Caesarean 
section, found a slight increase in NOS activity, in tissue obtained during labour 
compaied with that collected before labour. One possible explanation for this finding,
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is that the increase in NOS enzyme activity originates from the inflammatory cell 
infiltrate since inflammatory cells are recognised to be a rich source of NOS (Riesco et 
al ,  1993; Kolb gr cA, 1994).
We found no change in myométrial mast cell density before and after the onset of labour 
at term. The function of mast cells in the pregnant uterus remains unclear, although it 
has been proposed that myométrial mast cells regulate uterine contiactility during 
labour, (Rudolph et al ,  1993). Mast cells produce mediators, (histamine and 
serotonin) and prostaglandins which can induce strong contractions in human 
myometrium in vitro, (Cruz et a l ,  1989; Rudolph et al,  1990; Rudolph et a l ,  1993). 
Further, these cells are considered to play a pivotal role in wound healing, fibrosis and 
tissue remodelling (Galli, 1993), and might be involved in promoting collagen 
degradation and uterine involution in the post-natal period (Jeffrey et al ,  1991). We 
were surprised at the low density of mast cells in the pregnant myométrial biopsies 
since this is in contrast with the known distribution of mast cells in non-pregnant 
myometrium, (Mori et al,  1997). Since mast cell mediators are capable of stimulating 
uterine contractions, the low density of mast cells in pregnant myometrium may be 
involved in the maintainence of myométrial quiescence as the uterus expands during 
pregnancy. Whilst we could demonstrate no change in myométrial mast cell density 
following the onset of labour, mast cell mediators might be capable of stimulating 
uterine contractions at term since the sensitivity of human myometrium to histamine and 
serotonin is upregulated at the end of pregnancy (Cruz et al,  1989). This means that 
myométrial smooth muscle cells might be stimulated by mast cell mediators even when 
the mast cell density is reduced. In non-pregnant myometrium, the high density of mast 
cells has been proposed to have a role in implantation, (Brandon and Evans, 1983; 
Hore and Mehrotra, 1988), or in remodelling uterine smooth muscle and extracellular 
matrix during the menstrual cycle (Mori et al,  1997).
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The mechanisms involved in the accumulation, extravasation and degranulation of 
inflammatory cells in uterine tissues during parturition are poorly understood. 
Chemotactic cytokines, including interleukin-1, tumour necrosis factor-a and 
interleukin-8 seem to play a role (Osmers et al,  1995, Barclay et al,  1993, Chwalisz et 
al,  1994), as well as other chemotactic agents, such as C5a (El Maradny et a l ,  1995). 
E-selectin is involved in the infiltration of leukocytes to the maternal decidua and fetal 
membranes during labour (Rosenberg etal ,  1996).
Since the leukocytes in our myométrial biopsies were concentrated in and around blood 
vessels, we hypothesised that an up-regulation in the expression of vascular cell 
adhesion molecules in lower segment myometrium was involved in the accumulation of 
leukocytes in this tissue. ICAM-1, ICAM-2, PECAM and VCAM are members of the 
immunoglobulin superfamily, (Frenette and Wagner, 1996). ICAM-1 is important in 
the adhesion of monocytes, lymphocytes and neutrophils to activated endothelium, 
whilst VCAM binds to leukocyte integrins on many cells including eosinophils and 
activated T lymphocytes. E-selectin, a member of the Selectin family of adhesion 
molecules, is expressed by cytokine activated endothelial cells and has a major role in 
attracting neutrophils, monocytes, eosinophils and some lymphocytes, (Lasky 1992; 
Bevilacqua and Nelson, 1993).
The expression of cell adhesion molecules in the endometrium of the non-pregnant 
uterus is well described (Tawia et a l ,  1993; Tabibzadeh et a l ,  1994). A recent report 
has identified ICAM-1, VCAM, PECAM and E-selectin in pregnant human 
myometrium (Winkler 1998). We have shown that ICAM-1, ICAM-2, PECAM
and VCAM are expressed on the vascular endothelium in myometrium obtained before 
the onset of labour at term and we propose that these molecules play a role in regulating 
leukocyte trafficking into this tissue. We found no change in the localisation and 
intensity of staining of ICAM-1, ICAM-2, PECAM and VCAM in the biopsies obtained 
during labour compared with those obtained before the onset of labour. In contrast, E-
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selectin expression was absent in all of the biopsies collected before labour but was 
expressed in 3 of the 6 biopsies obtained during labour suggesting a role for this 
molecule in the recruitment of leukocytes in at least some of the tissues. These results 
are in broad agreement with Winkler et al,  (1998) who also found that E-selectin 
expression was up-regulated during labour. Since both we and Winkler et al.., (1998) 
have employed immunocytochemistry, further studies aie required using quantitative 
techniques, to confirm these changes in cell adhesion molecule expression during 
parturition.
Factors responsible for the initiation of paiturition remain obscure. We have 
demonstrated that leukocytes infiltrate both upper and lower uterine segment 
myometrium during spontaneous labour at teim, and we propose that these cells play a 
fundamental role in normal parturition. A better understanding of the mechanisms 
involved in the initiation of labour both at term and preterm, would allow the 
development of novel strategies to prevent premature delivery. Our results suggest that | |
strategies aimed at preventing the influx of inflammatory cells into the myometiium 
could be cmcial in averting preterm delivery, and thus in reducing the excess perinatal 
mortality and morbidity associated with this condition.
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Chapter 6
The biophysical effects of nitric oxide donors on the first 
trimester uterine cervix - a randomised controlled trial. 
Introduction
The control of cervical ripening is cmcial to the process of human parturition. Animal 
studies have shown that nitric oxide is a fundamental mediator of the ripening process. 
The nitric oxide generating system is present in the rat cervix and is up-regulated during 
labour both at term and preterm (Ali et al,  1995; Buhimschi et a l , 1996). In pregnant 
guinea pigs, the local application of the nitric oxide donor, sodium nitropmsside 
effectively produces ceiwical ripening without inducing labour (Chwalisz et al ,  1997). 
Cervical ripening is an active process involving remodelling of the cervical tissue. This 
process can be induced pharmacologically in the first trimester to facilitate procedures 
such as surgical termination. Pre-operative ceivical ripening reduces the morbidity of 
surgical teraiination, including haemorrhage, incomplete uterine evacuation, uterine 
perforation and cervical trauma (MacKenzie and Fry, 1981; Schultz et al ,  1983; 
Grimes et al,  1984). The role of nitric oxide in human ceivical ripening has not been 
investigated.
We hypothesize that nitiic oxide donors can effect cervical ripening in humans. We 
therefore performed a randomised contiolled trial to determine whether the nitric oxide 
donors isosorbide-5-mononitrate (IMN), and glyceryl trinitrate (GTN), can induce 
effective cervical ripening prior to surgical teimination of pregnancy. In addition, we 
compared their ripening effects to those of the prostaglandin analogue gemeprost, the 
cervical priming agent currently used in our hospital.
it
ê
s:
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Methods
A prospective, randomised controlled trial was performed involving 48 primigravid 
women referred for surgical termination of pregnancy by vacuum aspiration in the first 
trimester. The study was approved by the Local Research Ethics Committee and 
informed consent was obtained from each woman on the morning prior to operation. 
Forty-nine consecutive primigravid women undergoing termination of pregnancy were 
approached and one woman declined to participate in the trial. The remaining 48 
women were randomly allocated to one of 4 treatment groups: IMN, GTN, gemeprost, 
or no treatment (vaginal examination only). Block randomisation was performed using 
sequentially numbered, sealed, opaque envelopes prepared using random number tables 
and 12 women were allocated to each treatment group. The envelopes were opened and 
the treatment allocated by one investigator after consent was obtained.
We calculated that by studying 48 women (12 in each group), the study had a power of 
90% to show a difference of 20 Newtons between the treatment and no treatment 
groups at the 5% significance level assuming a standard deviation of 15. We 
considered this difference in force to be clinically significant.
Treatments in the 4 groups were either the nitric oxide donor IMN 40 mg (Ismo®, 
Boehringer Mannheim, Livingston, UK), the nitric oxide donor GTN 500 qg (non­
proprietary supply), the prostaglandin analogue gemeprost 1 mg (16, 16-dimethyl-trans 
delta 2 PGE% methyl ester, Farillon, Essex, UK), or no treatment (vaginal examination
only). Each medication was administered by one investigator to the posterior vaginal 
fornix 3 hours prior to surgery. Mean arterial blood pressure recordings were obtained 
before the medication was given and again when the patient was in the operating 
theatre.
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General anaesthesia was induced using an intravenous injection of propofol, (Diprivan®, 
Zeneca Pharma, Cheshire, UK), and alfentanil, (Rapifen®, Janssen, Bucks., UK), and 
maintained with intermittent repeat doses as required. The cervical diameter before surgical 
dilatation was recorded and the force required to dilate the cervix to 8mm was measured with 
a force sensing apparatus coupled to cervical dilators, (figure 6.1) as previously described 
(Richardson et ciL, 1989; Anthony et uL, 1982). All the procedures and recordings were 
performed by an experienced gynaecologist who was blind to the treatment given. Each of the 
treatments dissolved completely in the vagina, further ensuring that the operator was blinded 
to the treatment group. Suction evacuation of the uterus was then undertaken.
Figure 6.1 The force sensing apparatus was used to provide an objective assessment of the 
cervical resistance (Newtons).
One factor ANOVA was used to compare the patient characteristics (age, gestation and interval 
between treatment and surgery), and blood preassure data. The measurements for cervical 
diameter (mm) and forces required during cervical dilatation (Newtons) were analysed using
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the KiTiskal-Wallis test and significance determined using Mann-Whitney U tests. A 
value of p<0.05 was taken as significant. Each intervention group was compared to the
Table 6.1 Clinical details of the study subjects.
Treatment None(11=12) Gemeprost(n=12) IMN(n=12) GTN(n=12)
Patient age in years 21.8 (4.1) 22.2 (5.1) 20.8 (3.4) 22.3 (5.7)
Length of gestation in 
weeks
8.6 (0.8) 9.2 (1.4) 9.4 (1.3) 9.2 (0.9)
Interval between pre-treatment & surgical 
dilatation in minutes 163 (29) 164 (19) 154 (39) 169 (24)
Data are given as mean (standard deviation). n= number of subjects in each group, 
IMN= isosorbide-5-mononitrate, GTN= glyceryl trinitrate.
no treatment group and each nitric oxide donor treatment group was compared to the 
gemeprost group.
Results
The mean age, gestation and the interval between pretreatment and surgical dilatation for 
each group are shown in table 6.1. Both IMN and gemeprost increased the ceiwical 
diameter before dilatation, and reduced the cumulative force required to dilate the cervix 
to 8 mm, compared to no treatment (table 6.2). Pretreatment with glyceiyl trinitrate 
reduced the cumulative force required to dilate the cervix but had no effect on cervical 
diameter, (table 6.2). The force required to dilate the cervix in the gemeprost group 
was less than the IMN and GTN groups. No significant difference in the change in 
mean arterial blood pressure was detected among the groups after treatment.
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Table 6.2 Results of the intra-operative recordings.
Treatment None(n=12) Gemeprost(n=12)
IMN
(n=12)
GTN
(n=12)
Cervical diameter before 
surgical dilatation in mm 4.5 (4-5) 6 (5-7) a 5 (5-6)b
5 (5-6)
Cumulative force to dilate 
cervix to 8mm in Newtons
68
(56-75) 18C(6-27)
39 d 
(25-44)
54 G 
(27-58)
Data are given as the median (interquartile range), n = number of subjects in each 
group, IMN= isosorbide-5-mononitrate and GTN= glyceryl trinitrate.
The Kruskal-Wallis test was performed for cervical diameter, p=0.001, and for 
cumulative force, p=0.0002.
Cervical diameter greater than no treatment, (a) p<0.002, (b) p<0.006.
Cumulative force less than no treatment, (c) p=0.0002, (d) p<0.006, (e) p<0.05.
Discussion
This randomised trial is the first to demonstrate that a nitric oxide donor induces human 
cervical ripening. The effect of nitric oxide donors on human cervical ripening has not 
previously been investigated objectively. However, the effects of sublingual GTN on 
the non-pregnant cervix have been subjectively assessed. Shaker et a l ,  (1993) found 
that GTN had no significant effects on the ease of embryo transfer after in-vitro 
fertilization. Yadava (1990) reported that the nitric oxide donor GTN facilitated the 
transcervical introduction of intra-uterine contraceptive devices. A recent uncontrolled, 
observational study concluded that GTN patches suppress uterine contractions in 
preterm labour (Lees et al ,  1994) The effect of these patches on the cervix was not 
determined.
Cerwical ripening is characterised by a decreased cervical collagen concentration, an 
increase in hydration and an alteration in the ground substance (Calder and Greer,
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1992). The mediators of this process are incompletely defined. Liggins (1981) 
compared the process of cervical ripening to an inflammatory reaction and suggested 
that immunological mediators play a ciircial role in the process. Nitric oxide is involved 
in the acute inflammatory response and amplifies the cytokine cascade stimulated during 
this response (lanar'o et al,  1994). Potential mechanisms of action of nitric oxide in the 
ripening process are via interactions either with prostaglandin biosynthesis or with lytic 
enzymes such as matrix metalloproteinases. Nitric oxide is known to stimulate 
cyclooxygenase to increase the production of pro-inflammatory prostaglandins 
(Salvemini et al ,  1993). Furthermore, in the kidney, nitric oxide has been shown to 
stimulate matrix metalloproteinases which break down collagen (Trachtman et al,  
1996).
Whilst prostaglandins have an established therapeutic role in cervical ripening pre- 
operatively in the first trimester, they are associated with a number of adverse 
symptoms including abdominal pain, nausea, vomiting and diarrhoea (Henshaw and 
Templeton, 1991). Abdominal pain occurs in up to 74% of women receiving 
gemeprost prior to termination of pregnancy in the first trimester (Helm et al ,  1988) 
and arises from myométrial activity induced by the prostaglandin analogue. The ideal 
ceiwical ripening agent would induce cemcal remodelling without stimulating uterine 
activity. Nitric oxide donors ai*e such agents. Nitric oxide donors relax the 
myometrium whilst inducing ceiwical ripening (Norman, 1996). These agents could 
therefore be used as an alternative to prostaglandins to induce cervical ripening prior to 
intrauterine procedures in the first trimester thereby avoiding the side effects associated 
with prostaglandins. A formal assessment of adverse symptoms with each pretreatment 
was not performed in this study since a larger sample size would be required to address 
this issue. If nitric oxide donors are to be used in clinical practice, an assessment of 
their side effect profile in comparison with the prostaglandins is required. This issue is 
addressed in chapter 7.
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This study has shown that nitric oxide donors can induce cervical ripening before first 
trimester surgical termination of pregnancy. We have shown that gemeprost (1 mg) is a 
more effective ripening agent than either IMN (40 mg) or GTN (500 qg). The efficacy 
of nitric oxide donors for this indication, may be improved by using a larger dose of the 
nitric oxide donor or by using an alternative preparation, such as a vaginal paste or gel, 
and further trials are required to test this hypothesis. If the efficacy of nitric oxide 
donors can be improved and an acceptable side effect profile demonstrated, this opens 
up the exciting possibility of a role for nitric oxide donors in cemcal ripening prior to 
induction of labour at term. Before such randomised controlled trials ai*e undertaken, 
the safety of nitric oxide donors in late pregnancy must be established.
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Chapter 7
A randomised trial of nitric oxide donors for cervical 
ripening: an evaluation of the side effect profile of a nitric 
oxide donor in comparison with a prostaglandin. 
Introduction
Cervical ripening before first trimester surgical termination of pregnancy facilitates the 
procedure whilst reducing the operative morbidity (MacKenzie and Fry, 1981; Schultz 
et ah, 1983; Grimes et a l ,  1984). Pharmacological agents commonly used for this 
indication include laminaria in North America and prostaglandin analogues in the United 
Kingdom. Whilst prostaglandins produce more effective cervical ripening and are more 
convenient to administer than laminaria, (Helm a/., 1988), they aie associated with a 
number of adverse effects including abdominal pain, nausea, vomiting and diarrhoea 
Henshaw and Templeton, 1991). The ideal cervical ripening agent should be effective, 
easy to administer and have a low incidence of side effects.
The inflammatory mediator nitric oxide is a fundamental mediator of cervical ripening in 
animals (Buhimschi et a l ,  1996; Ah et a l ,  1995). The nitric oxide donor, sodium 
nitroprusside produces effective ripening when applied locally to the guinea pig cervix 
(Chwalisz et al,  1997). In a randomised controlled trial, we have shown that the nitric 
oxide donors isosorbide-5-mononitrate and glyceryl trinitiate can induce effective 
cervical ripening compared to no treatment in primigravid women, when administered 
per vaginam in the first trimester of pregnancy (Thomson et al ,  1997b - chapter 6). 
Since these agents are smooth muscle relaxants (Norman, 1996), they should induce 
cervical ripening without causing abdominal pain due to myométrial contractions, the 
most commonly reported side effect in women receiving prostaglandins in eaiiy 
pregnancy (Helm et al,  1988; Henshaw and Templeton, 1991; El-Refaey et al,  1994).
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We hypothesise that nitiic oxide donors can effectively ripen the cervix before first 
trimester surgical termination of pregnancy with fewer side effects than prostaglandin 
analogues. We therefore performed a three-group randomised trial to compaie the 
clinical effects of the nitiic oxide donor, isosorbide mononitrate (IMN, 40 mg and 80 
mg) and the prostaglandin analogue, gemeprost before first trimester surgical 
termination of pregnancy. In addition, we performed a concurrent observational study 
to determine whether the cervical ripening effects of IMN are clinically sufficient.
Methods
(a) Randomised study to compare the clinical effects o f IMN (40 and 80  
mg) and gemeprost.
Between Januaiy and November 1997, 67 primigravid women scheduled for surgical 
termination of pregnancy by vacuum aspiration in the first trimester were recruited to 
this randomised trial; one woman was excluded before randomisation when she was 
found to be multigravid (figure 7.1). The study was approved by the local research 
ethics committee and informed consent was obtained from each woman on the morning 
before the operation. Exclusion criteria from the study included: any previous 
pregnancy, previous cervical surgery, signs of thieatened miscaniage or concurrent 
maternal disease. The gestation of each pregnancy was determined from both the 
menstrual histoiy and clinical evaluation of uterine size. The women were randomly 
allocated to one of three treatment groups: the nitric oxide donor IMN 40 mg (Elantan® 
40, Schwarz Pharma Ltd., Bucks., UK), IMN 80 mg, or the prostaglandin analogue 
gemeprost Img (16, 16-dimethyl-trans delta 2 PGEi methyl ester, Faiillon, Essex,
UK). Block randomisation was performed using sequentially numbered, sealed, 
opaque envelopes prepared using random number tables and 22 women were allocated 
to each treatment group. The envelopes were opened and the tieatment allocated by one 
investigator after consent was obtained. Each medication was administered by the same
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investigator to the posterior vaginal fornix three hours prior to surgery. Treatment 
allocation was concealed from patients until the end of the study period.
66 randomised
22 completed trial
22 assigned IMN 40 mg
22 completed trial22 completed trial
22 assigned 
IMN 80 mg
67 registered patients
22 assigned 
gemeprost 1 mg
1 not randomised 
because multigravid
Figure 7.1 Flow chart showing the women's progress through the randomised 
study. IMN = isosorbide-5-mononitrate.
The primary outcome measures were the development of adverse symptoms for each 
active treatment group. These were assessed using a symptom questionnaire 
administered before the medication was given and again immediately prior to surgery. 
The same investigator administered the symptom questionnaire on each occasion. At 
these time points, peripheral arterial pulse rates and mean arterial blood pressure 
recordings were obtained using an automated electronic device, (Dinamap Plus®, 
Critikon, Florida, USA). For all women, general anaesthesia was induced using an 
intravenous injection of propofol, (Diprivan®, Zeneca Pharma, Cheshire, UK), and 
alfentanil, (Rapifen®, Janssen, Bucks., UK), and maintained with intermittent repeat 
doses as required. Secondary outcome measures were the cervical diameter before 
surgical dilatation and the force required to dilate the cervix to 8mm measured with a 
force sensing apparatus coupled to cervical dilators (figure 6.1), as previously
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described in chapter 6. AU the procedures and recordings were performed by two 
experienced gynaecologists who were blind to the treatment given. Each of the 
treatments dissolved completely in the vagina, further ensuring that the operators were 
blinded to the treatment group. Suction evacuation of the uterus was then undertaken 
and the total volume lost, including both blood and products of conception, was 
measured from a calibrated suction jar.
Using Altman's nomogram, (Altman, 1982) we calculated that by studying 66 women 
(22 in each active treatment group), the study had a power of 85%, at the 5% 
significance level, to show a reduction of two thirds in the incidence of abdominal pain 
between the active treatment groups. This calculation is based upon a 70% incidence of 
abdominal pain occurring in the gemeprost group (Helm et al,  1988). We considered 
that such a reduction in the frequency of abdominal pain would be clinically significant.
f
■ Ï'I(b) Observational study to determine whether the cervical ripening  
effects o f IMN are clinically sufficient.
It is current practice to omit preoperative cervical ripening in parous women undergoing 
first trimester termination of pregnancy, (RCOG, 1997) since the force required to 
dilate the paious cervix is significantly less than that required for the primigravid cervix 
(Anthony et al ,  1982). We considered that for a cervical ripening agent to be 
considered clinically effective in primigravid women, it should reduce the cemcal 
resistance to a level similai* to that measured in parous women. We therefore recmited 
22 consecutive paious women scheduled for surgical termination in the first trimester as 
a reference group for cervical resistance. The study was approved by the local research 
ethics committee and infoimed consent was obtained from each woman on the morning 
before operation. Each woman had had at least one normal vaginal delivery and 
exclusion criteria included previous cervical surgery and signs of tlireatened 
miscarriage. In these women, the primary outcome measures were the cervical diameter
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before surgical dilatation, the cumulative force required to dilate the cervix and the 
intraoperative blood loss which were measured as described above.
Statistics
One factor ANOVA was used to compare the patient characteristics (age, gestation and 
interval between treatment and surgery), pulse and blood pressure data between the 
treatment groups. Data on intraoperative blood loss, cervical diameter and forces 
required during cervical dilatation were analysed using the Kruskal-Wallis test or the 
Mann-Whitney U test. The incidence of pre-operative side-effects was compared using 
Fisher's exact test.
Results
Table 7.1 Clinical details of the women participating in the study. Data are given as
(a) Randomised study to compare the clinical effects of IMN (40 and 80  
mg) and gemeprost.
The mean age, gestation and interval between pretreatment and surgical dilatation, in 
each active treatment group are shown in table 7.1.
mean (standard deviation). IMN = isosorbide-5-mononitrate.
%
Gemeprost IMN 40 mg IMN 80 mg Parous group
(n == 22) (n = 22) (n == 22) (n == 22) 1
Age (years) 21.8 (4.1) 22.6 (6.6) 21.9 (6.2) 27.0 (4.9)
Gestation (weeks) 9.0 (1.2) 9.3 (1.1) 9.3 (1.0) 9.1 (1.0)
Interval between pre-treatment 169 (24) 169 (37) 170 (42) - 5.
-
and surgical dilatation (min) ■
_ ____
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Sixty-eight per cent of women in the IMN 40 mg group and 59% in the IMN 80 mg 
group remained asymptomatic, significantly more than the 14% of women in the 
gemeprost group (p<0.001 and p<0.005 respectively). Significantly more women who 
received the prostaglandin analogue gemeprost experienced abdominal pain (p<0.0001) 
and vaginal bleeding (p<0.01) when compared with either of the IMN groups. More 
women in each of the IMN groups developed a headache (p<0.05) when compared 
with the gemeprost group. No significant difference was found between the IMN 40 
mg and 80 mg groups in reported symptoms (table 7.2). No significant difference in 
the change in mean arterial blood pressure or pulse rate was detected among the groups 
after treatment.
Table 7.2 Incidence of new symptoms occurring after administration of the cervical 
ripening agent. IMN = isosorbide-5-mononitrate.
Gemeprost 
(n = 22)
IMN 40 mg
(n = 22)
IMN 80 mg 
(n = 22)
n (%) n(%) n (%)
Asymptomatic 3(14) 15 (68) a 13 (59) a
Abdominal pain 16 (73) l(5 )b 0 (-)b
Diarrhoea 2(9) O(-) O(-)
Dizziness O(-) 3(14) 1(5)
Headache O(-) 5(23)C 7 (32) d
Nausea/vomiting 4(18) 1(5) 2(9)
Palpitation O(-) 1(5) 3(14)
Vaginal bleeding 7(32) 0 (-)e 0(-)G
a. significantly greater than gemeprost group, p<0.005
b. significantly less than gemeprost group, p<0.0001
c. significantly greater than gemeprost group, p<0.05
d . significantly greater than gemeprost group, p<0.01
e. significantly less than gemeprost group, p<0.01
*
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The efficacy of each agent to dilate the cervix and reduce the cervical resistance is 
shown in table 7.3. Pretreatment with gemeprost was more effective at ripening the 
cervix than either dose of IMN. Gemeprost (1 mg) increased the diameter of the 
cervical os before surgical dilatation compared with the 40 mg IMN group (p<0.05), 
and was associated with a lower cervical resistance than either dose of IMN (p<0.02). 
There were no significant differences in the cervical resistance between the two IMN 
groups. Prtreatment with gemeprost resulted in significantly less (p<0.0005) measured 
intraoperative blood loss compared with either dose of IMN (table 7.3).
Table 7.3 Results of the intra-operative recordings for both the randomised 
comparison and the observational study. Data are given as the median (interquartile 
range). IMN = isosorbide mononitrate.
Gemeprost 
(n = 22)
IM,N 40 mg 
(n = 22)
IMN 80 mg 
(n = 22)
Parous group 
(n = 22)
Cervical diameter before 6 5 5 5
surgical dilatation (mm) (5-7)* (4 -5 ) (5 -5 ) (3 -6 )
Cumulative force to dilate 21 40 36 34
cervix to 8 mm (N) (7-38)** (23 - 54) (27 - 60) (18-61)
Intra-operative blood 58 143 160 135
loss (ml) (45 - 90)*** (90 - 220) (105 - 295) (50-225)
(*) significantly greater than IMN 40 mg and parous groups, p<0.03
(**) significantly less than IMN 40 mg, IMN 80 mg and parous groups, p<0.02
(**=*=) significantly less than IMN 40 mg, IMN 80 mg and parous groups, p<0.0005
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effects o f IMN are clinically sufficient.
Pretreatment of primigravid women with IMN resulted in a cervical resistance similar to 
that in the pai'ous group (table 7.3). There was no significant difference in the
Discussion
(b) Observational study to determine whether the cervical ripening
measured intiaoperative blood loss between each IMN group and the parous group of 
women (table 7.3). Furthermore, no woman in any group required plasma volume 
expansion, blood transfusion or reoperation for vaginal bleeding and no woman in the 
study had a blood loss greater than 500 ml.
This randomised study demonstrates that the nitric oxide donor IMN has fewer side 
effects than the prostaglandin analogue gemeprost when used to ripen the cervix before 
first trimester surgical termination of pregnancy. The nitric oxide donor is associated
:
with a lower incidence of abdominal pain and pre-operative vaginal bleeding and a 
higher proportion of patients remaining asymptomatic. However, more women
V
receiving the nitric oxide donor experienced a headache. The prostaglandin analogue
■ '
produced a greater reduction in force and was associated with a lower intraoperative 
blood loss than either dose of the nitric oxide donor. The concurrent observational 
study demonstrated that pretreatment of primigravid women with IMN results in a 
cervical resistance similar to that of the parous group, whilst the intiaoperative blood 
loss was similar in the IMN and parous groups.
The side effect profile of prostaglandin analogues administered in the first trimester of 
pregnancy is well characterised and includes nausea, vomiting, diarrhoea, abdominal 
pain and vaginal bleeding (Helm et a l, 1988; Henshaw and Templeton, 1991; Lawrie et 
a l,  1996). These effects are thought to arise because the prostaglandins stimulate 
contractions of uterine and gastiointestinal smooth muscle. Whilst it has been 
suggested that misoprostol, an orally active synthetic analogue of prostaglandin E i, is
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associated with fewer side effects than gemeprost, (El-Refaey et a l,  1994) a more 
recent study has reported a high incidence of vaginal bleeding (50%), abdominal pain 
(47%) and vomiting (22%) in women given misoprostol in the first trimester of 
pregnancy (Ngai et a l,  1996). It has been suggested that the antiprogestogen 
mifepristone represents an acceptable and effective cei-vical ripening agent (WHO, 
1990; Henshaw and Templeton, 1991). Whilst this agent has the advantage of being 
effective after oral administration, it is also associated with side effects, (including 
nausea, vomiting, vaginal bleeding and abdominal pain) and requires a latent period of 
36-48 hours for the drug to act (Ngai et a l, 1996).
The side effect profile of nitric oxide donors administered vaginally has not been 
described. Their recognised side effects when administered by other routes (oral, 
sublingual, transdermal and intravenous), include headache, dizziness, postural 
hypotension and tachycardia (Robertson and Robertson, 1995). Two studies have 
assessed the effects of nitroglycerin, a nitric oxide donor, administered either as 
transdermal patches or as an intravenous infusion (20 pg/min), during pregnancy (Lees 
et a l,  1994; Ramsay et a l, 1994). No significant changes in maternal heart rate or 
systemic blood pressure were detected, although headache was reported to Lees et al.
(1994) by one third of the women. Other groups have found that larger doses of nitric 
oxide donors administered during pregnancy have significant adverse effects on the 
maternal cardiovascular system. Intravenous nitroglycerin, up to 5 pg/kg per minute 
(Cotton et a l,  1986; Grünewald et a l, 1995) and a single 5 mg dose of sublingual 
isosorbide dinitrate increased maternal pulse rate and decreased mean arterial blood 
pressure (Thaler et a l, 1996).
In our study, when IMN was administered locally to the cervix, 60 - 70 % of women 
remained asymptomatic and there were no significant changes in mean arterial blood 
pressure or pulse rate. This low incidence of side effects may reflect the first uterine 
pass effect whereby vaginal drug administration results in high uterine and low serum
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concentrations (Bulletti et a l, 1997). We have previously shown that vaginal 
administration of IMN allows effective ripening of the uterine cervix (Thomson et a l , 
1997b - chapter 6) and the study reported here indicates that such an approach is 
associated with minimal systemic side effects.
An accumulation of nitric oxide donor in the uterine smooth muscle would be expected 
to relax the myometrium (Norman, 1996) thereby minimizing preoperative abdominal 
pain and vaginal bleeding. One potential disadvantage of this effect is that myométrial 
relaxation, or lack of stimulation to contract during surgical evacuation might result in 
an increased intraoperative blood loss. Haemostasis in the placental bed depends not on 
the coagulation system, but rather myométrial contraction, the so-called living ligature, 
in the first instance. Prostaglandin analogues such as gemeprost, which cause 
myométrial contractions, are associated with a lower intraoperative blood loss when 
compared with placebo (Greer et a l, 1992). We found that the measured loss in each 
IMN group was not significantly greater than in a parous group of women receiving no 
treatment. Blood loss was lower in the gemeprost group, as would be expected with an 
agent provoking uterine contractility, than either the parous group or the groups 
receiving IMN. These data suggest that although the uterotonic effects of 
prostaglandins are associated with a reduction in measured blood loss, the myométrial 
relaxant effects of nitric oxide donors do not result in an increased blood loss compared 
with the parous control group. Moreover, no woman in any of the groups had a 
clinically significant intraoperative blood loss as assessed by the need for plasma 
volume expansion, blood transfusion or reoperation for blood loss.
The efficacy of the prostaglandin analogue gemeprost to ripen the cervix is significantly 
better than either dose of IMN. Our results suggest that the ability of IMN to ripen the 
cervix is not dose dependent, although we have assessed only two doses of the nitric 
oxide donor. Our previous work, which included a primigravid, control group given 
no treatment, has shown that IMN 40 mg and gemeprost 1 mg reduced the cemcal
135
resistance by 40 % and 70 % respectively (Thomson et a i, 1997b - chapter 6). Whilst 
it is widely accepted that a reduction in the force required to dilate the cervix reduces 
both operative morbidity and long term effects of cervical damage (MacKenzie and Fry, 
1981; Schultz et a l, 1983; Grimes et a l, 1984), there are no data on how much force is 
considered acceptable. In the absence of such data, we propose that the force required 
to dilate the parous cervix is a clinically acceptable target for ripening agents since it is 
current practice to omit preoperative cervical ripening in these women (RCOG, 1997). 
We have shown no significant differences in the cervical resistance of primigravid 
women pretreated with IMN and untreated parous women, suggesting that the cervical 
ripening effects of IMN are clinically sufficient. One caveat to this conclusion is that 
the comparison between the IMN groups and the parous group was made in an 
observational study since randomisation was not possible for the group of parous 
women. It seems essential that any cervical ripening agent used, should have minimal 
side effects. As we demonstr ate in this chapter, the nitric oxide donor IMN appears to 
be such an agent.
This study has demonstrated that the nitric oxide donor IMN has fewer side effects than 
gemeprost when used to ripen the cervix in the first trimester of pregnancy. Later in 
pregnancy, cervical ripening is commonly employed to facilitate induction of labour. 
Whilst prostaglandins are the agents most commonly used to prepare the cervix at term, 
they are associated with excessive myometiial activity and an abnormal fetal heart rate 
pattern in 7% of women (Wing et a l, 1995). Nitric oxide donors relax the 
myometrium, and these agents may have advantages over the prostaglandins to ripen 
the cervix later in pregnancy (Norman et a l, 1998). However, the safety of nitric oxide 
donors in the third trimester must be established before their efficacy for this indication 
is determined.
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Chapter 8.
Conclusions
The factors involved in the initiation of human parturition remain obscure. Studies in 
animals have shown that the L~arginine nitric oxide system is crucially involved in the 
maintenance of myometiial quiescence and the initiation of cervical ripening. The 
purpose of this work was to investigate the role of nitiic oxide in human parturition. 
Data in chapter 2 shows that each of the three isoforms of NOS is widely expressed in 
the pregnant human uterus. However, there is no change in either the expression or 
enzyme activity of NOS in tissues, (myometrium, placenta or fetal membranes) 
obtained before and during the onset of spontaneous labour at term. These findings 
indicate that a decline in the synthesis of nitric oxide is not the final activating factor in 
the onset of human labour.
The biological effects of nitric oxide are prolonged by superoxide dismutase (SOD), 
and attenuated by xanthine oxidase. Data in chapter 3, show that Cu/Zn, Mn SOD and 
xanthine oxidase are present within pregnant uterine tissues. However, there is no 
change in the expression of these enzymes as determined by immunocytochemistry, 
between tissues obtained before or during labour. Oui’ data also shows that these 
tissues possess SOD activity and that there is no difference in total SOD enzyme activity 
between tissues obtained before or after the onset of labour. It therefore seems unlikely 
that these enzymes are involved in the initiation of labour, although their wide 
distribution suggests that they may be important in the maintenance of pregnancy.
The data presented in chapter 4 show that the myométrial expression of the constitutive 
isoforms of NOS, eNOS and bNOS, is up-regulated during pregnancy and 
subsequently declines during the third trimester. This increase in the expression of the 
nitric oxide system may contribute to the relative quiescence of the myometrium during
137 I
. ï
pregnancy. Further, the decline in cNOS expression during the third trimester may be 
one of the factors governing the transition from Braxton Hicks contractions to the
:myométrial contractions of labour. i
iInflammatory mediators play a crucial role in human parturition and inflammatory cells 
are known to infiltrate the cervix, placenta, decidua and fetal membranes during labour.
Data in chapter 5 demonstrate that inflammatory cells, predominantly neutrophils and 
macrophages infiltrate the myometrium during spontaneous labour at term. Whilst the 
infiltrate is predominant in the lower uterine segment, it is also present in the 
myometrium of the uterine body. An increased expression of the cell adhesion 
molecule, E-selectin occurs on the vascular endothelium of myométrial biopsies 
obtained during labour, suggesting a role for this molecule in the accumulation of
leukocytes. These results suggest that inflammatory cell infiltration is part of the 
physiological mechanisms that occur in the myometrium during parturition. Further 
understanding of this process may suggest new strategies aimed at preventing preterm 
delivery.
The results of a randomised controlled trial, presented in chapter 6, show that the nitric 
oxide donors IMN (40 mg) and GTN (500 flg), administered per vaginam produce 
significant ripening of the first trimester human cervix. The results of a larger 
randomised controlled trial, presented in chapter 7, demonstrate that IMN has fewer 
side effects than the prostaglandin analogue gemeprost when administered per vaginam V-
in the first trimester of pregnancy. The nitric oxide donor is associated with a lower 
incidence of abdominal pain and pre-operative vaginal bleeding and a higher proportion 
of patients remaining asymptomatic. However, more women receiving the nitric oxide 1
donor experienced a headache. The data from a concunent observational study indicate 
that the cervical ripening effects of IMN (40 and 80 mg), though less than the effects of 
gemeprost (1 mg), are clinically sufficient.
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In summary, it seems clear that nitric oxide withdrawal does not play a part in the acute 
stimulus to labour at term. An up-regulation of the L-ai'ginine nitric oxide system in 
myometrium may be involved in the maintenance of uterine quiescence during 
pregnancy and further studies are required to determine whether a decline in uterine 
NOS expression occurs in preterm labour. The data presented here indicate that nitiic 
oxide donors are an acceptable and effective class of cervical ripening agent and could 
replace prostaglandins for pre-operative cervical ripening in the first trimester of 
pregnancy. Since nitric oxide donors have been investigated as tocolytic agents in the 
management of preterm labour, and these agents induce significant ripening of the 
human cervix, at least in the first trimester of pregnancy, it would seem sensible that 
clinical studies investigating the tocolytic effects of nitric oxide donors should include 
an assessment of the cervical state.
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